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CHAPTER 1 INTRODUCTION
1.1 Post translational modifications
Human genome (~20,000-25,000 genes) encodes more than 1 million proteins (1).
The higher complexity of the proteome has been found during last two decades due to
the development of technology in identifying post-translational modifications (PTMs)
(1,2). Proteins carry unique functions within the cellular context and their maturation,
localization, function and interactions with other proteins or nucleic acids regulated by
PTMs. A PTM typically occurs at the specific type of amino acid residues within the
protein. Many PTMs are reversible and depend on the accessibility of the enzymes that
catalyze the formation and removal of a specific PTM. Local environment around the
modification also important (3). For example, the sensitivity of protein cysteine oxidation
depends on the solvent exposure and the presence of positively charge amino acids in
the local environment. In nature, most of PTMs are reversible and involved in regulating
protein function. Due to the reversibility nature, PTMs are playing an important role in cell
signaling pathways by turning on or off the function of signaling molecules in response to
different physiological and pathological stimuli (4). For instance, kinases catalyze protein
phosphorylation and involved in regulating cellular signaling. Phosphatases are a class
of enzymes that can remove phosphate groups from serine, threonine or tyrosine, thereby
reversing the effect of phosphorylation (5). Similarly, protein oxidative modifications,
including sulfenylation, nitrosylation and glutathionylation are also important for regulation
of redox signaling pathways associated with important cellular processes such as cell
proliferation, apoptosis, differentiation and migration (6).
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1.2 Redox homeostasis and oxidative and nitrosative stress
Reactive oxygen species (ROS) and reactive nitrogen species (RNS) are
considered as by-products of cellular metabolism and catalytic reactions (7). In nature,
cells evolved in a way that regulate the production and the removal of ROS and RNS.
High levels of reactive species can damage cellular components and dysregulate
numerous cellular processes by inactivating or hyperactivating signaling proteins. Under
physiological conditions, ROS and RNS are mainly involved in regulation of redox
signaling pathways by reversible cysteine oxidation (6). Therefore, it is crucial to have a
balance between ROS production and detoxification for a maximum productivity of
cellular functions.

Figure 1.1 - Schematic representation of ROS and RNS production, and antioxidant
system, i.e. redox homeostasis vs. oxidative stress.

Redox homeostasis is the maintenance of the balance between the production and
removal of reactive species (Figure 1.1) (8). Dysregulation of cellular metabolism and
improper ROS disposal system can result in a high level of ROS leading to an oxidative
or nitrosative stress (Figure 1.1).
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Oxidative and nitrosative stress associated with many disease conditions,
including diabetes, cardiovascular diseases, neurodegenerative diseases and cancer
(9,10). The major molecular mechanism of ROS and RNS is oxidation of cysteine
residues in proteins. Protein cysteine thiols are sensitive towards the change in cellular
redox state (11). Under control generation of ROS, cysteine residues can undergo
reversible oxidation. On the other hand, an increased level of ROS can irreversibly oxidize
cysteine residues of a protein. Many oxidative modifications, if not all, affect protein
function. The reactive cysteine residues can present in the active site or in distal sites.
For example, protein phosphatase has a cysteine residue in the active site that is highly
susceptible to oxidation (5). Oxidation of surface cysteine residues act as a redox sensor
of the protein as well as a protective mechanism for spreading the effect of ROS into the
other critical cysteines. Oxidation of cysteine residues away from the active site may not
affect enzyme activity, but it alters protein-protein interactions and protein structure that
can affect protein function (12). Among various cysteine oxidations, S-glutathionylation is
reversible and referred to as formation of disulfide bond between protein cysteine and a
glutathione (GSH). S-Glutathionylation regulates protein function not only under
physiological concentrations of ROS/RNS, but also under oxidative or nitrosative stress
(13).
1.3 Sources of reactive oxygen and nitrogen species
The existence of reactive species such as ROS and RNS are first identified nearly
six decades ago in 1954 and predicted to be related with aging process (14-16). Mostly,
free radicals, such as super oxide anion (O2•−) and nitric oxide (NO•) can produce from
different intracellular processes. These free radicals are highly reactive and have a very
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short half-life (nanoseconds) (17). Further reactions can generate other free radicals or
non-radical ROS and RNS (Table 1.1).
Table 1.1- Different forms of ROS and RNS.

Due to the presence of one or more unpaired electrons in a single orbit, free
radicals are highly unstable and quickly react with other species or converted to less
reactive and stable forms. For example, after generation of O2•−, these radicals are
converted in to less reactive and stable non-radical hydrogen peroxide (H2O2) by
superoxide dismutase (18). Hydrogen peroxide is more cell permeable than O2•− and
diffuses to other cellular compartments to mediate redox signaling under physiological
concentrations. NO can be reacted with H2O2 to generate more reactive peroxynitrite
(ONOO-). Similarly, H2O2 can further generate more reactive radicals, such as hydroxyl
(.OH), hydroperoxyl radicals (.OOH) (Scheme 1.1).
Fe2+ + H2O2 ----> Fe3+ + .OH + OHFe3+ + H2O2 ----> Fe2+ + .OOH + H+
Scheme 1.1 – Fenton’s reaction. Metal ion can react with H2O2 and have electron transfer ability.
H2O2 can be either oxidized or reduced by metal ion and generate hydroxyl radicals as byproducts.

However, intracellular ROS and RNS generation can divide into two broad
categories, including extracellular sources and intracellular sources. Extracellular sources
include small molecule drugs, pollutants, tobacco and radiation. Radiolysis of water can
also lead to formation of .OH, .OOH and O2•− (19). Intracellular sources are more diverse
and readily involve in generation of ROS and RNS through their biochemical reactions.
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Intracellular sources can further divide into two main classes. ROS and RNS generated
as a byproduct of enzyme activity or as a result of cellular processes at different cellular
organelles.

Figure 1.2 – The major intracellular sources of ROS and RNS. NADPH oxidase, nitric oxide
synthase and mitochondrial ETC are responsible for producing intracellular ROS. This figure
adopted from Kira et al. 2014, with permission from copy rights clearance center (20).

1.3.1 Enzyme-mediated ROS/RNS production
1.3.1.1 NADPH oxidases
NADPH oxidase is a multi-subunit membrane complex that closely interacts with
growth factor receptors and mediate the superoxide production in response to different
exogenous stimuli, including tumor necrosis factor (TNF), angiotensin II, platelet-derived
growth factor (PDGF) and epidermal growth factor (EGF) (21-25). There are seven
members of NADPH family oxidases (also known as NOX enzymes) which include NOX1,
NOX2, NOX3, NOX4, NOX5, dual oxidase 1(DUOX1) and DUOX2 (26,27). NOX
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enzymes generate lower levels of ROS that are involved in regulating signal transduction,
innate immune system and modulation of the extracellular matrix (28). NOX enzymes also
play an important role in host defense against toxic microorganisms. For example,
Neutrophils that have a high level of NOX enzymes can generate a large amount of ROS
as a response to host pathogen interaction. During phagocytosis, neutrophils internalize
microorganisms into a phagosome and deactivate them with NOX derived ROS (29). In
addition to neutrophils, NOX enzymes are expressed in other immune or non-immune
cells , such as endothelial cells, monocytes and smooth muscle cells (27). NOX enzymes
composed with five subunits: three subunits, such as p47phox, p67phox, p40phox are
localized to the cytosol while other two subunits gp91phox (catalytic subunit gp91phox or
NOX2; homologous to NOX1 and NOX4) and p22phox are found in membrane.
2O2 + NAD(P)H →

2O2•− + NADP+ + H +

Scheme 1.2 – NOX enzyme catalyzed univalent reduction of molecular oxygen.

Upon activation, the cytosolic part, p47phox undergoes phosphorylation and forms
complex with other two subunits, p67phox and p40phox. The three-subunit complex
translocate to the membrane and produces superoxide by the single electron reduction
of molecular oxygen. In this reaction, NADPH acts as the electron donor, and one electron
is transferred through flavin and heme containing catalytic gp91phox subunit to molecular
oxygen (30).
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Figure 1.3 – NOX enzyme mediated ROS. Growth factor can activate NOX multicomplex
membrane protein through activation of PI3K and small GTPase RAC1. One electron reduction
of molecular oxygen by NOX enzyme will produce superoxide anion to extracellular space, which
will be further dismutated to H2O2 and transferred to the cell through aquaporin. Since H2O2 has
a higher half-life, H2O2 can mediate the effect to oxidizing effect to sensitive cysteines in a range
of signaling proteins. This figure adopted from Kira et al. 2014, with permission from copy rights
clearance center (20).

The inability to generate enough ROS due to mutations in NOX2 catalytic subunit
associates with frequent or periodic bacterial and fungal infections, a condition called
chronic granulomatous disease (31). Therefore, a controlled production of ROS by NOX
enzymes is an essential physiological process that helps to keep cells healthy. ROS
produced by NOX enzymes are also involved in redox signaling that can mediate cell
growth, proliferation, survival and motility (32,33).
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1.3.1.2 Xanthine Oxidases
Xanthine oxidase (XO) is involved in ROS generation under pathological
conditions. Xanthine dehydrogenase (XDH) and XO are two forms of xanthine
oxidoreductase. Fundamental chemical reaction of XO is the oxidation of hypoxanthine
into uric acid. In this reaction, XO catalyzes the reduction of molecular oxygen to produce
H2O2 and O2.- (34).
XO + H2 O + O2 →
XO + O2 →

Uric acid + H2O2
XO −1 + O2 •−

Scheme 1.3 – ROS production by xanthine oxidase.

XO uses NADPH as an electron donor to produce NO. and ONOO-. XO catalyzes
the conversion of cellular nitrate into nitrite and NO.. It is also known that XO is feedback
inhibited by NO. (35).
1.3.1.3 Nitric oxide synthase (NOS)
NOS enzymes are a class of NO. producing enzymes and there are three isoforms
of NOS. NOS constitutively expressed in neuronal cells and endothelial cells are known
as nNOS and eNOS, respectively (36,37). These enzymes are regulated by calcium ion
levels to produce NO.. Calcium ion binds to calmodulin which is a calcium binding protein,
and this complex can bind to NOS (38-40). In the presence of other essential cofactors
(FAD, FMN, NADPH, tetrahydrobiopterin and heme), NOS produces NO. by converting
L-arginine to l-citrulline (41-43). In addition to NO. production, NOS also generate
superoxide under uncoupling conditions.
NOS + L-Arginine + O2•− + NADPH → NO• + L-Citrulline + NADP+
Scheme 1.4 – ROS production by nitric oxide synthase.
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NO. can react with superoxide to give rise other reactive chemicals such as ONOO -. NO.
plays an important role in vasculature including cell adhesion, inhibition of platelet
aggregation, and leukocyte interaction with the endothelium (44).
The third isoform of NOS is inducible NOS (iNOS) that mediates inflammatory
processes in macrophages. Macrophages form phagosome by engulfing and killing
invading pathogens. iNOS plays an indispensable role in deactivating pathogens, and
iNOS is constantly active in producing NO, independent of calcium levels (45). NO. is
highly diffusible across cell membrane and have a long half-life (~15 seconds). Therefore,
NO. can act on neighboring cells and react with other free radicals, proteins, and DNA.
1.3.2 Cellular organelles
1.3.2.1 Mitochondria
Mitochondrion is the power house of the cell. It produces the energy that is required
for the normal cellular functions. Mitochondria produce adenosine triphosphate (ATP) by
oxidative phosphorylation. These organelles are composed with inner and outer double
membrane, inter membrane space and matrix (46). A typical mitochondrion is about 2.5
µm in diameter and the number of mitochondrion within a cell can vary depending on the
cell type (47).
Mitochondrial metabolism consists with citric acid cycle (TCA) and oxidative
phosphorylation (OXPHOS). These metabolic processes are mainly powered by the
availability of metabolic intermediates, including pyruvate, fatty acids and amino acids
(46). TCA cycle produces the electron carriers, such as NADH and FADH, which shuttled
to the electron transport chain (ETC) to synthesize ATP. During electron transfer, isolated
mitochondria produce O2•− by consuming 1-2% of the available oxygen for respiration
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(48). The complex I and complex III are the major sites for O2•− generation. Mitochondrial
superoxide dismutase (mSOD) convert the unstable O2•− to stable and less reactive H2O2.
In addition to ETC, several other mitochondrial enzymes can also generate ROS. For
example, cytochrome b5 reductase and monoamine oxidases (MAO-A) are both found in
outer mitochondrial membrane and generate O2•− and H2O2 respectively (49,50).
Cytochrome b5 reductase uses NADPH as the substrate while MAO-A catalyzes the
oxidation of biogenic amines to generate ROS (49,51). There are several other
mitochondrial enzymes found in inner mitochondrial membrane and known to generate
ROS, including dihydroorotate dehydrogenase, dehydrogenase of α-glycerophosphate
and succinate dehydrogenase (52-54). Aconitase found in mitochondrial matrix and
produces hydroxyl radicals through Fenton’s reaction (55,56). α-Ketoglutarate
dehydrogenase catalyzes the oxidation of α-ketoglutarate to succinyl-CoA. Inhibition of
α-Ketoglutarate dehydrogenase and low levels of NAD+ are known to produce ROS (5759).
ROS generation by complex I
Complex I, also known as NADH-ubiquinone oxidoreductase, is a transmembrane
multi-protein complex and is located in the inner membrane of mitochondria (60).
Complex I is the entry site for electron carriers, such as TCA cycle derived NADH.
Complex I hold FMN, seven ion-sulfur (FeS) centers, and CoQ (61,62). Two electrons
from NADH transfer to CoQ through the shielded FeS centers. Therefore, it is less likely
to transfer electron from FeS clusters to molecular oxygen. Therefore, ROS will be
minimally produced during this process. Rotenone is a pharmacological inhibitor of
complex I and is known to generate ROS (63). Rotenone binds to the CoQ binding site,

11
and blocks electron transfer from FeS to CoQ, thereby generating ROS (64,65).
Superoxide production by complex I depends on the redox state of FMN and NADH/NAD+
ratio. In contrast, when mitochondria are respiring under normal conditions, superoxide
generation at complex I is minimal (66). An additional mechanism of ROS production at
complex I is the reverse electron transfer (RET) (48,66-68). When ATP production is low
and CoQH2/CoQ ratio is high, electrons are moving backward from CoQH2 towards
Complex I. ROS production by RET was inhibited when complex I is treated with
rotenone, indicating a back flow of electrons to complex I is through CoQ-binding site.
Therefore, electrons can further push back to the FMN site and oxidize NAD+ to form the
reduced NADH and superoxide (69).

Figure 1.4 – ROS production at mitochondrial complex I. Under increased NADH levels, FMN
can be in fully reduced form and generate superoxide by a reaction with molecular oxygen at a
FMN site. Revers electron transfer (RET) can generate ROS at CoQ-binding site of complex I.
This figure adopted from Kira et al. 2014, with permission from copy rights clearance center (20).

ROS generation in complex III
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Mitochondrial complex III, Ubiquinone: cytochrome c reductase, shuttles electrons
from CoQH2 to cytochrome c. Complex III holds 11 polypeptides, three heme groups and
an FeS center (70). During electron transfer, complex III interact with CoQ at Qi and Q o
sites. Isolated mitochondria treated with CoQH2 produced a large amount of superoxide
(54,71-73). Antimycin A (AMA), myxothiazol and stigmatellin are known complex III
inhibitors. AMA binds to Qi site and blocks electron transfer from Q0 site to Q1 site (Figure
1.5). Therefore, ROS are produced as a result of leakage of electron to molecular oxygen
by ubisemiquinone at Qo site (Figure 1.5). In contrast, Myxothiazol and stigmatellin
interact with Qo site by blocking electron transfer from CoQH2 to Qo site and Q0 to FeS
center respectively. Myxothiazol and stigmatellin do not produce superoxide, indicating
that blocking Qi site is the major reason for ROS production within the complex III (74,75).
Under normal conditions, in the absence of AMA, complex III does not produce a
significant amount of superoxide compared to RET in complex I.
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Figure 1.5 – Mitochondrial complex III electron movement and Q-cycle. Antimycin A inhibits
electron flow from Qo to Qi site and increases ROS production at a Qo site.

This

figure

modified from Zorov et al. 2014, with permission from copy rights clearance center (76).

1.3.2.2 Peroxisome
Peroxisome is a small organelle found in the cytoplasm of every eukaryotic cells
(77). Peroxisome is also known as microbodies, and it has a catabolic activity towards
long chain fatty acids, branched chain fatty acids, D-amino acids, and detoxification of
ROS (78). Peroxisome-associated catabolic enzymes produce ROS and RNS. For
example, peroxisomal oxidases catalyze the oxidative catabolism of fatty acids, purines
and D-amino acids and transfer electrons directly to molecular oxygen. Acyl-CoA oxidase,
xanthine oxidase, urate oxidase, D-amino acid oxidase and several other oxidases are
readily available in peroxisome for catabolic processes and involved in generating ROS,
such as H2O2 and O2•− (79-81). In addition to ROS, peroxisome also produces NO. by
iNOS (82). Although peroxisome consists with ROS detoxifying enzymes, such as
catalase, H2O2 and NO. can still penetrate the cytoplasm and participate either in redox
signaling or oxidative damage.
1.3.2.3 Endoplasmic reticulum (ER)
Endoplasmic reticulum (ER) is an organelle found in most cell types, while absent
in red blood cells (83). ER associates with protein synthesis, and lipid metabolism. The
accumulation of unfolded or misfolded proteins in the ER can lead to ER stress. As a
response to the ER stress, unfolded protein response pathway will be activated (UPR)
(84,85). During UPR, protein disulfide isomerase (PDI) is catalyzing the formation of
disulfide bond between cysteine residues of target proteins. Endoplasmic reticulum
oxidoreductin 1 (ERO1) can reduce the oxidized PDI through electron transfer from PDI
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to molecular oxygen in FAD-dependent manner (86,87). During this process, there is a
higher chance to generate O2•− and H2O2. In ER associated oxidative protein folding,
many disulfide exchange reactions occur. Therefore, as a side reaction of disulfide
formation, electrons can leak and react with molecular oxygen to produce ROS. Nearly
25% of ROS produced in the ER are estimated to be generated as a byproduct of
oxidative disulfide bond formation (88). In addition, the constitutively active NOX4 is
known to generate ROS under ER stress. Interestingly, during phagocytosis, PDI directly
interacts with NOX4 and produces superoxide (89).
1.4 ROS detoxifying system
Control generation of free radical species and other reactive species are involved
in regulation of cellular processes. However, over the time, continues production of these
species can accumulate inside the cell, which would be deleterious to the cell. Therefore,
cells have evolved with ROS detoxifying system, also called an antioxidant system.
Antioxidant system broadly divided into two major categories, including redox enzymes
and small-molecule antioxidants. Superoxide dismutase, catalase, glutathione reductase,
glutathione peroxidase, and peroxiredoxins are examples of redox enzyme that play a
vital role in maintaining redox homeostasis by neutralizing the harmful effect of ROS.
Small molecule antioxidants include glutathione, vitamin A, C, and E, β-carotene, zinc,
selenium, NADPH and pyruvate that are found in green vegetables (90).
1.4.1 Superoxide dismutase (SOD)
During ETC, highly reactive and unstable O2•− produced as a by-product of
respiration. Manganese-containing Mitochondrial superoxide dismutase (MnSOD) or
SOD2 are solely found in mitochondrial matrix, and neutralizes O2•− to produce less
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reactive H2O2 (91). The dismutase activity depends on the level of MnSOD expression,
and does not require other cofactors. However, overexpression of MnSOD closely
associates with deficiencies in development and fertility in mice (92), suggesting that a
controlled level of MnSOD or ROS is necessary for cellular function. MnSOD can be found
in range of tissues including heart, liver, muscle, brain and spleen, showing the
importance of MnSOD (93).
1.4.2 Catalase
Catalase found in most organisms, including plants, fungi, aerobic and anaerobic
microorganisms. Catalase is a homo-tetramer and each subunit holds one porphyrin
heme group that reacts with H2O2 (94). Catalase catalyzes the conversion of H2O2 to
molecular oxygen and water with a high turnover number (millions of H2O2 molecules per
second). Since, mitochondria and peroxisomes are generating a large amount of O2•−,
catalase is mostly found in mitochondrial matrix and peroxisomes (95). The lack of
catalase activity increases the risk of developing obesity, fatty liver and type 2 diabetes
(96).
1.4.3 Glutathione reductase
Glutathione reductase (GR) is an essential antioxidant enzyme for maintaining the
balance between oxidized glutathione (GSSG) and reduced glutathione (GSH). Typically,
the ratio of a reduced form over an oxidized form of glutathione represents the redox state
of the cell. In normal conditions, the ratio of GSH/GSSG is high (97). GSH is an essential
antioxidant that involves in detoxifying intracellular ROS (98). Therefore, reduction of
GSSG back to GSH is important, and this process catalyzed by GR. GR uses NADPH as
the reducing source, and a FAD prosthetic group used as an electron carrier during the

16
catalysis (99). Two catalytic cysteine residues (Cys58 and Cys63) are in proximity with
NADH and FAD. In general, catalytic mechanism of GR divided into two steps. In the first
step, NADPH will reduce oxidized GR. In the second step, GSSG is reduced by two
catalytic cysteine residues in GR, releasing two GSH molecules. (100). Since many of
antioxidant activities of GSH take place in mitochondria, GR mostly found in mitochondrial
matrix (101,102). In addition to the detoxification of ROS, GR activity is also important in
glutathione homeostasis because GSSG cannot cross the membrane (103).
1.4.4 Glutathione peroxidase
Glutathione peroxidases (GPx) are a family of selenium-containing enzymes that
scavenge H2O2 and use two GSH molecules to restore its catalytic function (104). There
are at least eight different isoforms of GPx (GPx1-8), which are widely expressed in
different tissues and found in different subcellular locations, including mitochondria (105).
Mitochondrial Gpx1 provides the protection against oxidative stress by detoxifying H2O2
produced by SOD. Active site selenocysteine in Gpx1 detoxify H2O2 to water. During the
catalysis selenocysteine oxidizes to selenol. Oxidized Selenocysteine will be then
reduced back with the reaction of two consecutive oxidation and reduction steps by GSH
(104). GPx1-knockout mice did not show any apparent complications, compromised
growth and fertility, and a severe damage under oxidative stress. However, lower levels
of GPx were associated with type 2 diabetes, multiple sclerosis and coronary heart
diseases, suggesting a role of GPx in maintaining redox homeostasis (106-109).
1.4.5 Peroxiredoxin
Peroxiredoxins (Prx) can efficiently detoxify H2O2 and lipid peroxides with the
activity of other redox enzymes, such as thioredoxin and thioredoxin reductase (110). In
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addition to scavenging mitochondrial hydroperoxides, Prx are also involved in redox
signaling (111). Peroxiredoxins categorized into six isoforms, including Prx1-Prx6. Prx3
and Prx5 are ubiquitously expressed in different tissues including mitochondria (112).
Therefore, Prx3 and Prx5 considered as mitochondrial peroxides, and their
overexpression protect against H2O2-induced oxidative damage in different tissues. All
peroxiredoxins are sharing the same catalytic mechanism, and broadly divided into two
categories depending on the number of cysteine residues in the active site. After one
catalytic round, Prx active site cysteines undergo catalytically inactive oxidation state. In
order to restore enzymatic activity, the oxidized form of peroxiredoxins are reduced by
thioredoxin, ascorbate or GSH. The oxidized thioredoxin formed during the reaction, then
reduced by thioredoxin reductase using NADPH as the reducing source.
1.4.6 Glutathione (GSH)
Glutathione is a tripeptide composed of glutamate, cysteine and glycine. GSH is
the most abundant thiol-containing small molecule that acts as an antioxidant in
mammalian and plant cells. GSH is involved in many cellular events, including ROS
scavenging (113). GSH concentration largely varies among subcellular locations where
GSH concentration is in the range of 2-10 mM (114). Since mitochondria handle more
than 90% of total ROS production in the cell, mitochondria have a higher concentration
of GSH than other organelles. GSH is biosynthesized intracellularly while it is degraded
outside of the cell (114). Two consecutive enzyme catalyzed reactions biosynthesize
GSH in cells. Firstly, g-glutamyl-cysteine ligase (GCL) catalyzes the formation of γglutamyl-cysteine peptide bond between cysteine and glutamate. Typically, cysteine is a
limiting amino acid, and GSH inhabits GCL. Therefore, GCL catalyzed first step is
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considered as the rate limiting step of GSH biosynthesis. Secondly, glutathione
synthetase (GS) catalyzes the coupling of γ-glutamyl-cysteine with glycine to form
glutathione (γ-glutamyl-cysteinyl-glycine or GSH). (this topic will discuss in chapter 2,
section 2.1). GSH is stable and present in high concentrations, because, it is evolved in
a way that can resist to intracellular peptidases and γ-glutamyl cyclotransferase due to
the γ-glutamyl-cysteine linkage and the presence of glycine residue respectively (115).

Figure 1.6 – Chemical structures of the reduce gluathione (GSH) and the oxidized
glutathione (GSSG).

GSH and GSSG are involved in maintaining the redox state of the cell with the
activity of other antioxidant agents and reducing sources, such as NADPH and FADH2
(116). An Intracellular redox potential of GSH/GSSG couple is estimated to be in the
range of -250 mV to -150 mV (116). GSH can either directly react with free radicals or
take part as a cofactor in other redox enzymes. GSH can directly react and detoxify
hydroxyl radicals or peroxynitrite (116,117). Direct reaction of GSH with free radicals can
generate thiyl radicals and finally generating GSSG (118). Gpx uses glutathione to
detoxify ROS, such as H2O2, organic peroxides and lipid peroxides. In this reaction, GSH
is oxidized to GSSG. Increased GSSG level is an indicative of oxidative stress. GSSG in
the ER serves as the main oxidizing source that induce formation of disulfide bond in
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nascent polypeptides, which is a critical step in protein maturation (119). In addition, GSH
can directly react with RNS, such as NO.. In this reaction, NO. first reacts to give
nitrosonium ion (NO+) by a copper-catalyzed reaction, which subsequently react with
GSH to form GSNO, S-nitrosoglutathione (120). Formation of GSNO is involved in
transportation of less stable NO., and GSNO reacts with the redox-sensitive cysteine
residues of proteins, which is known as protein nitrosylation.
1.4.7 Pyruvate
Pyruvate is a 3-C metabolic intermediate and the final product of glycolysis. DGlucose is the major precursor for pyruvate synthesis. Glucose is breaking down to
pyruvate by 9 sequential enzyme catalyzed reactions. Hexokinase catalyzes the first
reaction of glycolysis by converting glucose to glucose-6-phosphate. As a result of several
other enzymatic reactions, fructose1,6-bisphosphate will be produced as an intermediary
metabolite. Fructose1,6-bisphosphate then break down into two 3-C units by fructose
bisphosphate aldolase. These two 3-C units are further metabolized in to
phosphoenolpyruvate. Finally, pyruvate kinase catalyzes the synthesis of pyruvate from
phosphoenolpyruvate. Overall, in glycolysis, one glucose molecule generates two
pyruvate molecules, two NADH, two ATP and two water molecules (121). In addition to
the metabolic role, pyruvate non-enzymatically detoxifies O2•− and H2O2 to acetate and
CO2 (122). Physiological antioxidant properties of pyruvate are dependent on the
metabolic state of the cell. For example, when non-respiring diplomonads were
supplemented with physiological concentrations of pyruvate, the production of H2O2 was
diminished compared to the respiring saccharomyces cerevisiae (122). Therefore, the
availability of glucose is an important determinant of antioxidant capacity of the cell.
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1.4.8 Nicotinamide adenine dinucleotide phosphate (NADPH)
Well known antioxidant function of NADPH is to provide the reducing power to
other redox enzymes to maintain redox homeostasis. For example, the ratio of
GSH/GSSG is decreasing under increased production of ROS, due to the accumulation
of GSSG inside the cell. GR can reduce GSSG to regenerate GSH by using NADPH.
Also, when catalase binds to NADPH, it dramatically increases the life time of catalase,
thereby indirectly involves in detoxification of H2O2 (123).

In addition to its indirect

antioxidant function, NADPH also known to act as a direct ROS scavenger and found in
high concentrations (~5 mM) in mitochondria (124). Mitochondrial NADPH can be
generated via isocitrate dehydrogenase and malic enzyme in a NADP+ dependent
manner (125). Also, NADPH is produced by hydride transfer from NADH, during proton
transfer across the membrane, is also common (126). A significant portion of NADPH
pool is synthesized by pentose phosphate pathway (PPP) (127). Since, glucose-6phosphate is the preferred substrate for PPP, glucose availability is an important factor in
determining the NADPH biosynthesis (127).
Usually, peroxynitrite derived reactive species such as tricarbonate anion (CO3•−)
and nitrogen dioxide (NO2•) are involved in damaging macromolecules such as proteins
and nucleic acids. Therefore, alteration in protein structure and function will lead to
pathological conditions (128,129). Since, a large portion of ROS are produced within the
mitochondria, higher concentration of NAD(P)H is needed to detoxify them. Because,
several reports showed that NADPH can acts as a non-enzymatic ROS scavenger by
directly involving in detoxification of peroxynitrite derived CO3•− and NO2•. During this
reaction, O2•− and H2O2 are produced and detoxified by SOD and catalase (130).
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1.5 ROS and RNS in protein oxidation
Mitochondrial respiration and other enzymatic reactions can generate ROS and
RNS. ROS and RNS are involved in different cellular processes by modifying redox
sensitive proteins associated with signaling. Reactive species can damage normal protein
function by irreversible protein oxidation (24,131). ROS can react with protein thiols to
form both reversible and irreversible modifications such as sulfenic acid, sulfinic and
sulfonic acids. Protein function can be finely regulated or permanently inactivated by
cysteine oxidation (132). For example, glutathionylation, a reversible protein cysteine
oxidation, is not only involved in protecting reactive cysteine from irreversible oxidation,
but also it plays an important role in redox signaling. Glutathionylation is a well-studied
reversible oxidative modification, where it refers to the formation of disulfide bond
between a protein thiol and GSH (Figure 1.7 A) (133). On the other hand, the irreversible
cysteine oxidation, such as sulfonic acids, can inhibit enzyme activity by directly modifying
active site cysteine residues or other cysteines that are important for maintaining the
structure (134).
Glutathione is the major low molecular weight thiol in cells and acts as an
antioxidant to protect the cell from oxidative stress. Glutathionylation can form through
several transient

intermediates, including sulfenic acid

or nitrosothiol. While

glutathionylation can occur non-enzymatically, a few redox enzymes, including
glutathione transferase pi and glutaredoxin, are reported to enzymatically catalyze the
formation and reversal of glutathionylation, respectively (135).
Multiple proteins are regulated by glutathionylation in important cellular events,
such as proliferation, migration, cell signaling, and apoptosis (136). However, their
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functional importance is much less understood due to lack of chemical tools.
Development of effective biochemical tools for identifying and characterizing protein
glutathionylation will help profiling target proteins and furthering our understanding of
glutathionylation in redox regulation.

Figure 1.7 - An illustration of protein cysteine oxidation. Reactive cysteines can react
-.

with H2O2 / O2

and reactive nitrogen species to generate sulfenic or nitrosothiol, which can act

as intermediates for forming protein glutathionylation. Glutathionylation can take place chemically
or enzymatically by GSH and GSTP respectively. B) A Prolonged exposure to reactive species
can form irreversible cysteine modifications, such as sulfinic and sulfonic acids.

1.5.1 Protein S-glutathionylation
Under both physiological and oxidative stress conditions, a subset of protein
cysteines is oxidized (13). Among many thiol oxidations, protein glutathionylation is one
of the major oxidations. S-glutathionylation is mostly found in redox-sensitive cysteine
residues that depends on the local environment around the cysteine residue (137). The
addition of a GSH molecule to a protein cysteine can increase its overall negative charge
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and an increase in molecular weight by 305 Da. The downstream effect of such
modifications depends on the site of modification in the protein structure (137). For
example, S-glutathionylation in the active site cysteine residue can enhance or inhibit its
catalytic activity. S-Glutathionylation in cysteine residues distal to active site can alter
protein function by interfering with binding partners or affecting protein structure (138).
The susceptibility of cysteine thiol to undergo S-glutathionylation depends on
several factors. The first important determinant is accessibility of cysteine residues to
proximal donors of S-glutathionylation, such as superoxide, nitric oxide GSSG and
nitrosoglutathione (139).

Secondly, the local environment that can increase the

nucleophilicity of cysteine thiol is also one of the major factors in determining the
modification site of a protein. Proximity of cysteine residue to basic amino acids such as
lysine, arginine and histidine can increase the formation of thiolate anion by increasing its
nucleophilicity (3). Selenocysteine has a lower pKa value at physiological pH (~7.4), due
to hydrogen bonding with neighboring charged residues, including lysine. Cysteines that
are coordinated with metal ions, such as Mg2+ or Zn2+ can also lower the pKa of cysteine
thiol making them more nucleophilic (140). Because of low availability of reactive
cysteines and thiol reactive radicals, only a limited number of cysteine residues is
glutathionylated under physiological conditions. Under oxidative stress, there is a higher
chance for most of cysteine thiols to get oxidized through a disulfide bond with GSH.
Reversible S-glutathionylation regulates many of cellular processes under both normal
and pathological conditions. Therefore, it is important to understand chemical and
enzymatic routes of formation of protein S-glutathionylation and deglutathionylation.
S-glutathionylation from chemical reactions:
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In general, S-glutathionylation occurs by a thiol exchange reaction. A thiolate anion
can nucleophilically attack GSSG or another protein-GSH adduct. In this reaction, GSH
forms disulfide with a protein cysteine residue. Alternatively, different oxidative
intermediates of protein cysteine, including sulfenic acid, can react with glutathione to
form disulfide (Figure 1.8 A). But, there are several other chemical mechanisms that
facilitate formation of S-glutathionylation (Figure 1.8 B). Typically, ROS-mediated
reactions and RNS-mediated reactions are more common but it is very difficult to dissect
an exact mechanism for S-glutathionylation. In the presence of ROS, such as O2•−, thiols
in GSH or protein cysteine residues can oxidize to a highly reactive thiolate anion (GS-)
or a thiyl radical (GS.). These reactive intermediates can react with H2O2 to form sulfenic
acid (GSOH and PSOH) (equation 1). Further, GSOH can react again with GS- to
generate GSSG (equation 2). Protein thiolate can easily react with these glutathione
intermediates (GS., GS- and GSSG) to form S-glutathionylated cysteines (equation 3).
RNS are also involved as intermediates in S-glutathionylation. Several proteins, including
GAPDH and p21Ras, are known to undergo both S-nitrosation and S-glutathionylation.
RNS, such as NO. and N2O3, are involved in generation of nitrosothiols, such as GSNO
and PS-NO. As in Figure 1.8, the resulting RNS intermediates can react to give Sglutathionylation.
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Figure 1.8 – Chemical mechanisms of protein S-glutathionylation. A) The mechanisms for
S-glutathionylation via intermediates of thiolate and sulfenic acid. B) The chemical equations for
generating ROS and RNS intermediates that are mediate S-glutathionylation.

Enzyme catalyzed mechanism of S-glutathionylation:
In addition to chemical formation of S-glutathionylation, enzymatic formation and
removal of glutathionylation is also known. Glutathione S-transferases (GST’s) are a class
of enzymes that decrease the pKa of thiol group in GSH, thus increasing the
nucleophilicity and the reactivity of GSH for S-glutathionylation. GSTP is one of seven in
GST family and is reported to increase S-glutathionylation in specific substrates. For
example, oxidation of catalytic cysteine in peroxiredoxin to sulfenic acid can inhibit its
peroxidase activity. GSTP interacts with peroxiredoxin and facilitates the enzymatic
formation of S-glutathionylation of the active site cysteine, hence restoring the catalytic
activity. Other enzymes, such as glutaredoxin 1 (Grx1), glutaredoxin 2 (Grx2) and
gamma-glutamyl transpeptidase also play a role in S-glutathionylation. The enzymecatalyzed S-glutathionylation may occur on the less reactive cysteine in a specific protein.
For example, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) does not possess
cysteine residue with a low pKa. However, glutathionylation occur by reacting with GS. as
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the proximal donor that is catalyzed by glutaredoxin. In addition, Grx catalyzes Sglutathionylation in several other proteins, including actin and protein-tyrosine
phosphatase 1B (PTP1B).

Figure 1.9 – Glutaredoxin (Grx) for deglutathionylation. Grx catalyzes deglutathionylation
through A) monothiol and B) dithiol mechanism. GSSG is produced as result of both reactions.
GR reduces GSSG to generate reduced glutathione (GSH) with NADPH as a reducing source.
This figure adopted from Mashamaite et al. 2015, with permission from Portland press (141).

Another extensively studied role of Grx is its deglutathionylating function (6). Grx
catalyzes a removal of GSH from protein cysteine residues by the disulfide-exchange
mechanism through the reaction of catalytic cysteine of Grx or by GS- (142). First, catalytic
cysteine of Grx attacks and reduces disulfide on a target protein. During the first step, the
catalytic cysteine of Grx forms a disulfide with GSH. Secondly, a thiolate anion of
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glutathione can restore the catalytic cysteine by forming GSSG (monothiol mechanism).
In dithiol mechanism, catalytic cysteine forms a disulfide with an adjacent cysteine, which
releases reduced glutathione. An Oxidized form of Grx enzyme can be reduced to a
catalytically active form by two molecules of glutathione. In both mechanisms, GSSG is
released and will be reduced back to GSH by GR. In addition to Grx, sulfiredoxin (Srx) is
also engaged in deglutathionylation of several proteins, such as PRX1, actin and PTP1B
(143). Since glutathionylation of catalytic cysteine in PTP1B inactivates its phosphatase
activity, deglutathionylation plays a crucial role in regulating important signaling pathways.
1.5.2 Other protein cysteine modifications
In the presence of H2O2, reactive cysteine residues can be oxidized to form
reversible sulfenic acid (Figure 1.7 A). Several proteins are known to form sulfenic acid,
including Prx, NADH peroxidase, NF-kB, PTP’s and several mitogen-activated protein
kinases (MAPK’s) (132,144). Identification of sulfenic acid formation in proteins has been
approached indirectly by using a biotin-switch method and by direct methods, such as
azido- and alkyne-containing dimedone derivatives (145,146). Alternatively, the sulfenic
acid adducts formed by reacting with dimedone has been probed by using an antibody
(147). Sulfenic acid formation is labile to form glutathionylation. Alternatively, a constant
exposure to ROS can oxidize sulfenic acid irreversible cysteine oxidations such as sulfinic
acid and sulfonic acid. However, it is recently found that sulfinic acid can be reduced
back to sulfenic acid by Srx enzyme (148). A Prolonged exposure to ROS, Prx can be
oxidized to sulfinic acid. Srx selectively reduce the sulfinic acid to sulfenic acid in plant
and mammals (149,150). Sulfinic acid formation has been reported in several studies,
including matrix metalloproteases (MMP’s) and the Parkinson’s disease protein, Dj-1
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(151). In addition to ROS, NO. can react with protein thiols to form S-nitrosylated proteins.
Like S-glutathionylation, S-nitrosylation is involved in regulating different cellular
processes, such as trafficking, apoptosis and neural transmission (152-154).
1.6 Protein S-glutathionylation and its relevance to human diseases
1.6.1 Regulation of protein function by S-glutathionylation
protein thiols can be oxidized irreversibly to sulfinic and sulfonic acids under
oxidative stress. Not only the irreversible oxidation can lead to the inactivation of protein
function, but also result in the subsequent protein degradation (155). Protein Sglutathionylation serves two important functions under increased production of ROS or
RNS. First, S-glutathionylation protects protein thiols from permanent oxidation. Second,
the reversible S-glutathionylation involves in regulating protein function by inactivating or
altering its structure and protein-protein or protein-DNA interactions. the reversibility of Sglutathionylation allows for protein thiols to be reduced back to sulfhydryl form while
restoring the protein function. Some protein cysteine residues are glutathionylated even
under basal conditions indicating a regulatory function in different cellular processes
(156). S-glutathionylation can inhibit or active protein activity, or stabilizes protein
structure (157). For instance, some of metabolic enzymes, including tyrosine hydroxylate,
aldose reductase, creatine kinase and GAPDH, are inhibited upon glutathionylation (158161). S-glutathionylation of Cys186 and Cys181 in carbonic anhydrase III activate and
inhibit its phosphatase activity, respectively (162). In HIV-1 protease, there are two
conserved cysteine residues (163). While, glutathionylation of Cys67 is involved in
stabilization and activation of protease activity, glutathionylation of Cys95 is associated
with inhibition of protease activity (163).
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S-glutathionylation plays important roles in cellular signaling pathways in many
physiological processes, such as proliferation, apoptosis, differentiation and immunity
(164). Many kinases and phosphatases are found to be regulated by S-glutathionylation.
Protein kinase A, MAPK/extracellular -signal regulated kinase or ERK, PTP1B, and
MAPK/ERK kinase kinase (MEKK1) are glutathionylated under physiological and stress
conditions (4,165). Most of kinases are inhibited upon S-glutathionylation. For example,
an active site cysteine residue (Cys199) of protein kinase A (PKA) is glutathionylated,
which inactivates the kinase activity in a reversible manner (166). S-glutathionylation of
small GTPase, Ras, activates downstream signaling of ERK and AKT. Angiotensin II
induces glutathionylation of Ras, which is involved in hypotrophy in both smooth muscles
and cardiac myocyte (167,168). Also, Ras glutathionylation is involved in inhibition of
insulin signaling in endothelial cells (169). In addition to signaling proteins, Sglutathionylation regulates several transcription factors such as NF-Kb and Pax-8
(170,171). NF-kB is S-glutathionylated in both p65 and p50 subunits, which interferes with
its binding to DNA. Therefore, NF-kB glutathionylation can inhibits the transcription of
targeted genes (169,172).
1.6.2 Protein S-glutathionylation in human diseases
Age-related human pathologies are associated with increased production of ROS
and RNS (173). Diabetes is a complication where body does not respond to insulin or has
insufficient production of insulin due to destruction of β-cells (174). In both conditions,
glucose in blood can be found in a high level. This can lead to an excessive
supplementation of metabolites to mitochondria and generate increased amount of ROS,
which leads to mitochondrial dysfunction (175). In addition to an increased production of
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ROS, type 1 and type 2 diabetes show low levels of GSH and Gpx (176,177). Due to the
oxidized environment in diabetics, a high level of GSSG can induce protein Sglutathionylation. S-glutathionylation of certain proteins are considered as biomarkers for
identification of several disease conditions in human. Due to the difficulty of access in
human tissue samples, identification of S-glutathionylation in body fluids such as blood
are more common. For example, an increased level of S-glutathionylated hemoglobin is
a characteristic of type 2 diabetes (178). Hemoglobin S-glutathionylation may be a
potential biomarker for different pathologies, including hyperlipidemia, iron deficiency
anemia, chronic renal failure and hemodialysis (179-181).
Cancer cells rapidly proliferate partially due to the loss of control of different cellular
events involved in apoptosis, metabolism and redox homeostasis (182). Cancer cells rely
on aerobic glycolysis, namely Warburg effect (183). The increased glucose metabolism
is found to support the essential antioxidant activity by generating pyruvate and NADPH.
In a solid tumor, tumor cells largely experience a short of nutrients, which may
augment metastasis of tumor cells. Interestingly, several metastasis-related proteins are
found to be regulated by S-glutathionylation. Nucleoside diphosphate kinase (Nm23) is
considered as a tumor suppressor, and the decreased mRNA levels and mutations of
Nm23 are identified in several metastatic cancers, including breast and colon (184). Sglutathionylation of Nm23 at Cys109 can suppress its activity and increases the
metastatic properties (185). Similarly, actin S-glutathionylation inhibits its polymerization
and deglutathionylation by Grx1 can facilitate the actin polymerization (186,187). Since
the actin polymerization and depolymerization are essential to cell migration, Sglutathionylation of actin may play an important role in controlling cancer cell migration
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under altered redox state (188). Moreover, MAPK, such as p38, JNK and ERK, play key
roles in regulating cell migration (189-191). ERK is involved in regulating cell movement
by phosphorylating myosin light chain kinase or calpain while p38 governs the
directionality of the cell migration through phosphorylating MAPK-activated protein kinase
2/3. A recent study revealed that ROS produced by NOX4 induce MAPK phosphatase 1
(MKP-1) glutathionylation and subsequent inactivation of phosphatase activity, thereby
facilitating the monocyte migration (192). These data provide evidences for a possible
role of S-glutathionylation of MKP1 or other MKPs in cancer cell migration.
1.7 Analytical and biochemical methods for detection of S-glutathionylation
S-glutathionylation is the most extensively studied protein oxidation in an array of
human diseases. Over the years, several analytical and biochemical approaches have
been developed to visualize and identify glutathionylated proteins and their modification
sites. Most common detection method is an antibody approach. A range of antibodies
have been developed for different epitopes including glutathione, glutathione-BSA,
glutathione-glutaraldehyde-BSA, glutathione conjugated to Kyhole Limpet Hemocyanin,
and glutathione-conjugated protein complexes. Antibodies against glutathione derivatives
have been widely used for Western blot analysis and for immunoprecipitation of individual
glutathionylated protein (193-195).
Other detection methods include an indirect biotin-switch method, biotinylated
glutathione ethyl ester (BIOGEE), radiolabeled GSH, isotope-labeled GSH and tagged
GSH using glutathionyl-spermidine synthetase (196-198).
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1.7.1 Biotinylated glutathione ethyl ester (BIOGEE)
Biotinylated glutathione ethyl ester generated by derivatizing GSH molecule at
amine group of glutamate residue. This biotin tagged-GSH is not cell permeable.
Therefore, a carboxyl group of GSH molecule was modified to be an ethyl ester group. It
is expected that intracellular esterase can hydrolyze ethyl group once getting into the cell.
The released biotin-GSH could modify any protein cysteine residue in response to ROS
(Figure 1.10).

Figure 1.10 – A scheme for identification of S-glutathionylation by BIOGEE. This figure
adopted from Samarasinghe et al. (199).
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glutathionylation (200). BIOGEE has been used to identify various glutathionylated
proteins in response to ROS and growth factors (201,202). The biotin group allows to
enrich biotinylated glutathionylated proteins by streptavidin agarose beads. Using this
method, glutathionylated proteins can be visualized in a Western blot using streptavidinhorse radish peroxidase (strep-HRP). This method was also used with mass spectrometry
method in identifying glutathionylated proteins. After performing biotin pull-down,
glutathionylated proteins was digested by trypsin and the subsequent elution allows to
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identify modified peptides by mass spectrometry analysis (202). Further, this method was
modified to identify and quantify the degree of glutathionylation among different ROS.
Such improvements include addition of isotope-labeled biotin-GSH and the cleavable tags
to identify modification sites (197,202).
1.7.2 Biotin-switch method
Another method is a biotin switch method. In this method, S-glutathionylated
proteins are identified indirectly (203). First, cells are induced for glutathionylation by
ROS. After cell lysis, all free-thiols are blocked by reacting with thiol-reacting agents, such
as iodoacetamide (IAM) or N-ethylmaleimide (NEM). After irreversible blocking of all
unmodified thiols, S-glutathionylated cysteine residues are reduced by dithiothreitol
(DTT), tris(2-carboxyethyl)phosphine (TCEP) or a mutant form of Grx3 (202,204,205).
The reduced cysteine residues then react with biotin-NEM or biotin-IAM. Biotinylated
proteins that represent S-glutathionylated proteins can be visualized by Western blotting
(Figure 1.11). Similar to BIOGEE, biotin-switch method was used with mass spectrometry
(LC-MS/MS). Therefore, identification of glutathionylated proteins as well as their cysteine
modification sites can be deduced using biotin-switch method. A modified version of
biotin-switch method has been reported and successfully used to visualize
glutathionylated proteins within different compartments of fixed tissues or cells (205).
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Figure 1.11 – The example of a biotin switch method. After inducing glutathionylation, the
remaining cysteine residues were blocked with N-ethylmaleimide (NEM) and subsequent
reduction by Grx3 will expose glutathionylated cysteine residues. Then cysteine residues are
reacted with biotin-containing cysteine reactive reagent for the enrichment and identification by
LC-MS/MS. This figure adopted from Samarasinghe et al. 2015 (199).

1.7.3 Biotin-glutathionylspermin
GSH is present in a high concentration in eukaryotic cells as well as in prokaryotes.
In several types of bacteria, while a carboxylic group of a glycine residue in GSH molecule
is further modified with spermidine by glutathionylspermidine synthetase (GspS). The
synthesized gluathionylspermidine can be hydrolyzed by glutathionylspermidine amidase
(GspA) (206-208). In a recent study, GspS was used to generate biotinglutathionylspermine (biotin-Gsm) in mammalian cells to identify S-glutathionylated
proteins by LC-MS/MS (209). In this method, first, GspS is transiently expressed into
cells. Biotin-spermine was then incubated to generate biotin-Gsm inside the cell. Because
biotin-Gsm was synthesized inside the cell, this method can avoid an incubation of an
exogenous modified GSH, such as BIOGEE, in a high concentration, which may minimize
the perturbation of an intracellular redox status. In the presence of ROS stimulus, biotinGsm can undergo S-glutathionylation (Figure 1.12). Biotin-Gsm modified proteins can be
visualized by Western blotting and identified by LC-MS/MS. This approach was used to
identify 1400 modified cysteine residues in LC-MS/MS analysis.
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Figure 1.12 – A strategy to identify S-glutathionylated proteins using biotin-spermine and
glutathionylspermidine synthetase (GspS). Transfection of GspS followed by the incubation of
biotin-spermine generates biotin-glutathionylspermine (biotin-Gsm). In the presence of ROS,
sensitive cysteine residues can be modified by biotin-Gsm and the subsequent LC-MS/MS
analysis can identify glutathionylated proteins. This figure adopted from Samarasinghe et al. 2015
(199).

1.8 Current dissertation work in examining S-glutathionylation
Protein S-glutathionylation is implicated in a range of human diseases including
age-related diseases such as diabetes, neurodegenerative diseases, cardiovascular
diseases and cancer. Many of these diseases are associated with altered metabolism
and cellular redox homeostasis. For example, cancer cells rely on a high rate of glucose
uptake in order to provide enough energy for rapidly proliferating cells. Many cancer cells
are shown to produce high levels of ROS and RNS. S-glutathionylation is an oxidative
cysteine modification that regulates protein function due to its reversible nature.
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Identification and evaluation of functional consequences of S-glutathionylation in such
proteins allow basic understanding for development of therapeutics in the future.
However, despite several available biochemical approaches, identification and
characterization of S-glutathionylated proteins are challenging.
In this dissertation work, I will describe development of a novel chemical method
to detect S-glutathionylated proteins, and the application to identify S-glutathionylated
proteins in response to metabolic alteration. Moreover, functional roles of Sglutathionylation in cancer metastasis will also be elucidated.
In chapter 2, development of a clickable glutathione approach for detection of
glutathionylation will be discussed. In this study, we developed a selective and versatile
method for identifying and characterizing glutathionylation in cells by using a mutant of
glutathione synthetase (GS). We have engineered the active site of GS to catalyze an
incorporation of azido-Ala in place of glycine.

This generates the azide-containing

glutathione in cells, which undergoes glutathionylation upon ROS stimulus. The
subsequent bioorthogonal copper-catalyzed 1,3-dipolar cycloaddition reaction (click
reaction) with biotin-alkyne or fluorophore-alkyne allows a direct enrichment or detection
of glutathionylated proteome by biotin pull-down and fluorescence imaging, respectively.
The method presents a unique metabolic labeling of intracellular glutathione without
disturbing thiol-redox states and a chemical method for characterization of
glutathionylated proteins in response to ROS.
Chapter 3 will describe identification of glutathionylated proteins induced in
response to glucose metabolism and/or mitochondrial dysfunction Mitochondrial ROS
(mROS) are the key components of cellular damage and redox signaling. Cancer,
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ischemia and other pathological conditions are accompanied by elevated levels of mROS.
Although glucose metabolism is known to be associated with redox regulation,
glutathionylation in response to glucose metabolism remains unknown. To address this,
we employed a clickable glutathione approach in a HEK293-GS M4 stable cell line that
stably overexpresses the mutant of glutathione synthetase (GS M4). glutathionylation was
induced in response to antimycin A (AMA), glucose starvation, a combination of AMA and
glucose starvation.

Interestingly, glutathionylation was reversed by the addition of

glucose or pyruvate, suggesting that reversibility of glutathionylation is regulated by
glucose availability under mitochondrial dysfunction. We identified over 1200
glutathionylated proteins by LC-MS/MS analysis including several new glutathionylated
proteins, including PP2Cα. PP2Cα is a metal- dependent protein phosphatase involved
in metabolic stress and AMPK signaling. We found that PP2Cα is glutathionylated at C314
residue in response to metabolic stress, and glutathionylation of PP2Cα disrupted its
interaction with mGluR3, an important metabotropic glutamate receptor associated with
neurological disorders. Together, this study provides the importance of glucose
availability in regulating protein glutathionylation under mitochondrial dysfunction.
Chapter 4 will describe the functional role of PP2Cα S-glutathionylation in cancer
cell migration and invasion in response to metabolic alterations. PP2Cα is a
serine/threonine protein phosphatase which acts as a negative regulator of stress
responsive pathway. First, glutathionylation was systematically analyzed under a limited
concentration of glucose and oxygen availability. We found different glutathionylation
pattern in different cell lines in response to low glucose. Glutathionylation was selectively
induced in an invasive breast cancer cell line MDA-MB 231 compared to non-invasive

38
MCF7 cells, indicating a distinct redox response by metastatic cancer cells. Further, an
incubation of L-glutamic acid reversed the effect of low glucose. We also showed that
oxygen

availability is

also

important

for

glucose

deprivation-induced

protein

glutathionylation. Moreover, we found that PP2Cα glutathionylation enhances cancer cell
migration potentially by dephosphorylating and inactivating JNK under metabolic stress
in MDA-MB231 cells. Altogether, our data reveal an important regulatory role of PP2Cα
glutathionylation in cancer cell migration in response to metabolic stress.
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CHAPTER 2 METABOLIC SYNTHESIS OF CLICKABLE GLUTATHIONE FOR
STUDYING PROTEIN GLUTATHIONYLATION
2.1 Introduction
Protein glutathionylation is implicated in redox signaling under controlled
generation of reactive oxygen species by cytokines and growth factors (210). Most of
available chemical methods suffer from poor specificity and/or sensitivity. To overcome
these limitations and to develop a reliable method for identification of glutathionylated
proteins, we developed a chemical method which uses enzyme engineering, metabolic
synthesis and biorthogonal chemistry (199,211). First, we generated clickable glutathione
inside the cell which excludes the incubation of high concentrations of exogenous
glutathione. Glutathione biosynthesis is catalyzed by two enzymatically catalyzed
reactions (Figure 2.1). In the first step, γ-glutamylcysteine ligase (GCL), which is the rate
limiting enzyme, catalyzes the formation of an amide bond between a side chain
carboxylic group of glutamate (Glu) and an amine group of cysteine (Cys) to generate
γGlu-Cys dipeptide. The second step of glutathione biosynthesis is catalyzed by
glutathione synthetase (GS). GS catalyzes the formation of tripeptide (γGlu-Cys-Gly) by
ligating glycine (Gly) with a dipeptide γGlu-Cys (212,213).
We planned to incorporate a small clickable functional group onto a glycine residue
in glutathione. We envisioned that we can add clickable moiety on Gly of glutathione by
engineering GS. Since GCL involve in the rate-limiting step of glutathione biosynthesis,
metabolic synthesis of clickable glutathione may not affect the total glutathione or thiol
concentration in the cell (214). In addition, a glutathione-degrading enzyme, γ-glutamyl
transpeptidase, retains the specificity towards Glu in glutathione. Therefore, we further
envisioned that clickable glutathione may be degraded by glutathione-catabolic pathways
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(215). Also, interestingly, there are other naturally existing glutathione derivatives
containing β-Ala, Ser, or Glu in place of Gly in glutathione in plants (216), which may
justify the modification in clickable glutathione.

Figure 2.1- A scheme for GSH and azido-GSH biosynthesis. The First reaction is catalyzed
by γGluCys ligase to generate dipeptide γGlu-Cys. Glutathione synthetase catalyzes the second
step of GSH biosynthesis. GS mutant catalyzes azide- or alkyne-containing Gly derivatives to
form clickable GSH.

2.2 Design of clickable glutathione
Our design is based on a synthesis of azido-glutathione or glutathione containing
alkyne group in situ in cells. We thought that the GS active site could be engineered to
accommodate azide-or alkyne- containing Gly derivatives. Overexpression of GS mutant
allows metabolic synthesis of clickable GSH inside the cell. First, transient overexpression
of a GS mutant in HEK 293 cells will metabolically synthesize clickable glutathione in the
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presence of azide- or alkyne- containing Gly derivatives, such as L-azidoAlanine (LAzAla),

L-homopropargylglycine

(L-HPG)

or

L-propargylglycine

(L-PG).

After

glutathionylation is induced by incubation of exogenous H2O2, cells are lysed in the
presence of a thiol-blocking reagent. The subsequent bio-orthogonal click reaction with
appropriate alkyne or azide containing biotin or fluorophore is expected to selectively
detect glutathionylation by Western or in-gel fluorescence respectively (Figure 2.2). This
novel approach provides not only detection of glutathionylation by gel analysis, but also
identification of glutathionylated proteins by mass spectrometry analysis.

Figure 2.2 - Schematic diagram for the detection of glutathionylation by clickable GSH.

2.3 Results
2.3.1 Generation of glutathione synthetase mutants and kinetic analysis
Glutathione synthetase is a specific enzyme towards its substrates including
glycine. In the active site, there are several amino acids which are important for specificity
towards glycine. We noticed in the crystal structure of GS (PDB:2HGS) that two amino
acids (F152 and S151) are in a close proximity to a glycine residue of GSH (Figure 2.3
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A). We thought that a bulky structure of F152 in the GS active site does not allow
formation of glutathione derivatives containing other amino acids than glycine.
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Figure 2.3 – Crystal structure of GS WT and rearranged active site structures of GS M4. A)
Crystal structure and active site amino acid residues of glutathione synthetase enzyme. B) Model
structures of the active site in glutathione synthetase (GS) WT and mutants. Space filling (upper)
and stick (bottom) models of GS mutants are drawn from GS WT (PDB:2HGS) by using PyMol
program. The structure of azido-Ala is drawn in an arbitrary conformation that appears to have a
low steric hindrance.

Therefore, we thought we can mutate F152 and/or S151 in the active site of GS to
provide an extra space that may accommodate the azide- or alkyne-containing glycine
derivatives (Figure 2.3 B). We have generated several GS mutants with mutation of F152
and S151 residues. GS WT and GS mutants were overexpressed in bacteria and purified
by affinity chromatography (Figure 2.4 A and Figure A.2.1) and characterized by an ADPcoupled enzyme assay with pyruvate kinase (PK) and lactate dehyrogenase (LDH)
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(Figure 2.4 B) (217). Initial rates were fitted to the Michaelis-Menten equation. Km and kcat
values were calculated for all GS mutants and GS WT (Figure 2.4 C and Figure A.2.2).

Figure 2.4 – Purification and kinetic analysis of GS mutants. A) GS WT and GS mutants were
purified with high purity. B) Kinetic assays by enzyme coupled reactions using ATP consumption.
C) Michaelis-Menten plot for L-AzAla and GS M4 (F152A/S151G).

Kinetic data for all GS enzymes are summarized in Table 2.1. Since GS WT is
specific towards Gly, it did not catalyze other amino acids. GS WT catalyzes Gly with a
high catalytic efficiency (kcat/Km = 1095) and has a high binding affinity to Gly.
Interestingly, GS M1 (F152G) did not catalyze Gly and displayed a poor binding affinity
towards Gly compared to L-AzAla. The mutation of bulky F152 to a small glycine may
have created an enough space to accommodate glycine derivatives.GS M1 catalyzed LAzAla with high catalytic efficiency compared to other amino acids. Although GS M1
prefers L-AzAla over other substrates, GS M1 was not ideal. The binding affinity is still
poor and the Km value was high (2.46 mM). Also, the kcat/Km value is 25 times lower than
kcat/Km value for Gly by GS WT. We further hypothesized that a bigger space in the active
site pocket will increase the binding affinity of GS mutant towards L-AzAla.
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Table 2.1 - Kinetic data of GS WT and GS mutants with different amino acids.

Therefore, we generated a double mutant, GS M2 (F152G/S151G), that may give
a more space to accommodate L-AzAla in the active site of GS. Although, GS M2 has a
decreased Kcat value for L-AzAla, GS M2 improved the binding affinity by 10-fold when
compared to GS M1. Overall, GS M2 showed a 5-fold higher catalytic efficiency with
azido-Ala than GS M1, and only 6 times lower catalytic efficiency than GS WT for glycine.
However, it was found that GS M2 can catalyze both L-Met and L-AzAla with the similar
catalytic efficiency, suggesting that GS M2 lost its selectivity towards L-AzAla.
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In addition, we noticed that GS M3 (S151G) with a small size of mutation showed
significantly improved the selectivity towards L-AzAla over L-Met. Thus, we sought to
mutate F152 to alanine which may reduce the active site space in GS M2. Indeed, we
observed that the mutation of F152A together with S151G (GS M4) improved the
selectivity towards L-AzAla (Km = 0.09 mM) over Met (Km = 0.17 mM). GS M4 has the
highest catalytic efficiency (Kcat/Km = 630.6) towards L-AzAla. In addition, GS M4 had a
three-fold higher catalytic efficiency for L-AzAla over L-Met. GS M4 also could catalyze
both L-HPG and L-PG with a similar or slightly lower kcat/Km value to L-AzAla. Overall, in
vitro kinetic data provide evidences that GS M4 can efficiently catalyzes L-AzAla to
synthesize clickable glutathione.
2.3.2 Biosynthesis of clickable glutathione in HEK293 cells
In vitro kinetic data showed that GS M4 is the most efficient GS mutant with azidoAla. However, GS M4 can also catalyze L-Met albeit 3-fold lower catalytic efficiency than
azido-Ala. Therefore, we analyzed in vitro synthesis of glutathione derivatives by GS WT
and GS M4. Gly, L-AzAla, L-Met, γGlu-Cys and ATP were incubated with GS WT and/or
GS M4, as shown in Figure 2.5. The synthesis of glutathione derivatives was analyzed by
LC-MS with or without modification by fluorescein iodoacetamide (FL-IA). When the
reaction mixture reacted with FL-IA, the masses corresponding to endogenous GSH (m/z
308) and azido-GSH (m/z 363) shifted to m/z 695 and m/z 750, respectively. Masses
corresponding to endogenous GSH, azido-GSH and GSH containing L-Met (Met-GSH)
were extracted and overlaid in LC-MS analysis. In the presence of GS WT, the only mass
corresponding to endogenous GSH was detected without observing other masses for
azido-GSH and met-GSH (Figure 2.5 A and Figure A.2.3). In contrast, GS M4 synthesized
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the glutathione derivatives containing azido-Ala, Met, or Gly, but with the highest intensity
for azido-glutathione (Figure 2.5 B). In the presence of both GS WT and GS M4, there is
still significant amount of azido-glutathione in comparison to endogenous glutathione
(Figure 2.5 C).

Figure 2.5 - LC-MS analysis of in vitro biosynthesis of clickable glutathione. Individual GS
enzymes were incubated with γGlu-Cys, amino acids and ATP. The reaction mixture was then
treated with FL-IA and injected to LC-MS. The masses of endogenous GSH, azido-GSH and metGSH were extracted and overlaid. A) GS WT B) GS M4 C) GS WT and GS M4 were incubated
with other reactants and injected to LC-MS.

Next, we analyzed metabolic synthesis of clickable glutathione in cells. For
mammalian cell transfection, we produced a mammalian vector that can express GS M4
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(pCDNA3.1-GS M4) with n-terminal FLAG tag. A transient transfection of FLAG-tagged
GS M4 into HEK293 cells induced approximately 15-20-fold overexpression of the GS
mutant compared to endogenous GS WT (Figure 2.6 A). First, we analyzed total thiol
concentrations in cell lysate to check whether metabolic synthesis of clickable glutathione
interfere with intracellular redox state. Cells were lysed by three freeze-thaw cycles and
protein free lysates were analyzed for free thiols using bromobimane assay.

Figure 2.6 – GS M4 overexpression in cells. A) FLAG tagged GS M4 was transiently
transfected to HEK 293 cells and overexpression of GS M4 probed with anti-GS and anti-flag. B)
Intracellular thiol levels were determined by bromobimane assay. After transfection of GS M4,
cells were incubated with different concentrations of L-AzAla for 20 h. Cells were lysed by freezethaw cycles and protein free lysates were subjected to bromobimane assay.

An incubation of increasing concentrations of L-AzAla did not change the total thiol
concentration when compared to cells without transfection of GS M4 and incubation of L-
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AzAla. The data indicated that metabolic synthesis of clickable glutathione by GS M4 may
not alter intracellular redox state.
We further demonstrated the biosynthesis of azido-GSH in cells. L-AzAla, L-HPG
or L-PG were incubated for 20 h with GS M4-transfected cells. Cells were lysed by several
freeze-thaw cycles in 1X PBS with or without fluorescein-iodoacetamide. Protein free cell
lysates injected to LC-MS. The masses corresponding to endogenous GSH (m/z 308)
and azido GSH (m/z 363) were extracted and overlaid. only endogenous GSH was found
in cells without expression of GS M4 (Figure 2.7 A and 2.8 A). Masses corresponding to
other glutathione derivatives including azido-GSH were not detected in LC-MS analysis.
In contrast, when HEK 293 cells were transfected with GS M4 and incubated with LAzAla, we observed a mass ion peak for azido-GSH together with endogenous GSH
(Figure 2.7 B). The amount of azido GSH was gradually increased with an increasing
incubation time of L-AzAla. Incubation of L-AzAla for 6 h, 20 h and 40 h increased the
amount of azido-GSH up to 10%, 40% and 70% of endogenous GSH, respectively (Figure
2.7 C). In addition, the amount of azido-GSH was increased dose dependently when cells
were incubated with increasing concentrations of L-AzAla (Figure A.2.4). When HEK293
cells without transfection of GS M4 were incubated with L-AzAla, we observed only one
mass ion peak which is corresponding to endogenous GSH (Figure 2.8 B). We also
analyzed GS M4 selectivity towards L-AzAla over other amino acids for synthesizing
glutathione derivatives in cells.
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Figure 2.7 - LC-MS analysis of biosynthesis of clickable GSH. A) Protein free lysates from
control cells without azido-Ala and GS M4 transfection were injected to LC-MS.

Masses

corresponding to endogenous GSH and azido-GSH were extracted and overlaid. B) Cell lysates
were prepared after transfection of GS M4 and incubation of azido-Ala to HEK29C3 cells. Protein
free lysate were injected to LC-MS. C) Cells were lysed and derivatized with FL-IA after incubating
azido-Ala for different times.
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Figure 2.8 - LC-MS analysis of biosynthesis of other GSH derivatives. A) Masses
corresponding to different glutathione derivatives were extracted and overlaid with HEK293 cells
in the absence of azido-Ala. B) Masses for GSH and azido-GSH were analyzed from HEK293
cells in the absence of GS M4 overexpression after incubation of azido-Ala. C) Masses
corresponding to GSH, azido-GSH, L-Met containing GSH (Met-GSH), alanine containing GSH
(Ala-GSH) and reduced form of azido-GSH (aminoalanine-GSH) were analyzed from cells after
transfection of GS M4 and an incubation of azido-Ala.
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Importantly, overexpression of GS M4 and incubation of L-AzAla led to a selective
synthesis of azido-GSH. We did not detect any glutathione derivatives containing either
methionine (Met-GSH) or alanine (Ala-GSH) (Figure 2.8 C). Despite the fact that an azide
group can be reduced to an amine group in an intracellular environment, we did not
observe a mass (m/z 724) corresponding to a reduced form of azido-GSH (glutathione
with amino-alanine) indicating the relatively high stability of an azido group inside the cell
(Figure 2.8 C).

Figure 2.9 - Biosynthesis of clickable GSH using L-HPG and L-PG. Cell lysates prepared from
cells with A) L-HPG and B) L-PG were subjected to LC-MS analysis after modifying with FL-IA.

Moreover, we checked the biosynthesis of GSH derivatives containing an alkyne
group. HEK293 cells were transfected with GS M4 and incubated with L-PG or L-HPG.
An incubation of L-PG or L-HPG produced their corresponding glutathione derivatives
(Figure 2.9 A and B). We detected a lower intensity of GSH containing L-HPG when
compared to GSH containing L-PG. L-HPG is a methionine surrogate which is known to
be incorporated into proteins. These LC-MS study further provides the evidence that
clickable GSH can be synthesized upon expression of the GS M4 mutant in cells.
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2.3.3 Analysis of glutathionylated proteins by in-gel fluorescence and Western
blotting
Metabolic tagging of clickable glutathione is a selective and versatile chemical
approach to detect glutathionylated proteome in cells. To induce glutathionylation in
HEK293 cells, GS M4 transfected cells were incubated with L-AzAla for 20 h followed by
the Incubation of hydrogen peroxide (H2O2). Then, cells were lysed and subjected to click
reaction with fluorophore-alkyne or biotin-alkyne in the presence of CuBr. We used CuBr
instead of common CuSO4 / TCEP method because of disulfide in glutathionylation. After
one hour of click reaction, glutathionylation was visualized by in-gel fluorescence or
chemiluminescence with streptavidin-HRP. All negative controls without GS M4, L-azidoAla, or H2O2 (Figure 10 A lanes 1-7) did not show fluorescence signals for
glutathionylation. In contrast, in the presence of GS M4, L-AzAla and H2O2 (Figure 10 A
lane 8), click reaction produced numerous fluorescence bands corresponding to
glutathionylated proteins. To confirm that the fluorescence signal results from
glutathionylated proteins, we treated cell lysate (used in lane 8 Figure 10 A) with DTT
prior to click reaction with rhodamine-alkyne. A treatment of DTT showed disappearance
of fluorescence signal suggesting that the fluorescence signal results from a disulfide
bonds formation between azido-GSH and protein cysteine residues in response to ROS
stimulus (Figure 10 A lane 12). We observed the similar result after click reaction with
biotin-alkyne and the subsequent Western blotting analysis with streptavidin-HRP (Figure
A.2.5 A).
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Figure 2.10 - Analysis of glutathionylated proteins using metabolically synthesized azidoGSH. A) HEK 293 cells were incubated with or without L-Azido-Ala and induced with 1 mM H2O2
or B) varying concentration of H2O2 for 15 minutes, followed by cell lysis and click reaction.
Glutathionylation probed as shown above.

To assess the sensitivity of clickable glutathione approach, GS M4 overexpressing
cells were treated with an increasing concentration of H2O2 (0.1-1 mM) (Figure 2.10 B).
There was a significant intensity of glutathionylated proteins even at a low concentration
of H2O2 (100 µM) (Figure 2.10 B lane 6). We did similar experiment by varying the LAzido-Ala concentration, which showed similar levels of detection for glutathionylation
even with a low concentration of L-Azido-Ala (0.3 mM) (Figure A.2.5 B). We also analyzed
glutathionylation in different cell lines using the clickable glutathione approach. GS M4
was transiently transfected to three different cell lines including HEK293, HBEC3-KT and
A549 cells. After incubation of L-AzAla, cells were induced for glutathionylation. The
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intensity of glutathionylation was similar between HEK 293 and HBEC3-KT cells while A
549 cells displayed a relatively lower signal of glutathionylation in response to H2O2
(Figure A.2.6). These data demonstrated that clickable glutathione can be used to study
glutathionylation in different cell lines in response to ROS stimuli.
Several clickable glycine derivatives can be incorporated into proteins during de
novo protein biosynthesis. For example, L-HPG is a well-known methionine surrogate. It
has been shown that L-HPG can be incorporated into proteins (218). We further
compared detection of glutathionylation using L-azido-Ala versus L-HPG and L-PG.
HEK293 cells expressing GS M4 were incubated with clickable Gly derivatives (L-HPG or
L-PG). After ROS stimulation and click reaction with rhodamine alkyne or rhodamine
azide, glutathionylation was detected by in-gel fluorescence (Figure 2.11). In the absence
of GS M4, L-AzAla or H2O2, cells did not produce significant amount of signal compared
to the cells with all three components (Figure 11 lane 1-3 compare with lane 4). The
diminished fluorescence signal in L-azido-Ala incubated cells without GS M4
overexpression and H2O2 incubation (Figure 11 lane 2), indicates that L-azido-Ala is not
incorporated into proteins during protein biosynthesis. In contrast, an incubation of LHPG alone (Figure 11 lane 6) produced numerous bands even without GS M4 and ROS
stimuli, suggesting that L-HPG is incorporated into proteins.
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Figure 2.11 – Studying possible incorporation of amino acid derivatives to protein
biosynthesis. After incubating L-AzAla, L-HPG and L-PG separately with or without GS M4
overexpression and ROS stimuli, prepared cell lysates were subjected to click reaction with
rhodamine alkyne and glutathionylation detected by in-gel fluorescence.

An incubation of L-PG did not produce any labeling of proteins (Figure 11 lane 911). After treatment of H2O2, there was a significant signal for glutathionylation albeit a
slightly lower intensity of signals when compared to glutathionylation detected by L-azidoAla or L-HPG (Figure 11 lane 12). From this study, we concluded that L-AzAla is the most
efficient clickable amino acid for identifying protein S-glutathionylation.
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2.3.4 Reversibility of azido-glutathionylated proteins
Glutathionylation is a highly dynamic post translational modification due to the
reversibility of the disulfide bond. Glutaredoxin (GRX1) is a well-known redox enzyme that
catalyzes the reduction of disulfide bond in glutathionylated proteins and GRX1 is
involved in maintaining the redox balance in the cell (219). We carried out in vitro GRX1
assay to examine whether azide group in clickable glutathione interferes with GRX1mediated deglutathionylation. GS M4-transfected cells were incubated with L-AzAla and
treated with H2O2 for 15 minutes prior to lysis. The lysates were then incubated with
recombinant GRX1. glutathionylation was significantly decreased after incubation with
GRx1 when compared to without GRX1 (Figure 2.12 A). This suggests that a small azide
functional group in glutathione may be tolerated for deglutathionylation by GRX1
(compare lane1 and 2 in Figure 2.12 A).
Next, we evaluated protein deglutathionylation in HEK293 cells. After transfecting
and incubating L-AzAla, cells were induced with H2O2 for glutathionylation. After 15minute induction, cell culture medium was replaced with a fresh medium without H2O2 for
different time points. cells were then lysed at 0, 0.5 and 1 h time points and were analyzed
for glutathionylation after click reaction with biotin-alkyne.
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Figure 2.12 – Reversibility and clickable glutathionylated proteins. After incubating L-AzAla
with GS M4 overexpressing HEK293 cells and ROS stimuli cell lysates were prepared and
subjected to click reaction with rhodamine alkyne and glutathionylation detected by in-gel
fluorescence. A) Lysates were incubated with purified GRX1 protein and subjected to click
reaction, probed by fluorescence. B) HEK293 Cells were washed with PBS for different time
points after induction with H2O2 for 15 minutes. Then click reaction was performed with rhodaminealkyne to assess reversibility of glutathionylation.

Deglutathionylation was readily induced after removing H2O2 from cells (lane 4 and
lane 3, Figure 2.12 B). These data confirm that deglutathionylation can be detected by
azido-GSH, showing that clickable glutathione can be used to detect a reversible change
of glutathionylation in cells.
2.3.5 Fluorescence imaging
The clickable glutathione approach can be used to study various aspects of protein
glutathionylation. For example, we envision that clickable glutathione can be used to
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visualize glutathionylated proteins and the localization by fluorescence imaging. This
technique excludes the incubation of primary and secondary antibodies for visualization.
In addition, a clickable glutathione approach can be coupled with a proximity ligation, a
sensitive technique that is used to study protein-protein interactions and to visualize
PTMs in individual proteins by fluorescence imaging (220). Therefore, we sought to
demonstrate fluorescence imaging of glutathionylated proteins in cellular context. HEK
293 cells were grown on a glass cover slip and L-AzAla was incubated in cells with or
without GS M4 transfection. Cells were then induced for glutathionylation by 15 min
incubation of 1 mM H2O2. Cells were fixed by cold methanol and washed with PBS to
remove an excess amount of cellular glutathione. Then, click reaction was performed
with Alexa Fluor 647 alkyne (AF647). cells were then extensively washed and mounted
on glass cover slips using a mounting solution containing DAPI.
Cells incubated with L-azido-Ala in the presence of GS M4, produced a strong
fluorescence signal (Figure 2.13 E). Glutathionylated proteins were localized in the
cytoplasm and in the nucleus. On the other hand, cells without GS M4 did not produce
any fluorescence signal for glutathionylation (Figure 2.13 B), supporting that clickable
glutathione can be used to visualize glutathionylated proteins using fluorescence imaging.
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Figure 2.13 – Visualization of glutathionylated proteins by fluorescence imaging. L-AzAla
was incubated with HEK 293 cells with (D-F) or without (A-C) GS M4 for 20 hours. Cells were
fixed, blocked and subjected to click reaction with AF647-alkyne. Fluorescence images were
captured for DAPI (A, D) and Cy5, for glutathionylation (B, E). Overlaid images shown in (C and
F).

2.3.6 Identification of individual glutathionylated proteins
We further sought to couple a clickable glutathione approach with mass
spectrometry techniques to identify new glutathionylated proteins. As a proof of concept,
we carried out a pull-down experiment of glutathionylated proteins. To enrich
glutathionylated proteins, cell lysates were subjected to click reaction with biotin-alkyne.
Then, glutathionylated proteins were bound to streptavidin agarose beads (221). Proteins
were then eluted by heating in a SDS loading buffer, and the eluted proteins were
separated by running SDS-PAGE. Glutathionylated proteins were visualized by silver
staining. There were significant amount of glutathionylated proteins when compared to
the control (Figure 2.14 A lane 4).
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Also, this method can be used to probe individual glutathionylated proteins by
immunoprecipitation and Western blotting. After metabolic labeling, individual
glutathionylated proteins were immunoprecipitated using relevant primary antibodies and
subjected to on-bead click reaction with biotin alkyne. PTP1B and Hsp90 are known to
undergo glutathionylation. Therefore, PTP1B and Hsp90 were selected for the analysis
of glutathionylation by immunoprecipitation and Western blotting (5,222). After
immunoprecipitation and on bead-click reaction (223), the eluted protein were probed for
glutathionylation with strep-HRP.

Figure 2.14 – Identification of glutathionylated proteins. A) Lysates subjected to click reaction
with biotin alkyne and biotinylated protein were enriched with streptavidin-agarose beads, and
eluted. Glutathionylated proteins were visualized by silver staining. B) After metabolic labeling,
HSP90 and PTP1B were immunoprecipitated, followed by on bead-click reaction with biotin
alkyne. Eluted proteins were probed as shown above.
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There was a strong signal of glutathionylation for both PTP1B and HSP90 after incubation
of H2O2 (Figure 2.14 B). These data showcase that clickable glutathione can be used to
enrich glutathionylated proteins and the potential mass spectrometric studies.
2.4 Discussion
Protein glutathionylation is a reversible cysteine oxidative modification that
controls protein function (6). Glutathionylation is the disulfide bond formation between a
GSH and cysteines in proteins that take place in the presence of ROS or RNS. Many
proteins are likely to be regulated by glutathionylation (156). Therefore, identification of
protein glutathionylation would make a significant contribution to understanding protein
glutathionylation. Although there are several methods to study protein glutathionylation,
most of tools still suffer from limitations (224). To overcome these limitations, we
developed a versatile chemical method, which metabolically synthesizes clickable
glutathione by a mutant of glutathione synthetase.
Glutathione biosynthesis is an enzyme catalyzed two-step process where the first
enzyme GCL catalyzes the rate limiting step of the formation of dipeptide γGlu-Cys
(213,225). The second enzyme GS catalyzes a ligation of Gly with g-Glu-Cys to form
γGlu-Cys-Gly tripeptide (GSH). we sought to engineer a GS active site in a way that
catalyzes azide- or alkyne-containing Gly derivatives to make clickable glutathione. After
performing a series of site-directed mutagenesis within vitro GS kinetic assay, we found
GS M4 efficiently catalyzes L-AzAla, L-PG and L-HPG to generate clickable glutathione.
Because L-AzAla, L-HPG and L-PG are amino acid derivatives, there is a
possibility of these amino acids being incorporated into proteins during translation.
Consistent with previous studies, our data indicated that L-HPG was significantly
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incorporated into protein biosynthesis while L-AzAla and L-PG were not incorporated into
proteins (226). Although L-PG was not incorporated into proteins, L-PG did not detect
glutathionylation sensitively. Therefore, we concluded that L-AzAla is the best Gly
derivative to generate clickable glutathione inside the cell and to study protein
glutathionylation.
Next, LC-MS analysis confirmed efficient metabolic synthesis of azido-GSH.
Importantly, metabolic synthesis of azido-GSH did not affect the total thiol content of the
cell. Clickable glutathione approach sensitively detected glutathionylated proteins in
response to low concentrations of H2O2. Compared to other methods, azido functional
group is small and tolerated by cellular redox enzymes such as GRX1. Pulse-chase
experiment, where cells were induced for de-glutathionylation by removing ROS
containing medium, showed that azido-GSH containing proteins readily undergo
deglutathionylation by intracellular redox enzymes. In vitro GRX1 assay data also
supported towards similar conclusion that azido-GSH can be tolerated by redox enzymes
unlike other bulky glutathione derivatives such as BIOGEE.
One advantage of clickable glutathione approach is it can couple with mass
spectrometry for the identification of glutathionylated proteins and their modified cysteine
residues. Our data indicated that azido-GSH can use to enrich glutathionylated proteins
by biotin pull-down. Bioorthogonal click reaction allows selective detection and
enrichment of glutathionylated proteins. This method can be improved to identify those
proteins after trypsin digestion and LC-MS/MS analysis. Further, this method can be used
to identify modified cysteine residues by using a cleavable biotin-alkyne with click
reaction. Selective cleavage of glutathionylated peptides can identify by mass
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spectrometry. In addition to identification by mass spectrometry, azido-GSH also can be
used to identify or used to validate glutathionylated proteins by Western blotting.
Immunoprecipitation of individual proteins and on bead click reaction with biotin-alkyne
identified several known glutathionylated proteins by probing with streptavidin-HRP. This,
can also be approached by doing biotin pull-down with clicked lysate and subsequent
analysis of eluted proteins by primary antibodies against protein of interest. Another
important application of clickable glutathione approach is that visualization of
glutathionylated proteins by fluorescence imaging in live or fixed cells. Our data indicated
that glutathionylated proteins can be readily visualized by cellular fluorescence without
using antibodies. This approach can further improve to visualize individual
glutathionylated proteins by coupling with other advanced technologies such as proximity
ligation assay. In future, these applications will allow to study the effect of site specific
glutathionylation on protein interaction and their cellular localization. Overall, we have
generated GS M4 mutant that catalyzes the synthesis of azido-GSH with high catalytic
efficiency, in cells. Thus, our chemical approach with clickable glutathione provides a
chemoselective and versatile handle for studying glutathionylation without altering the
thiol content of the cell.
2.5 Experimental procedure
2.5.1 Reagents and materials
N-Ethylmaleimide (NEM), 5-(Iodoacetamido)fluorescein (FL-IA), phosphoenol
pyruvate (PEP), adenosine 5′-triphosphate disodium salt hydrate (ATP), type II rabbit
muscle lactate dehydrogenase (LDH), type II rabbit muscle pyruvate kinase (PK), γglutamylcysteine, β-nicotinamide adenine dinucleotide, reduced disodium salt hydrate
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(NADH), L-glycine (Gly), L-alanine (Ala), L-methionine (Met), L-valine (Val), copper(I)
bromide, anti-FLAG antibody and anti-GS antibody were purchased from Sigma Aldrich.
Streptavidin-horseradish peroxidase (HRP) was purchased from Thermo Scientific. HRPconjugated anti-mouse and anti-rabbit secondary antibodies were purchased from GE
healthcare (U.K). Polyethyleneimine “MAX” was purchased from Polysciences, Inc
(USA). 3-Azido-L-alanine HCl (L-AzidoAla) was purchased from Jena Bioscience
(Germany). L-homopropargyl-glycine (HPG) and L-propargyl-glycine (PG) were
purchased from Life Technologies and Pep-Tech Corporation, respectively. Ni-NTA
agarose was purchased from QIAGEN. EDTA-free protease inhibitor cocktail was
purchased from Roche. All cell culture reagents and medium were purchased from Life
Technologies.
2.5.2 Competent cell preparation
DH5α cells were used to extract plasmid DNA and BL21 cells were used for protein
overexpression. To generate chemically competent DH5α and BL21 cells, first, a tiny
amount from both cell stocks were streaked on two separate agar plates without any
antibiotic. Agar plates were incubated in a bacterial incubator at 37 oC for overnight
(approximately 16 h). On the following day, a single colony was inoculated in a 5 mL of
Luria broth (LB) medium without any antibiotic and incubated in a bacterial shaker for 16
h. LB media (5 mL) containing bacterial cells were diluted into an autoclaved 1 L LB
medium and incubated in a bacterial shaker until OD600 reach to 0.4. Then cells were
transferred into autoclaved, ice-cold centrifuge bottles and cells were harvested by
spinning at 5000 rpm for 15 minutes. After this step, all other steps were done on ice or
at 4 0C. Cells were washed once with sterile filtered ice-cold 100 mL of 100 mM MgCl2
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solution and centrifuged to remove supernatant. Then cells were re-suspended in 100 mL
of 100 mM CaCl2 and incubated for 20 minutes. After centrifugation, supernatant was
removed and the resultant pellet was re-suspended in 100 mL of 85 mM CaCl2 and 15%
glycerol (v/v) and incubated for another 30 minutes. After the 30 minute incubation, cells
were collected by centrifugation and re-suspended in 10 mL of 85 mM CaCl2 and 15%
glycerol (v/v) and aliquoted (100 µL) into autoclaved and chilled eppendorf tubes.
Competent cells were flash frozen in liquid nitrogen and stored in -80 0C freezer.
2.5.3 Long term storage of bacterial cells
A single colony was inoculated in 5 mL of LB media and incubated for 16 h in a
bacterial shaker at 37 0C. In the following day, a portion (750 µL) of overnight culture was
mixed with 250 µL of autoclaved 65% glycerol in an eppendorf tube, flash froze in liquid
nitrogen and stored in -80 0C freezer.
2.5.4 Bacterial transformation
An aliquot of competent DH5α or BL21 cells were thawed in ice. Once competent
cells are thawed, 50 µL of cells were mixed with ice-cold plasmid DNA (50 ng) and
incubated on ice for 20 minutes. Then tubes were incubated in a heat block at 42 0C for
45 seconds and immediately placed on ice for another 2 minutes. Then cells were mixed
with 400 µL of super optimal broth with catabolite repression (SOC) medium and
incubated for 30 minutes in a bacterial shaker at 37 0C. Then cells were briefly collected
by centrifugation at 4000 rpm for 5 minutes and a half of media was removed and cells
were re-suspended in the rest of medium and evenly spread on agar plates containing
appropriate antibiotic. Plates were then incubated in a bacterial incubator at 37 0C for 16
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h. Always included a negative control (cells without DNA) for the confirmation and to
check for possible contamination.
2.5.5 Plasmid DNA isolation (mini and maxiprep)
A clump from cell stock containing plasmid DNA was inoculated in LB (5 mL for
miniprep and 250 mL for maxiprep) containing appropriate antibiotic and incubated in a
bacterial shaker (200 rpm) at 37 0C for 16 h. Overnight 5 mL culture was centrifuged
(4000 rpm for 5 min) and cell pellet was resuspended in 250 µL of P1 solubilizing buffer
(50 mM Tris-Cl, pH 8.0, 10 mM EDTA, 100 μg/mL RNAse A). Then cells were incubated
with 250 µL of P2 lysis buffer (200 mM sodium hydroxide, 1% SDS) for 3-5 minutes (no
more than 5 minutes). Lysis buffer was neutralized with the addition of 350 µL N3 buffer
(3.0 M potassium acetate, pH 5.5) and incubated for 5 minutes at room temperature. Cell
debris were precipitated by centrifugation at 13 000 rpm for 10 minutes. Clear cell lysate
was carefully transferred to DNA binding spin columns without any solid debris. Extracted
plasmid DNA was bound to the membrane after high speed centrifugation at 13 000 rpm
for 1 minute and flow through was discarded. Then spin columns were washed twice with
500 µL of washing buffer (Qiagen) and liquid was discarded by high speed centrifugation
after each wash. Bound DNA was eluted with 50 µL water by centrifugation at high speed
for 1 minute. DNA concentrations were measured by nanodrop before using in cloning
procedures. For DNA purification by maxiprep, manufacturer protocol was followed as
described in protocols under product number K0491 from ThermoFisher Scientific.
2.5.5 Subcloning
2.5.5.1 Polymerase chain reaction (PCR)
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GS WT gene was amplified from pCMV6-GS vector by performing Polymerase
chain reaction (PCR). PCR was carried out using a thermocycler (Eppendorf Mastercycler
Gradient). Approximately 50 ng of plasmid DNA (2 μL from 50 ng/uL stock) containing GS
WT gene incubated with 5 µL of 10X ultra pfu buffer, (200 mM Tris, 100 mM (NH4)2SO4,
100 mM KCl, 1% TritonX-100, 20 mM MgSO4, 1 mg/mL BSA, pH 8.8), forward and
reverse primers (1 μL from 10 μM stocks), and dNTPs (2 μL of 10 mM; 2.5 mM of each
base). The final PCR reaction volume adjusted to 49 μL by adding deionized water. After
mixing well, 1 μL of Pfu ultra-enzyme was added and incubated in a thermocycler
programmed as indicated in the Table 2.2. Amplified DNA was purified by gel extraction
method after running a DNA agarose gel as described in QIAgen gel extraction kit (cat #
28704).
Table 2.2 - PCR program for GS amplification.

Cycle

Temp (0C)

Time

Number of
cycles

Initial denaturation

95

5 min

1

Denaturation
Annealing
Extension
Final extension

95
65
72
72

45 sec
45 sec
1.5 min
15 min

35

1
35

2.5.5.2 Restriction digestion
GS WT gene was inserted into pET28A (Novagen Catalogue number – 698643)
bacterial expression vector after double restriction digestion with NdeI and HindIII.
Amplified GS WT (1 μg) were incubated with 5 μL of 10X cutsmart NEB buffer and 1 μL
from each NdeI (20,000 units/mL) and HindIII-HF (20,000 units/mL) restriction enzyme, 1
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μL from 10 mg/mL BSA stock and finally reaction volume was set to 50 μL with deionized
water. After mixing well, reaction mixture was incubated in an incubator at 37 0C. After 1
h of incubation, 10 μL from 6X DNA loading dye (10 mM Tris-HCl (pH 7.6) 0.03%
bromophenol blue, 0.03% xylene cyanol FF, 60% glycerol 60 mM EDTA) was added and
digested GS gene was separated in an agarose gel (120 mV for 30 minutes) and purified
by gel extraction. Similarly, restriction digestion by same restriction enzymes and gel
extraction was performed for empty pET28A bacterial expression vector and used for
ligation.
2.5.5.3 Ligation
Double digested GS WT and pET28A were mixed in 1:3 ratio (0.020 pmol and
0.060 pmol) with 2 μL of 10X T4 DNA ligase buffer, 1 μL from 100 mM ATP stock,1 μL
from T4 DNA ligase (400,000 units/ml) and final reaction volume set to 20 μL with
deionized water. Ligation mixture was mixed well and incubated in an incubator at 16 0C
for 20 h. Ligase enzyme was heat inactivated by incubating ligase reaction mixture at 65
0C

for 15 min. Then mixture was chilled on ice for another 15 minutes, transformed into

DH5α and plated on agar plates containing 50 μg/mL Kanamycin according to the protocol
described in 2.5.4. A single colony was inoculated in LB containing 50 μg/mL Kanamycin
and incubated for 16 h and plasmid DNA (pET28A-GSWT) was purified using the protocol
described in section 2.5.5. After purification, DNA concentration was measured by
nanodrop and ligation was confirmed by DNA sequencing.
2.5.6 Site-directed QuickChange mutagenesis
GS mutants were generated by QuickChange mutagenesis. pET28A-GSWT was
used as the template to generate GS M1 (F152G). pET28A-GSWT 50 ng was mixed with
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5 μL of pfu buffer. Quick change forward and reverse primers (all quick-change primers
are listed in Table 2.4) were incubated in two separate PCR tubes with template and pfu
buffer. After adjusting the volume to 49 μL with deionized water, 1 μL of pfu ultra enzyme
was added to each tube. Two tubes containing above components were incubated in a
thermocycler and subjected to 2 thermocycles as indicated in the Table 2.3. After that,
reaction mixtures in two tubes were mixed together and incubated in the thermocycler for
another 18 cycles using the program shown in table 2.3. Reaction mixture was then
incubated with 1 μL of Dpn1 (20,000 units/mL) for 1 h at 37 0C. Finally, 2 μL from Dpn1
digested PCR reaction was transformed into DH5α using the protocol described in section
2.5.4.
Table 2.3 - PCR program for QuickChange mutagenesis.

Temp (0C)

Cycle

Time

Number of
cycles

Initial denaturation

95

5 min

1

Denaturation
Annealing
Extension
Final extension

95
55
72
72

45 sec
45 sec
10 min
20 min

2 or 18

4

Hold

1
35

Table 2.4 - QuickChange primers for GS mutants.

Mutant enzyme

Primer sequence 5’ to 3’
F-primer GAA ATC AAC ACC ATC TCT GCC AGC GGT
GGG GGC CTG GCC TCC
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GSM1

R-primer GGA GGC CAG GCC CCC ACC GCT GGC AGA
GAT GGT GTT GAT TTC

GSM2

F-primer GAA ATC AAC ACC ATC TCT GCC GGC GGT
GGG GGC CTG GCC TCC
R-primer GGA GGC CAG GCC CCC ACC GCC GGC
AGA GAT GGT GTT GAT TTC

GSM3

F-primer GAA ATC AAC ACC ATC TCT GCC GGC TTT
GGG GGC CTG GCC TCC
R-primer GGA GGC CAG GCC CCC AAA GCC GGC AGA
GAT GGT GTT GAT TTC

GS M4

F-primer GAA ATC AAC ACC ATC TCT GCC GGC GCT
GGG GGC CTG GCC TCC
R-primer GGA GGC CAG GCC CCC AGC GCC GGC
AGA GAT GGT GTT GAT TTC

2.5.7 Generation of expression vectors
Wild type GS (GS WT) gene was amplified by PCR using a forward primer with
NdeI restriction site (5'-GGT GGT CATATG GCC ACC AAC TGG GGG AGC-3') and a
reverse primer with Hind III restriction site (5'-GGT GGT AAGCTT CTA CAC AGG GTA
TGG GTT GTC CAG GAC TGC-3'). Amplified GS WT PCR products were subcloned into
the pET28a bacterial expression vector. All GS mutant (M1, M2, M3 and M4) constructs
were made using pET28a-GS WT as the template by site-directed quick-change
mutagenesis (Primers used in QuickChange mutagenesis listed in the Table S1). GS M2
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clone was PCR amplified using a forward primer with HindIII restriction site and Nterminal FLAG-tag sequence (5'-GGT GGT AAG CTT ATG GAT TAC AAG GAT GAC
GAT GAC AAG ATG GCC ACC AAC TGG GGG AGC-3') and a reverse primer with XhoI
restriction site (5'-GGT GGT CTCGAG CTA CAC AGG GTA TGG GTT GTC CAG GAC
TGC-3'). Amplified GS M2 PCR product was sub-cloned into the pCDNA3.1(+)
mammalian expression vector. QuickChange mutagenesis was performed using
pCDNA3.1-GS M2 as the template to introduce Kozak sequence with a forward primer
(5'-GCT AGC GTT TAA ACT TAA GCT TGC CAC CAT GGA TTA CAA GGA TGA CG3') and a reverse primer (5'-CGT CAT CCT TGT AAT CCA TGG TGG CAA GCT TAA
GTT TAA ACG CTA GC-3'). pCDNA3.1-GS M2 plasmid was used to generate GS M4 for
mammalian expression. For glutaredoxin (GRX1), the gene was amplified by PCR using
a forward primer (5’-GAC GAC CAT ATG GCT CAA GAG TTT GTG AAC TGC-3’) and a
reverse primer (5’-GGT GGT AAG CTT CTA CTG CAG AGC TCC AAT CTG CTT TAG3’). GRX1 PCR product was subcloned into pET28a. All cloned plasmids were confirmed
by DNA sequencing of entire open reading frames.
2.5.8 Bacterial protein expression and purification
All the bacterial expression constructs were transformed into E. coli BL21 (DE3)
cells and transformed cells were inoculated in Luria broth (LB) media containing
Kanamycin (50 μg/mL), and incubated overnight at 37 oC in a bacterial shaker. Growing
bacterial cells were diluted into 1L of LB media containing kanamycin. Cells were grown
at 37 oC until OD600nm reached at 0.8 and then induced with isopropyl-1-thio-β-Dgalactopyranoside (IPTG) (0.4 mM) at 16 oC. After 20 h of induction, cells were collected
by centrifugation at 4,000 rpm for 20 min at 4 oC. Collected cells were re-suspended in
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lysis buffer (50 mM Tris-HCl pH 8.3, 300 mM NaCl and 10 mM imidazole) and lysed by
double passing through a chilled French press at 1,000 psi. After removing the cell debris
by high speed centrifugation at 14,000 rpm for 30 min at 4 oC, supernatant was incubated
with Ni-NTA beads (prewashed with lysis buffer) for 1 h at 4 oC. Lysates were then drained
and beads were washed three times with wash buffer (50 mM Tris-HCl pH 8.3, 300 mM
NaCl) containing 25 mM imidazole and His-tagged GS protein was eluted with elution
buffer (50 mM Tris-HCl pH 8.3, 300 mM NaCl) containing 300 mM imidazole. Positive
fractions were collected and dialyzed against 50 mM Tris buffer pH 7.4, 10% glycerol and
1 mM DTT overnight, followed by concentrated using a centrifugal filter device (Millipore).
Protein concentration was measured by Bradford assay (Bio-Rad) using bovine serum
albumin as the standard. Grx1 was expressed as described above, but with induction at
37 oC for 5 h.
2.5.9 Enzyme assay
Kinetics parameters for GS WT and other GS mutants were determined by
measuring consumption of NADH with ATP-regenerating system, pyruvate kinase (PK)
and lactate dehydrogenase (LDH).S4 The NADH consumption was monitored by UV
absorbance at 340 nm. The reaction mixture (0.2 mL) contained 100 mM Tris-HCl buffer
(pH 7.4), 150 mM NaCl, 25 mM MgCl2, 0.2 mM NADH, 2 mM phosphoenolpyruvate
(PEP), 5 mM ATP, 15 units of LDH, 10 units of PK, 2 mM γ-glutamylcysteine and 0.5 μg
of GS enzyme. Different amino acids, including Gly and L-azido-Ala, were used as
substrates ranging from 0.01 mM to 5 mM while γ-glutamylcysteine was kept at saturated
levels. Reactions were started by adding 0.5 or 1 μg of GS WT or mutants, and the
decrease of absorbance was measured at 340 nm using DU730-Beckman coulter UV/Vis
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spectrophotometer. To calculate initial rates for different substrate concentrations, the
linear region of the curve was considered. Initial rates were then fitted to the MichaelisMenten equation V = Vmax [S] / (Km + [S]) using Graphpad prism 5.01 to calculate Km and
Kcat values for individual substrates.
2.5.10 Cell culture
Human embryonic kidney (HEK) 293 cells were grown in high glucose Dulbecco’s
Modiﬁed Eagle’s Medium (DMEM) supplemented with heat inactivated 10% fetal bovine
serum (FBS) and 5 U/mL of penicillin and 5 μg/mL of streptomycin. Cells were plated at
least two days before being subjected to any experimental procedure in a humidified
incubator at 37 oC and 5% CO2.
2.5.11 Starting a new cell line
A cell stock stored in liquid nitrogen vapor phase was taken out and thawed in 37
oC

water bath. Then cells were centrifuged at 1000 rpm for 5 minutes and supernatant

was discarded. Cell pellet was resuspended in 1mL of complete medium and transferred
to a 10 cm dish containing 9 mL of complete DMEM medium. Cells were incubated in a
humidified incubator at 37 oC and 5% CO2.
2.5.12 Mammalian cell splitting
When HEK293 cells are nearly 80-90% confluent, cells were washed with 10 mL
of warm PBS. Then, 1 mL of 0.25% trypsine-EDTA solution was added to a10 cm dish
(0.5 mL for 6 cm dish) and incubated for 3-5 minutes at 37 oC. After trypsinization, 10 mL
of complete DMEM medium was added to neutralize trypsin activity and cells were
resuspended to avoid clumping. Then 1 mL of trypsinized cells were transferred to fresh
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sterile 10 cm dishes containing 9 mL of complete DMEM medium and incubated in the
humidified incubator at 37 oC and 5% CO2.
2.5.13 PEI-max transfection
When cells were about 70-80% confluent, GS M4 was transfected using
polyethylenimine (PEI-max) as the transfecting agent. A stock solution of PEI-max was
prepared by dissolving 10 mg of PEI-max in 1 mL of autoclaved deionized water. Then
solution was basified with 6 M NaOH until pH reached 7-7.5. After adjusting pH, stock
solution was sterile filtered using a syringe filter (0.2 µm, 13 mm). Working solution of 1
mg/mL PEI-max solution was prepared by 10 times dilution of 10X stock solution in sterile
water. First, cell culture media was removed from 10 cm dishes and replaced with 9 mL
of DMEM without penstrep and FBS. To two1.5 eppendorf tubes, 500 µL of DMEM without
penstrep and FBS was added. To a one tube, 12 µL of 1X PEI-max was added and to
the other tube, 5 µg of DNA was added and incubated for 10 minutes in room temperature.
After ten minutes, both tubes were mixed together and a single tube containing PEI-max
and DNA was incubated for another 15 minutes at room temperature. Then 1 mL of DNAPEI-max complex was added dropwise to a single 10 cm dish, mixed gently and incubated
in a mammalian cell culture incubator. After 6 h, medium containing DNA-PEI-max
complex was removed and cells were incubated for another 18 or 42 h in fresh complete
DMEM medium.
2.5.14 Cell lysis
To detect glutathionylation sensitively, cells must lyse immediately after removing
ROS containing medium. Lysis buffer was prepared by adding 1 mL of 10% SDS, 1 mL
of IGEPAL, 100 µL of TWEEN-20 to 98 mL of Tris buffer saline (TBS, pH-7.4, 150 mM
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NaCl). TBS lysis buffer can store in cold room for months. To make 1 mL of complete
lysis buffer, 100 µL of protease cocktail mixture (prepared by dissolving one crushed
protease tablet in 2 mL of sterile water) and 50 µL from 1 M N-ethylmaleimide (NEM)
were mixed with 850 µL of TBS lysis buffer. Lysis buffer was kept on ice until use. Cells
were washed once with ice-cold PBS and all remaining liquids were aspirated in to the
waste container. Then 500 µL of lysis buffer was immediately added on to the cells and
cells were scraped out with a cell lifter. Cells were collected by lifting cell culture dish to
a 45-degree angle and with a 1mL pipet. Tubes containing cells and lysis buffer were
placed in a rotary shaker for 30 minutes at 4 0C. After incubation, cell debris were removed
and clear cell lysate was collected to a fresh eppendorf tube after centrifugation at 14,000
rpm for 20 minutes.
2.5.15 Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE)
SDS-PAGE gel was prepared using separating and stacking buffers. Prior to that,
glass plates (1.5 mm, BioRad) were washed and dried before mounting on the gel
preparing rack. Separating bufer mixture for 12% gel was prepared by mixing 2 mL of 4X
Tris/SDS buffer (1.5 M Tris, 0.24 M HCl; pH 8.8, 0.4% SDS), 2.4 mL of 40% acrylamide
(BioRad; 37:1), 3.62 mL of distilled water, 80 µL of 10% (w/v) of freshly made ammonium
persulfate (APS) and 8 µL of N, N, N’, N’-tetramethylthylenediamine (TEMED; Sigma)
and carefully added in between the glass plate up to ¾ of the short glass plate. After
pouring separating layer, methanol or isopropanol was immedietly added over the
separating layer. After 30 minutes, stacking buffer mixture was prepared (by mixing 1 mL
of 4X Tris/SDS buffer (1.5 M Tris, 0.24 M HCl; pH 6.8, 0.4% SDS), 0.5 mL of 40%
acrylamide, 2.48 mL of distilled water, 20 µL of fresh 10% (w/v) APS, and 4 µL TEMED)
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and poured over the separating layer after removing methanol or isopropanol and drying.
Immediately after pouring the stacking layer, 10-well or 15-well comb was put through the
glass plates and kept for another 30 minutes before using. Once samples are ready for
electophoretic separation, comb was removed and transferred to the SDS-PAGE running
container together with electrodes. Then, SDS-running buffer (1X; 0.025 M Tris; 0.05 M
glycine 0.5% SDS) was poured up to the level indicated in the container and closed the
lid before running for desired time at 150 V or 200 V. After running the gel, glass plates
were separated, gel was exposed and washed with water before staining or Western
blotting.
2.5.16 Coommassie staining
After running SDS-PAGE, protein contaning gel was washed twice in distilled
water and fixed in fixing solution (50% methanol and 10 glacial acetic acid) for 30 minutes.
Then fixing solution was discarded and the gel was stained in staining solution (0.1%
Coomassie Brilliant Blue R-250 in 50% methanol and 10 % glacial acetic acid) for 1 h
after microvawing for 1 minute at full power or incubated overnight without microvawing.
Before destaining, gel was washed three times with distilled water to remove excess
staining solution. Then the gel was destained in 40% methanol and 10% glacial acetic
acid overnight. The destained gel stored in 5% glacial aceic acid until imaging.
2.5.17 Western blotting
To transfer protein bands in SDS-PAGE gel to a PVDF membrane, Westen blotting
was carried out. First, stacking layer of the gel was removed and separarting layer was
washed several times using distilled water and transfer buffer (10% methanol,24 mM Tris
and 194 mM glycine). To make the gel sandwich, black side of the cassette was placed
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on the surface of the bench and pre-wetted fiber pad was placed on the top of it. Then
pre-wetted filter paper and the gel was placed on the fiber pad one after the other. Then
pre-wetted membrane was placed on the top of the gel followed by the second filter paper
and fiber pad to complete the sandwich. At this stage, it is critical to remove any air
bubbles from the membrane before closing and locking the cassette. Place the cassette
in the module facing black side of the cassette to black side of the module. Take the whole
set up to the transfer container with an ice block and fill the tank with transfer buffer.
Transfer is carried out at 90 V for 2 h on ice. After the transfer, cassette was unlocked by
unclamping the white latch and fiber and filter paper was removed. The membrane was
washed once with 1X TBST and proceeded to the antibody probing.
2.5.18 Metabolic labeling and click reaction
At 70-80% confluence, 2.5 μg of GS M4 plasmid was transfected using PEI-Max
as the transfecting agent in 6 cm dishes. After 48 hours, different concentrations of Lazido-Ala, HPG and PG were incubated (separately in individual experiments) with cells
for another 20 h or varying time periods. Cells were then treated with hydrogen peroxide
for 15 min. For glutathionylation turn-over studies, the medium containing hydrogen
peroxide was removed and replaced by fresh medium. Cells were then lysed in TBSTween lysis (50 mM Tris-HCl, 150 mM NaCl, 0.1% SDS, 1% IGEPAL, 0.1% TWEEN-20)
containing 50 mM N-ethylmaleimide and EDTA-free protease inhibitor. Protein
concentration was determined by Bradford assay. For click reactions, 100 μg of cell
lysates were precipitated by adding cold acetone (4 times volume to cell lysates) and
incubation at -20 oC for 1 hour. The precipitate was re-dissolved in 100 mM Tris buffer pH
7.4. Lysates were then mixed with click reagents, [0.1 mM biotin-alkyne, rhodamine-
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alkyne or rhodamine-azide, 0.2 mM Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine
(TBTA) and 0.4 mM CuBr] for 1 h at RT. To monitor in vitro deglutathionylation by Grx1
enzyme, lysate was incubated with 10 µg of purified GRX1 in the presence of 1.5 mM
GSH for 30 min at 37 oC. Lysates were then subjected to click reactions. Lysates labeled
by click reaction were resolved on 12% SDS-PAGE, followed by Western blotting or direct
detection of in-gel fluorescence. After transferring to PVDF membrane, the membrane
was blocked with 5% BSA in TBST (50 mM Tris-HCl, 150 mM NaCl, 0.1% Tween) and
incubated with streptavidin-HRP (1:1000) in 5% BSA in TBST for 2 h at RT, and analyzed
for chemiluminescence to visualize biotinylated proteome. Anti-GS (1:1000) and antiFLAG antibody (1:1000) and appropriate HRP-conjugated secondary antibodies were
used to visualize expression levels of GS WT or M4 mutant.
2.5.19 LC-MS analysis of glutathione
To monitor in vitro biosynthesis of glutathione and glutathione derivatives, in vitro
assay was analyzed by LC-MS (SHIMADZU, Nexera X2). In a reaction mixture, 5 mM γglutamylcysteine, 10 mM ATP, 5 mM Gly, 5 mM Met and 5 mM Azido-Ala were incubated
with GS WT, GS M4, or a mixture of GS WT and GS M4 in a ratio of 1:5 for 2 h at 37 oC.
The reaction was quenched by spin-filtering enzymes with centrifugal device (MW cutoff
3,000 Da, Millipore). The filtrate free of proteins was treated with fluoresceiniodoacetamide (FL-IA) (1.5 mM) for 1 h at RT and injected into LC-MS. To monitor
biosynthesis of azido-glutathione in cells, cells were lysed in 1xPBS by repeating freezethaw three times in the presence or absence FL-IA. Lysates were spin-filtered through
centrifugal device (MW cutoff 3,000 Da) to remove proteins. Proteins-free filtrate was then
injected into LC-MS.

In mass ion chromatogram, the masses corresponding to
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glutathione or glutathione derivatives were extracted. Individual mass extraction ion
chromatograms were overlaid.
2.5.20 Bromobimane assay
To calculate the overall thiol content, protein-free lysates were incubated with 0.5
mM bromobimaneS5 in 0.1 M Tris buffer for 30 min at 25 oC in the dark. Fluorescence (λex
390 nm and λem 478 nm) was measured using Synergy H1 Hybrid Multi-Mode Microplate
Reader (Biotek).
2.5.21 Fluorescence imaging of glutathionylation
HEK 293 cells were grown on glass cover slips in a six well plate. At about 40%
confluence, HEK 293 cells were transfected with GS M4 mutant, using PEI-Max as the
transfecting agent. Cells with or without GS M4 mutant were incubated with L-azido-Ala
(1 mM) for 20 h, and treated with H2O2 (1 mM) for 15 min. Cells were then washed with
PBS once, fixed with cold methanol for 15 min at -20 oC, and washed with PBS three
times. All free thiols were blocked by N-ethylmaleimide (50 mM) for 15 min at RT. After
washing with PBS, cells were blocked with 1xTBS containing 0.1% TWEEN-20 and 3%
BSA for 30 min at RT. Cells were rinsed twice with PBS, and subjected to click reaction
in 1xTBS in the presence of TBTA (0.1mM) and CuBr (0.2 mM) and Alexa Fluor 647alkyne (Invitrogen) (20 μM) for 30 min at RT. After extensive washing with PBS, the glass
cover slips were mounted on microscope slides with a mounting solution containing DAPI.
Slides were stored at 4 oC in dark until imaging. Fluorescence images were monitored
and captured with Olympus fluorescence microscopy (BX 41) for nucleus staining with a
DAPI channel (λex 350 nm, λem 470 nm) or for glutathionylation with Cy5 channel (λex 650
nm, λem 670 nm).
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2.5.22 Enrichment of glutathionylated proteins by streptavidin-agarose
HEK 293 cell lysates (2 mg) were prepared after GS M4 transfection and
incubation of L-AzidoAla (1 mM). Lysates were subjected to click reaction with biotinalkyne. Reaction was performed at RT for 1 h in 1xTBS (0.5 mL) containing 0.2 mM biotinalkyne, 0.4 mM TBTA and 1 mM CuBr with gentle vortex at least twice during the reaction.
Each reaction tube was incubated with1 mL of ice-cold acetone for 30 minutes at -20 0C.
Precipitated proteins were centrifuged at 6500xg for 4 min. Protein pellets were washed
with cold methanol (0.5 mL) twice, followed by centrifugation. Proteins were re-dissolved
with a brief sonication in 1xTBST (0.2 mL) containing 1.2% SDS. The final SDS
concentration was diluted to 0.2% by adding 1xTBST (1 mL). Proteins were then mixed
with pre-washed streptavidin-agarose beads (100 μL) for 1 h at RT. Streptavidin-agarose
beads were washed three times with 1xTBST and eluted with 1X SDS loading buffer (100
μL). Proteins were separated by SDS-PAGE. Enriched glutathionylated proteins were
visualized by silver staining.
2.5.23 Identification of individual glutathionylated proteins (Immunoprecipitation
and on bead click)
HEK 293 cell lysates (1 mg) were prepared after GS M4 transfection and
incubation of L-AzidoAla (1 mM). Lysates were incubated with primary antibodies for
PTP1B (Santacruz) and HSP90 (BD Bioscience) at 4 oC. After 1 hour, cell lysates were
incubated with pre-washed protein G agarose (Invitrogen) (50 μL) overnight at 4 oC. After
washing three times with 1xTBST (0.5 mL), proteins on beads were subjected to on beadclick reaction with biotin-alkyne. Click reaction was performed in 1xTBST containing
biotin-alkyne (0.2 mM), TBTA (0.4 mM) and CuBr (1 mM) for 20 h at 4 oC. Proteins on
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beads were then washed with TBST (1 mL) three times and eluted with a SDS-loading
buffer. Eluted samples were separated on SDS-PAGE, and probed with streptavidin-HRP
(1:1000, 3% BSA in TBST) or primary antibodies for PTP1B (1:1000 dilution) and HSP90
(1:1000 dilution), followed by secondary antibodies.
2.5.24 Determination of protein concentration using Bradford protein assay
Cell lysates were diluted by 20X and 40X using distilled water. First, 19 µL and 39
µL of distilled water were transferred to two 500 µL eppendorf tubes. Then 1 µL from
lysate was mixed in each tube to give 20X and 40X diluted lysates. Out of 20 µL and 40
µL of total diluted mixture, 10 µL was pipetted out and transferred to two wells of clear
96-well plate. Then 200 µL from quick start 1X Bradford reagent was mixed and air
bubbles were removed using a needle. Absorbance was then measured at 595 nm using
a plate reader. Lysate concentrations were calculated using the standard curve equation.
For standard curve, 10 mg/mL BSA was serially diluted to make 0.5, 0.4, 0.25, 0.15 and
0.05 mg/mL. In a similar manner, 10 µL from each standard BSA solution was mixed with
200 µL of quick start 1X Bradford reagent and absorbance was measured at 595 nm.
2.5.25 Silver staining
After electrophoresis, gel was washed for 5 minutes with distilled water. Washing
continued for another two times before fixation. Then gel was incubated in fixing solution
(30% ethanol, 10% acetic acid) for 15 minutes. Fixing solution was discarded and fix
again with fresh fixing solution for 15 minutes. After fixation, gel was washed twice with
10% ethanol solution for 10 minutes at room temperature followed by two time washing
with distilled water for another 10 minutes. Sensitizer solution (Pierce Silver Stain Kit,
catalog number 24612) was prepared by mixing 25 µL of sensitizer solution in 10 mL of
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distilled water and the gel was sensitized for 1 minute and two washings with distilled
water for 1 minute each. Next, gel was stained in stain working solution (0.5 mL of Silver
Stain Enhancer in 10 mL of Stain solution) for 30 minutes. Gel was washed with distilled
water for 20 seconds twice quickly before developing the stain with developer working
solution (0.25 µL of Enhancer in 10 mL of Developer solution) for 3-5 minutes until protein
bands appear. Staining was quenched by the addition of 5% acetic acid solution. Gel was
washed well with distilled water before taking pictures.
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CHAPTER 3 CHARACTERIZATION OF GLUTATHIONYLATED PROTEINS IN
RESPONSE TO METABOLIC ALTERATION
3.1 Introduction
Glucose metabolism provides necessary metabolites for generation of ATP via the
electron transport chain (ETC) in mitochondria (227). Reactive oxygen species (ROS) are
produced in mitochondria as a byproduct of respiration (228). Many cancer cells have an
elevated level of ROS when compared to normal cells, partially due to their increased
cellular metabolism (229). Importantly, glucose or its metabolite is fluxed into pentose
phosphate pathway (PPP) to generate NADPH, a reducing source for many redox
enzymes that are important for maintaining redox homeostasis. Therefore, cancer cells
appear to rely on excess glucose availability and its metabolism for both energy
generation and redox homeostasis (230). An elevated level of mitochondrial ROS in
cancer cells can trigger redox-mediated signaling associated with cancer cell phenotypes,
such as increased proliferation rate, decreased apoptosis, cell survival and migration
(231-234). Similarly, high levels of mROS were observed in pancreatic β cells, in
response to high glucose or hyperglycemia (235-237).
On the other hand, a low concentration of glucose in cells also induces generation
of ROS (238,239). One study showed that increased levels of H2O2 and superoxide were
produced in isolated rat β cells when they were exposed to a low concentration of glucose
(0-5 mM) (240). Similar response was observed also in several insulin-secreting cells
(241,242). Cells with a low level of glucose can produce superoxide specifically by
mitochondrial complex 1. ROS production is further intensified, partially due to a low
expression level or activity of anti-oxidant enzymes (243-246). Under these conditions, it
was shown that AMP activated kinase (AMPK) initiates apoptosis in pancreatic β cells
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(247). Since AMPK activation is interconnected with mTOR/autophagic pathway, a low
level of cellular glucose also plays a role in autophagy (248,249).
In addition, it is reported that glucose depletion together with hypoxia increases
the production of ROS via activating unfolded protein response (UPR) (250). The UPR is
known to induce ROS by several enzyme-catalyzed reactions, such as protein disulfide
isomerase and ER oxidoreductin 1 (251,252). UPR is also associated with cell death by
inducing apoptosis through activating ATF4, C/EBP-homologous protein (CHOP) and
caspases-12, highlighting significant cellular phenotypes in response to glucose depletion
or metabolism (250,253,254). It is further shown that glucose deprivation induces cell
death in MCF7/ADR cells via activation of mitogen-activated protein kinase (MAPK)
pathway (255).
NADPH is an essential reducing agent, which is important for maintaining cellular
redox homeostasis (256). PPP is one of NADPH synthesizing processes in cell. In cancer
cells, glucose is fluxed into PPP to produce NADPH, which is necessary for anabolic
reactions and detoxification of reactive species. Thus, glucose depletion slows down
NADPH production and disturbs redox homeostasis and ROS detoxification (225).
Glucose depletion also increase ROS production in the mitochondrial electron transport
chains, contributing to a metabolic oxidative stress in the cell (255).
Age-related diseases, including cancer and diabetes, are associated with an
increased production of mROS. High levels of ROS leads to mitochondrial DNA
mutations. Mitochondrial dysfunction is a common feature of many age-related diseases.
Although mitochondrial dysfunction and glucose depletion are involved in production of
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mROS, glutathionylation is not systematically evaluated under glucose depletion and/or
mitochondrial dysfunction.
3.2 Approach
To induce mitochondrial ROS, we used the electron transport chain blockers.
Antimycin A (AMA) and rotenone are well-known for blocking the ETC, which generates
ROS at complex III and complex I, respectively (257). To investigate protein
glutathionylation in the presence of AMA or rotenone, we employed our clickable
glutathione approach with GS M4 mutant (211). First, we generated HEK293-GS M4
stable cells which stably overexpress a GS M4 mutant. L-AzAla was then incubated with
HEK293-GS M4 cells for 20 h. After serum starvation for another 4 h, cells were treated
with AMA (2 μg/mL) with or without glucose for different time points. Glutathionylated
proteins were visualized by a bioorthogonal click reaction using fluorophore-alkyne or
biotin-alkyne. Glutathionylated proteins were further identified by LC/MS/MS analysis
(Figure 15).

Figure 3.1 - The work flow for identifying glutathionylated proteins in response to
mitochondrial ROS.
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3.3 Results
3.3.1 Characterization of HEK293-GS M4 stable cells for the generation of azidoGSH
First, HEK293-GS M4 cell line was evaluated for synthesis of clickable glutathione.
After generation of HEK293-GS M4 stable cell line, L-AzAla was incubated for the
synthesis of azido-GSH. It was found that cells generated the similar amount of azidoGSH (N3-GSH) to endogenous GSH within 20 h (Figure 3.2 A). In addition, a free thiol
content and several redox enzyme levels were examined in HEK293-GS M4 stable cells.
HEK293-GS M4 and HEK293 cells showed the similar thiol concentrations and
expression levels of redox enzymes (Figure 3.2 B and C). Therefore, these data support
that the stable expression of GS M4 in HEK293/GS M4 did not alter an intracellular redox
state significantly.
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Figure 3.2 - Evaluation of azido-glutathione (N3GSH) biosynthesis, cellular thiol
concentration and redox enzyme levels in HEK293-GS M4 cells. (A) HEK293 cells, stably
expressing GS M4, was incubated with (bottom) or without (top) azido-Ala for 20 h. Cell lysates
were injected for LC-MS and extracted ion mass of endogenous glutathione (black) and azidoglutathione (pink) were overlaid. B) Protein free cell lysates were analyzed for free thiol content
by bromobimane assay. C) Cells were lysed using TBST (0.1% TWEEN20) and checked for redox
enzyme levels including TRX1 and GRX1.

3.3.2 Mitochondrial ROS and protein glutathionylation
After confirming efficient synthesis of azido glutathione in stable cells, we next
evaluated glutathionylation in response to mROS. To study protein glutathionylation,
HEK293-GS M4 stable cells were incubated with azido-Ala (0.6 mM) for 20 h. Cells were
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then washed once with PBS. After serum starvation for 4 h, different concentrations of
AMA were added to cells for different time points with or without glucose. After click
reaction with fluorophore-alkyne, glutathionylated proteins were visualized by in-gel
fluorescence. An incubation of AMA to KEK293/GS M4 cells for 2 h did not induce
glutathionylation (Figure 3.3, lane 3). However, AMA induced glutathionylation in a timedependent manner. Incubation of AMA for 22 h induced a significant intensity of
glutathionylation (Figure 3.3, lane 4).

Figure 3.3 - Glutathionylation in response to mitochondrial ROS generation. HEK293-GS
M4 cells were treated with L-AzAla for 20 h. Then AMA was incubated for different time points.
After lysing, cell lysates were subjected to click reaction with fluorophore alkyne and analyzed by
in-gel fluorescence.
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3.3.3 Glucose availability controls protein glutathionylation under mitochondrial
dysfunction
To investigate the role of cellular metabolism in glutathionylation, we evaluated
HEK293-GS M4 cells in the presence and absence of glucose or glutamate. Cells were
serum starved for 4 h and treated with glucose or glutamine free medium for 2 h. After
cell lysis, lysates were analyzed for glutathionylation by in-gel fluorescence. Both glucose
(Figure 3.4 lane 2) and glutamine (Figure 3.4 lane 4) removal did not induce
glutathionylation within 2 h period. This suggests shorter incubation time was not
sufficient to induce enough stress in the cells. Next, we evaluated how glutathionylation
will be changed upon incubation of AMA in the absence of glucose.

Figure 3.4 – Glutathionylation in response to depletion of glucose and glutamate. After
incubation of azido-Ala to HEK293-GS M4 cells for 20 h, cells were subjected to the following
stimulus. Cells were incubated in glucose-free medium and glutamine free medium for 2h. Cells
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were lysed and performed click reaction with cy-5 alkyne and analyzed by in-gel fluorescence
after running SDS-PAGE.

Cells were treated with AMA in the presence and absence of glucose.
Glutathionylation was significantly induced within 1 h in response to AMA in the absence
of glucose (Figure 3.5 A, lane 4, 5 and 6). On the other hand, an incubation of AMA at a
high concentration of glucose (25 mM) did not induce glutathionylation (Figure 3.5 A, lane
3). These data clearly indicate that glucose availability is important to induce
glutathionylation. Also, under glucose starvation, glutathionylation was induced by AMA
in a dose dependent manner. Importantly, the level of glutathionylation was inversely
correlated with glucose availability. When cells were incubated with decreasing
concentrations of glucose in the presence of AMA, the level of glutathionylation was
increased, indicating dependence of glutathionylation on glucose availability (Figure 3.5
C).
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Figure 3.5 - Protein glutathionylation is highly dependent on glucose metabolism in the
presence of the electron transport chain blocker. After incubation of azido-Ala to HEK293-GS
M4 cells, cells were subjected to the following stimulus. (A) glucose starvation with antimycin A in
a time-dependent manner, (B) glucose starvation with an increasing concentration of antimycin
A, (C) decreasing glucose concentrations with antimycin A. After stimulus, cell lysates were
subjected to click reaction with rhodamine-alkyne, and analyzed for in-gel fluorescence.

Figure 3.6 - Glutathionylation under physiological glucose concentration. L-AzAla treated
cells were incubated in 5 mM glucose containing medium for different time intervals with or without
AMA treatment. After lysing and click reaction with cy-5 alkyne glutathionylation was analyzed by
in-gel fluorescence.

increasing incubation time of antimycin A in a physiological glucose

concentration (5 mM).

Similarly,

glutathionylation

was

induced

under

a

physiological

glucose

concentration (5 mM) when cells were treated with AMA for different times (Figure 3.6).
HEK293-GS M4 stable cells displayed a time dependent increment of glutathionylation
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when treated with increasing concentrations of AMA under a physiological glucose
concentration (5 mM). This suggest that ETC blockers alter the cellular redox state by
generating high levels of ROS under limiting glucose concentrations, thereby inducing
protein glutathionylation. More importantly, this study found that glucose metabolism is
an important factor for controlling the level of protein glutathionylation.
3.3.4 Glutathionylation under glycolysis inhibition and mitochondrial dysfunction
To

further

confirm

that

glucose

metabolism

is

important

for

protein

glutathionylation, we examined glutathionylation after inhibiting glycolysis by a known
pharmacological inhibitor. 2-deoxygluocose (2-DG) is an analogue of glucose which is
lack of 2-hydroxyl group. 2-deoxyglucose binds and inhibits hexokinase, which decrease
glycolysis (258). 2-deoxyglucose has been used to study the importance of glucose
metabolism (259). In this project, we evaluated glutathionylation in response to glycolysis
inhibition, which is likely to mimic glucose depletion.
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Figure 3.7 - Induction of glutathionylation by treatment of 2-deoxyglucose (2-DG) with
electron transport chain blockers. After incubation of azido-Ala to HEK293-GS M4 cells for 20
h, cells were serum-starved for 4-h. Cells were then incubated in glucose (5 mM) and antimycin
A (2 µg/mL) with an increasing concentration of 2-DG for 2 h. After stimulus, cell lysates were
subjected to click reaction with rhodamine-alkyne, and analyzed for in-gel fluorescence.

HEK293/GS M4 cells were incubated with L-AzAla (0.6 mM) for 20 h, followed by
serum starvation and incubation of 2-deoxyglucose different concentrations in the
presence of 2 µg/mL of AMA for 2 h. All conditions were carried out in the presence of 5
mM glucose in the medium. After cell lysis and click reaction with cy-5 alkyne,
glutathionylation was analyzed by in-gel fluorescence. In the absence of AMA and 2-DG,
glutathionylation did not induce in response to a physiological glucose concentration.
However, glutathionylation was significantly induced when cells were treated with AMA
and 2-DG under similar condition (Figure 3.7). Interestingly, glutathionylation was further
increased with an incubation of increasing concentrations of 2-DG, indicating AMA
induces glutathionylation in response to glycolysis inhibition (Figure 3.7).
3.3.5 Reversibility of glutathionylation controlled by glucose availability
Next, we evaluated whether glutathionylation is reversible depending on glucose
availability. After inducing glutathionylation under glucose starvation with AMA, we reintroduced glucose to glucose starved cells. Interestingly, glutathionylation signal was
decreased when glucose was re-introduced to cells, showing the importance of glucose
availability (Figure 3.8 A lane 6-8).
Interestingly, the similar deglutathionylation was observed when pyruvate was
added to cells instead of glucose. pyruvate is an intermediate metabolite of glycolysis
(Figure 3.8 A lane 3-5). glutathionylation level was decreased upon addition of pyruvate.
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However, addition of lactate, a reduced form of pyruvate, did not change the level of
glutathionylation (Figure 3.8 B). Overall, these data prove that glucose acts as a key
regulator for maintaining redox state of the cells and regulating the level of global protein
glutathionylation.

Figure 3.8 - Glutathionylation is reversed by re-addition of glucose. After incubation of azidoAla to HEK293-GS M4 cells for 20 h, glutathionylation was induced by glucose starvation with the
treatment of antimycin A for 2 h. Subsequently, (A) glucose (GL, 5 mM), pyruvate (Py, 5 mM) or
(B) lactate (La, 10 mM) was individually added to the cells for the indicated time periods. Cell
lysates were subjected to click reaction with rhodamine-alkyne, and analyzed for fluorescence.

3.3.6 Glutathionylation by different ETC blockers
ETC blockers increase ROS generation at different sites in oxidative
phosphorylation. In order to investigate the differential effects of ETC blockers,
HEK293/GS M4 cells were treated with inhibitors of complex I and complex III. In a similar
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manner to AMA, an incubation of rotenone, a complex I inhibitor, induced glutathionylation
under glucose starvation. (Figure 3.9 A and B). Next, we analyzed and compared
glutathionylation upon incubation of two complex III inhibitors, myxothiazol and AMA. Both
complex III inhibitors induced the similar level of glutathionylation under glucose
deprivation, indicating similar effects on glutathionylation by different ETC blockers.

Figure 3.9 - Glutathionylation in response to ETC blockers and glucose deprivation. A) After
incubating stable cells with L-AzAla, cells were induced with rotenone different concentrations
with or without glucose. B) Direct comparison of the effect of AMA and complex I inhibitor
rotenone. C) Direct comparison of AMA and another complex III inhibitor myxothiazol.

3.3.7 ROS and glutathione levels in response to glucose deprivation and
mitochondrial dysfunction
The ETC blockers, including AMA, are known to induce ROS and alter the redox
state of the cell (260). To investigate how AMA affects cellular redox state, we analyzed
ROS levels, GSH and GSSG upon incubation of AMA in the presence or absence of
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glucose. HEK293/GS M4 cells were incubated with L-AzAla (0.6 mM) for 20 h. Cells were
then induced for glutathionylation. The level of ROS was measured by 2′,7′Dichlorofluorescin diacetate (DCF) for 1 h at 37 0C in phenol red free DMEM. An
incubation of AMA or glucose depletion increased the level of ROS. Obviously, the level
of ROS was further increased when AMA was treated to cells under glucose depletion
(Figure 3.10 A).

Figure 3.10 - ROS and glutathione levels in HEK293-GS M4 stable cells. A) ROS levels were
determined by DCF assay in AMA treated and non-treated cells in the presence and absence of
glucose. Thiol levels were determined by bromobimane fluorescence assay after inducing with
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AMA with or without glucose supply. After lysis by freeze and thawing, protein free lysates were
reacted with bromobimane and fluorescence data for B) reduce thiol levels C) total thiol levels
were measured using a plate reader. D) By subtracting reduce GSH from total GSH level, oxidized
GSH was calculated and shown as a GSSG/GSH ratio.

The cellular level of GSH was also measured by bromobimane assay. Cells were
lysed by several freeze-thaw cycles in PBS and protein-free lysates were analyzed for
thiols. In the presence of AMA, the level of reduced GSH was decreased in a timedependent manner (Figure 3.10 B). However, total thiol concentration did not change
upon incubation of AMA (Figure 3.10 C). Overall, the ratio of GSSG/GSH was significantly
increased when cells were treated with AMA for 2 h under glucose starvation, suggesting
a significant oxidative stress in cells. These data suggest an important role for glucose
metabolism in maintaining ROS levels.
3.3.8 Protein glutathionylation in response to glucose deprivation
We further evaluated glutathionylation under glucose starvation condition without
using the ETC blockers. HEK293/GS M4 cells were subjected to glucose starvation with
different incubation times. Depletion of glucose in HEK293/GS M4 cells did not induce
glutathionylation significantly within 5 h, but induced a strong level of glutathionylation at
20 h (Figure 3.11 A and B).
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Figure 3.11 - Clickable GSH approach for detection of protein glutathionylation in response
to different glucose concentrations. A) Stable cells were treated with different concentrations
of glucose for 5 h. Lysates were analyzed by in-gel fluorescence after the click reaction with Cy5Alkyne. B) Stable cells were treated with glucose free media for 20 h. Then analyzed by in-gel
fluorescence. C) Detection of protein glutathionylation in glucose dose dependent manner for 20
h.

Importantly, the level of glutathionylation was increased with decreasing
concentrations of glucose. Interestingly, glutathionylation were readily observed even at
physiological (5 mM) and hypoglycemic (3 mM) concentrations. (Figure 3.11 C). It was
also found that glutathionylation was induced under glucose deprivation for 13 h (Figure
B.3.1). All together, these data further support that glucose availability is an important
factor for regulation of glutathionylation.

100
3.3.9 Glutathionylation in response to oxygen availability
It was known that oxygen availability is an important factor for generation of ROS.
We next evaluated whether glutathionylation is induced depending on oxygen availability.
Cells were subjected to different conditions of oxygen and glucose concentrations. LAzAla was incubated with HEK293-GS M4 cells for 20 h. Two cell culture dishes,
containing high glucose and no glucose medium were incubated under normal oxygen
concentration (21%). Another two cell culture dishes were incubated with or without
glucose, inside a hypoxic modular chamber saturated with low oxygen concentration
(1%). Cells were lysed immediately after incubation and glutathionylation was detected
by in-gel fluorescence after click reaction. Glucose starvation under normoxic condition
(21% oxygen) induced a significant level of glutathionylation (Figure 3.12 lane 2 vs 1).
However, glucose starvation under hypoxic condition (1% oxygen) did not show a
significant level of glutathionylation induction (Figure 3.12 lane 3 and 4). These data
indicated that oxygen is necessary for inducing glutathionylation under glucose
deprivation.
The induction of hypoxia was confirmed by monitoring the elevated level of hypoxia
inducible factor 1 α (HIF1α) (Figure 3.14 A). In addition, redox enzymes, such as GRX1
and catalase, did not significantly change under hypoxic or normoxic conditions,
suggesting the detected glutathionylation difference is not due to a change in redox
enzyme levels (Figure 3.14 B). Next, we evaluated glutathionylation under different
oxygen concentrations. Consistently, we did not observe detectable level of
glutathionylation when oxygen concentration maintained at 0 or 1% (Figure 3.13 lane 16). In contrast, glutathionylation was readily induced with an increasing oxygen
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concentrations (5 or 21%) under glucose starvation condition. These data showed a dose
dependent increment of glutathionylation in response to different oxygen supply (Figure
3.13 lane 8 and10). Overall, these data support the fact that oxygen availability is an
important factor for inducing protein glutathionylation.

Figure 3.12 – Glutathionylation under a limited oxygen supply. Stable cells were incubated
with L-AzAla and incubated with or without glucose in a hypoxia chamber containing 1 and 21%
oxygen. After 13 h cells were immediately lysed and performed click reaction and analyzed by ingel fluorescence.
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Figure 3.13 - Oxygen availability regulates protein glutathionylation. HEK293-GS M4 stable
cells were incubated with 0.6 mM L-AzAla for 20 h and media was replaced with serum free
medium containing different amounts of glucose prior to the incubation in hypoxic chamber
containing 0%, 1%, 5% and 21% oxygen. Cells were lysed and analyzed by in-gel fluorescence
after click reaction.
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Figure 3.14 – Levels of HIF1α and redox enzymes in response to glucose-oxygen depletion.
A) Cell lysates, prepared from normoxic and hypoxic conditions were analyzed by Western
blotting for the induction of HIF1α and B) the detection of redox enzymes including GRX1 and
catalase.

Next, we evaluated glutathionylation in a hypoxic condition with subsequent reoxygenation. HEK293-GS M4 stable cells were first subjected to oxygen-glucosedepletion (OGD) (1% O2 and no glucose) for 8 h. Subsequently, cells were exposed to a
normal oxygen atmosphere for 0, 20 and 120 minutes under normal or depleted glucose
conditions. cells were then lysed and analyzed for glutathionylation after performing click
reaction with Cy5-Alkyne (Figure 3.15). Glucose deprivation or OGD did not induce a
significant level of glutathionylation during 8 h. (Figure 3.15 lane 1-6). However, we
observed time dependent glutathionylation in cells after OGD and re-oxygenation for 20
and 120 minutes (Figure 3.15 lane 9 and 12). Similar results were observed in HEK293GS M4 cells after 13 h OGD and 1h re-oxygenation experiment (Figure B.3.3). Altogether,
these data indicated that oxygen availability is important for inducing glutathionylation
under prolonged glucose starvation.
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Figure 3.15 - Detection of the effect of re-oxygenation on protein glutathionylation. After LAzAla incubation for 20 h, HEK293-GS M4 cells were maintained under 1% oxygen with or without
glucose for 8 h (OGD). Then cells were exposed to 21% oxygen for different time points (OGD/R).
Cells were lysed at indicated time points and analyzed by in-gel fluorescence after click reaction
with Cy-5 Alkyne.

3.3.10 Identification of glutathionylated proteins using LC-MS/MS
Glucose starvation together with AMA treatment induces glutathionylation in
numerous proteins. To identify these proteins, we used a biotin pull-down experiment
followed by LC-MS/MS analysis (Figure 3.16 A). Global glutathionylation was induced in
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HEK293-GS M4 cells after treating AMA together with glucose deprivation. After
induction, cells were lysed and subjected to click reaction with biotin alkyne.

Figure 3.16 – Biotin pull-down and elution for analysis of glutathionylated proteins. A)
Approach for pull-down and mass analysis: after click reaction with biotin-alkyne, glutathionylated
proteins enriched by streptavidin-agarose were eluted for silver staining or directly digested onbeads for LC-MS/MS analysis. B) Analysis of enriched proteins by silver staining.

Biotinylated proteins were then incubated with streptavidin agarose beads and
eluted by a SDS loading dye. Eluted samples were analyzed by silver staining.
Glutathionylated proteins were significantly enriched in a condition of glucose starvation
with incubation of AMA. In contrast, enrichment of glutathionylated proteins were
minimum with high glucose (25 mM) and lack of AMA treatment (Figure 3.16 B lane 4
against lane 1-3).
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Figure 3.17 – Proteomic analysis of glutathionylated proteins. A) The number of identified
glutathionylated proteins by LC-MS/MS analysis are displayed as a venn diagram. ‘Positive’ and
‘negative’ indicate proteins enriched in Figure 3.16 B lane 4 and 1, respectively. B) Comparison
of identified proteins according to the spectral count in positive and negative samples.

We further analyzed the samples prepared for lane 1 and lane 4 (Figure 3.16 B)
by mass spectrometry. After enrichment of glutathionylated proteins on streptavidin
beads, proteins were digested with trypsin on bead. Then eluted samples were subjected
to LC-MS/MS analysis. From mass analysis, we identified 1249 candidate proteins in the
positive sample (lane 4 in Figure 3.15 B) and 278 proteins in the negative sample (lane 1
in Figure 3.15 B). Relatively smaller number of proteins (244) were found in both positive
and negative samples (Figure 3.17 A). More importantly, 1291 proteins had 10-fold or
higher enrichment in the positive sample over negative sample (Figure 3.17 B).
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We analyzed identified proteins using the DAVID gene ontology program. This
analysis allows us to categorize proteins depending on their localization, molecular
function and cellular process. The majority of glutathionylated proteins were found in
cytosol. Proteins were involved in many different cellular processes, such as RNA
processing, cell cycle, DNA repair, aging and stress sensing (Figure 3.18 C, D, E)). In
addition, we compared identified glutathionylated proteins with previously known
glutathionylated proteins (figure 3.19 A). It was found that a half of candidate proteins that
we identified were previously reported for glutathionylation, but there were 800 new
glutathionylated proteins in our LC-MS/MS analysis. Also, we compared our data with
sulfenylated proteins reported previously (figure 3.18 B). Approximately a half of
sulfenylated proteins were found as potential candidate proteins for glutathionylation in
our

analysis,

indicating

a

close

interconnection

between

sulfenylation

and

glutathionylation. In addition, top 120 proteins that were found in our mass analysis with
high spectral counts were analyzed by DAVID Program for their localization, cellular
function and processes, which is listed in a table. Also, these proteins were compared
with databases of previously reported glutathionylated and sulfenylated proteins (Table
B.3.1). These data provide evidences for the sensitivity and the versatility of clickable
GSH in studying protein glutathionylation.
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Figure 3.18 – Gene ontology analysis of identified glutathionylated proteins. A) Comparison
of glutathionylated proteins in glucose starvation/antimycin A with previous proteomic data of
glutathionylome B) or sulfenylome by treatment of exogenous H2O2. C) DAVID gene ontology
(GO) analysis of identified glutathionylated proteome. Identified proteins were annotated to
depending on subcellular location, D) molecular function and E) cellular processes.
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3.3.11 Validation of glutathuonylated proteins by biotin pull-down and Western
blotting
Next, we sought to validate the candidate proteins identified from mass analysis
by pull-down and Western blotting. After inducing glutathionylation by incubating AMA
under glucose starvation, cells were lysed. After cell lysis, click reaction was performed
with biotin-alkyne, followed by enrichment of glutathionylated proteins by biotin pull-down.
Enriched proteins were eluted and probed with primary antibodies againts different
individual proteins. Cell lysates were probed with same antibodies before and after
streptavidin pull down. We confirmed several proteins for glutathionylation: Hsp90, actin
and catalse were glutathionylated within 1 h of induction while other proteins such as
PTP1B, PP2cα and AMPK are found to be glutathionylated at 2 h (Figure 3.19 A).
Importantly, we identified several new gluathionylated proteins including catalase,
SMYD2 and PP2Cα (Figure 3.19 A).
We further evaluated the reversibility of several individual glutathionylated proteins
upon incubation of pyruvate. It was found that PTP1B, catalse and PP2Cα are readily
undergoing deglutathionylation within 30 minutes of pyruvate treatment (Figure 3.19 B).
In contrast, actin and catalse did not show significant deglutathionylation upon incubation
of pyruvate within 1 h, indicating that there may be differential selectivity of
deglutathionylation in a time-dependent manner (Figure 3.19 B).
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Figure 3.19 - Validation of glutathionylated proteins by pull-down and Western blotting. A)
After incubation of azido-Ala to HEK293-GS M4 cells for 20 h, cells were subjected to glucose
starvation with antimycin A in a time-dependent manner. B) After glucose starvation with
treatment of antimycin A for 2 h, pyruvate was added to cells. After click reaction with biotinalkyne, the individual proteins were probed by specific antibodies before and after the pull-down.

3.4 Discussion
Glutathionylation is a protein cysteine oxidation and taking place under elevated
ROS conditions, found in many pathological conditions (173). Although many proteins are
found to be glutathionylated in response to exogenous ROS stimulus, protein
glutathionylation in response to glucose metabolism and/or induction of mitochondrial
ROS is not systematically analyzed. In this chapter, we studied glutathionylation in
response to mitochondrial dysfunction using clickable glutathione approach (211).
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We prepared a stable cell line HEK293-GS M4 that express GS M4. It was found
that stable expression of GS M4 in HEK293 cells did not significantly alter the total free
thiol content and expression levels of redox enzymes. LC-MS analysis showed that a
significant amount of azido-GSH was synthesized in HEK293/GS M4 cells. Overall, our
data support that clickable glutathione is well-tolerated in cells. Therefore HEK293-GS
M4 cells behave similar to normal HEK293 in terms of intracellular redox state.
Next, to evaluate glutathionylation under mitochondrial dysfunction, we used
pharmacological inhibitors of the ETC, such as rotenone, AMA and myxothiazol (261).
AMA and myxothiazol are complex III inhibitors while rotenone is a specific inhibitor of
complex I. Because ETC inhibitors are known to generate mROS, these inhibitors may
mimic mitochondrial dysfunction. Cellular metabolism is an important factor that
associated in regulating redox homeostasis (229). Specially, glucose metabolism plays
an important role by generating two important metabolic products, including pyruvate and
NADPH (230). While pyruvate acts as free radical scavenger, NADPH is the major
reducing source which used antioxidant machinery (Figure 3.20) (122,130). Indeed,
glutathionylation was readily induced in response to AMA treatment under physiological
glucose concentrations and this effect was significantly increased when cells exposed to
glucose deprivation. Moreover, in agreement with glutathionylation data, AMA treatment
increased ROS production, reduced GSH levels and increased GSSG levels. Therefore,
we hypothesized that ETC inhibitor induced mROS were detoxified by high glucose.
Interestingly, AMA did not induce glutathionylation when cells incubated in high glucose,
suggesting an important regulatory role for glucose metabolism in glutathionylation.
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We further confirmed the significance of glucose availability in glutathionylation by
evaluating both global and individual protein deglutathionylation. After induction, cells
were treated with either glucose or its metabolic intermediate pyruvate. Addition of these
metabolites could induce rapid deglutathionylation. Our data for glutathionylation and
deglutathionylation demonstrate an important role of glucose metabolism in controlling
protein glutathionylation.

Figure 3.20 – Schematic representation of glucose and mitochondrial metabolism in redox
homeostasis and glutathionylation.

Since glucose availability is an important determinant of protein glutathionylation
and glucose deprivation is known to induce ROS, we next evaluated protein
glutathionylation under glucose deprivation (262). When stable cells were exposed to
glucose deprivation for longer incubation (20 h), glutathionylation was significantly
induced compared to shorter time incubation (2 h and 5 h). Also, decreasing
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concentrations of glucose induces glutathionylation in a dose dependent manner within
20 h.
In the ETC, ROS are generated by reduction of molecular oxygen. Because there
are reports showing that hypoxia induces ROS, we examined protein glutathionylation in
response to O2 availability (Figure 3.20) (250). When stable cells incubated in a low
oxygen environment, glucose deprivation did not induce glutathionylation even under a
long incubation, indicating that glucose deprivation induced-ROS levels are low or not
enough to induce glutathionylation in a hypoxic condition compared to a normoxic
condition. On the other hand, when cells were exposed to increasing concentrations of
oxygen, glucose deprivation could induce glutathionylation significantly. These data were
further supported by reoxygenation experiments. As our data show, re-oxygenation could
induce glutathionylation after hypoxic incubation of stable cells. Overall, a systematic
evaluation of glutathionylation in response to glucose and oxygen deprivation
demonstrated that oxygen availability as an important factor for inducing glutathionylation.
In addition to sensitive detection of glutathionylation in both global and individual
proteins, clickable glutathione method is compatible with mass spectrometry to identify
glutathionylated proteins under different physiological and pathological conditions.
Therefore, we employed our clickable glutathione approach to find glutathionylated
proteins under mitochondrial dysfunction and glucose deprivation. Click reaction with
biotin-alkyne and pull-down with streptavidin agarose beads enriched numerous
glutathionylated proteins. Trypsin digestion of enriched proteins and LC-MS/MS analysis
identified more than 1400 glutathionylated proteins. Among identified proteins, 434 and
285 proteins were previously known for glutathionylation and sulfenylation respectively.

114
Also, GO analysis by DAVID program indicated that many identified proteins are involved
in various cellular processes, indicating importance of glutathionylation in range of cellular
events. We further validated the identified proteins by pull-down and Western blotting,
including PP2Cα, which is a metal dependent serine/threonine protein phosphatase.
PP2Cα is known to be involved in different cellular processes such as proliferation,
apoptosis, cell cycle and cell migration by directly acting on several mitogen activated
protein kinases (MAPK), including p38, JNK (263-265). Mostly PP2Cα acts as a negative
regulator of stress sensing pathways. Therefore, further characterization and functional
studies on PP2Cα glutathionylation is sought and described in Chapter 4.
3.5 Experimental procedure
3.5.1 HEK293-GS M4 Stable cell preparation
To determine the minimum hygromycin B concentration that required for killing
HEK293 cells, different concentrations of hygromycin B were incubated with HEK293
cells and monitored over 10-14 days. First, a serial dilution of hygromycin B was carried
out as listed in Table 3.1. After trypsinization, 1 X 105 cells, per well, were seeded on a
six-well plate and incubated at 37 0C for 24 h. Then cell culture medium was replaced
with fresh medium containing different concentrations of hygromycin B (Table 2.1). Cells
were monitored over two weeks and minimum concentration of 200 µg/mL of hygromycin
B was selected for the stable cell preparation. HEK293 cells were transiently transfected
with pCDNA3.1-GS M4 plasmid using lipofectamine 2000 as a transfecting agent.
Another 10 cm cell culture dish was maintained without transfection as the control. After
24 h of transfection, cells were trypsinized and maintained in a 12-well plate in fresh
complete medium for 24 h. Then cells culture medium was replaced with fresh complete
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medium with or without 200 µg/mL hygromycin B for two to three weeks. Cell culture
medium was replaced every day until most of the cells are dead. Once all cell debris are
washed away with warm PBS, stable cells containing cell colonies were picked using a
200 µL pipet tip and transferred to a well of 96-well plate. Cells were maintained in 200
µg/mL of hygromycin B containing medium until cells become confluent. Then cells were
split in to a 24-well plate. When cells become confluent, cells were transferred to a 6-well
plate. After 24 h, cells were lysed and lysates were analyzed for GS M4 overexpression
by probing with anti-flag antibody. Rest of the cells were maintained in 10 cm cell culture
dishes and stable cell stocks were prepared and stored in liquid nitrogen vapor phase for
long term usage.
3.5.2. PEI-max transfection
General transfection procedure using PEI-max was described in Chapter 2, section
2.5.13.
3.5.3 Cell lysis
Detailed cell lysis procedure was described in Chapter 2, section 2.5.14.
3.5.4 Cell culture and assays
HEK293-GS M4 cell line, which is stably overexpressing glutathione synthetase
mutant 4 (GS M4), was prepared according to a stable cell generation protocol. Briefly,
after transfection of GS M4, HEK293 cells expressing GS M4 was selected and grown in
the presence of hygromycin B (100 µg/mL). FLAG-tagged GS M4 expression in HEK293GS M4 cells was confirmed by Western blotting with anti-FLAG antibody. Cells were
maintained in DMEM (high glucose) with 10% fetal bovine serum (FBS), penicillin (100
units/mL), streptomycin (100 μg/mL), and hygromycin B (100 µg/mL) at 37°C in 5% CO 2
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humidified incubator. PP2Cα wild type and mutant plasmids were transfected using PEImax at 80% confluency in DMEM without FBS/antibiotics. Cells with or without
transfection were incubated with 0.5 mM L-azido-alanine (azido-Ala) for 20 h. Cells were
then washed with PBS once, and incubated for serum-starvation for 4 h in the presence
of azido-Ala (0.25 mM). After washing with PBS, cells were incubated with and without
antimycin A or rotenone in glucose-free (glucose starvation) or glucose-containing DMEM
for different time points. For deglutathionylation, glucose (5 mM), pyruvate (5 mM), or
lactate (10 mM) was added for another 2 h. Cells were lysed using a lysis buffer [Tris HCl
100 mM, NaCl 150 mM, pH 7.4, 0.1% Tween 20, a protease inhibitor cocktail tablet, 100
µM PMSF and 50 mM N-ethylmaleimide (NEM)]. After incubation for 0.5 h at 4°C and
centrifugation at 14,000 rpm, the cell lysates were collected and protein concentration
was measured by Bradford assay.
3.5.5 SDS-PAGE
General SDS-PAGE procedure was described in Chapter 2, section 2.5.15
3.5.6 Western blotting
General Western blotting procedure was described in Chapter 2, section 2.5.17
3.5.7 Click reaction and biotin pull-down
Concentrations of cell lysates were measured using Bradford assay as described
in 2.5.15. Lysates (100 µg), prepared by addition of NEM during cell lysis, were
precipitated by adding cold acetone (1:4 by volume) for 30 min in -20°C. Samples were
then centrifuged at 14,000 rpm for 3 min, and the pellet was redissolved in click buffer
(0.1 M Tris-HCl pH 7.4) by sonicating for 5 seconds. Click reaction was performed as
described in the previous study.(266) Briefly, click reaction was carried out for 1 h at room
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temperature with biotin-alkyne (0.2 mM) or rhodamine alkyne (0.2 mM) in the presence
of CuBr (1 mM) and Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (TBTA) (0.4 mM).
Click reaction was terminated by adding a SDS-loading buffer and proteins were
separated by SDS-PAGE. Glutathionylated proteins were visualized by in-gel
fluorescence or Western blotting using streptavidin-HRP. For pull down experiments, after
click reaction, all the proteins were precipitated by cold acetone, centrifuged, and washed
once with cold methanol. The precipitate was completely dissolved in PBS containing
1.2% SDS, and further diluted ten times with PBS before incubating with streptavidin
agarose beads (100 µL) at room temperature for 3 h. Beads were washed extensively
with PBS and finally with water. Proteins on beads were eluted by a SDS-loading buffer,
separated by SDS-PAGE, transferred to PVDF membrane, and probed with various
primary antibodies. Alternatively, proteins on beads were digested by trypsin, and eluted
for LC-MS/MS analysis.
3.5.8 LC/LC-MS/MS analysis
The streptavidin agarose beads after enrichment were pelleted and washed twice
by Dulbecco’s phosphate-buffered saline (DPBS). After resuspending in 50 µL of 6 M
urea/PBS, the beads were incubated at room temperature for 1 h. 100 µL DPBS was then
added to dilute urea to a final concentration of 2 M. On-bead trypsin digestion was
performed overnight at 37 °C with sequencing-grade trypsin (2 µg) and 1 mM CaCl2 (100
mM stock in water). The peptide digests were centrifuged and the supernatants were
collected. The beads were washed twice with water (2 × 75 µL). All supernatants and
washes were combined and acidified with 15 µL formic acid. The samples were stored at
-20 °C until mass spectrometry analysis. LC/LC-MS/MS analysis was performed on an
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Agilent 1200 series HPLC coupled to an LTQ-Orbitrap Discovery mass spectrometer
(ThermoFisher). Peptide digests were pressure loaded onto a 250 µm fused silica
desalting column packed with 4 cm of Aqua C18 reverse-phase resin (Phenomenex). The
peptides were eluted onto a biphasic column (100 µm fused silica with a 5 µm tip, packed
with 10 cm Aqua C18 reverse-phase resin (Phenomenex) and 3 cm Partisphere strongcation-exchange resin (SCX, Whatman) using a gradient of 5-100% Buffer B in Buffer A
(Buffer A: 95% water, 5% acetonitrile, 0.1% formic acid; Buffer B: 20% water, 80%
acetonitrile, 0.1% formic acid). The peptides were then eluted from the SCX onto the C18
resin and into the mass spectrometer using four salt steps as previously described.(267)
The flow rate through the column was set to ~0.25 L/min and the spray voltage was set
to 2.75 kV. One full MS scan (FTMS) (400-1800 m/z) was followed by 18 data dependent
scans (ITMS) of the nth most intense ions with dynamic exclusion enabled. The generated
tandem MS data was searched using the SEQUEST algorithm against the human UniProt
database.

SEQUEST

output

files

were

filtered

using

DTASelect

2.0.(267)

Glutathionylated proteins with two or higher fold enrichment were selected and analyzed
using DAVID functional annotation tool.
3.5.9 Cell viability assay
HEK 293 cells were grown on a six-well plate by adding same number of cells into
each well. After 24 h, cells were incubated in DMEM only for 3 h. Cells were then
subjected to different conditions for 24 h: 1) no treatment (25 mM glucose, 0 μg/mL
antimycin A), 2) glucose starvation (0 mM glucose), 3) antimycin A (1 μg/mL) 4) glucose
starvation (0 mM glucose) with antimycin A (1 μg/mL antimycin A), and 5) 0.01% DMSO
(amount used to dissolve antimycin A). Antimycin A was dissolved in DMSO. Cells were
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subjected to trypan blue cell viability assay. Briefly, cells were detached by treating with
0.05% trypsin, and diluted with the medium. Then 100 µl of trypan blue reagent was
added to the 100 µl of medium with the cells and 20 µl of sample was loaded on to the
slide and analyzed the percentage of viable cells by TC 20 automated cell counter
(Biorad). The data was shown after duplication of two independent experiments.
3.5.10 ROS assays
HEK293 cells (10,000 cells per well) were seeded and incubated at 37 oC, 5% CO2
for 24 h for attachment on 96-well black plates with transparent flat bottom. Cells were
then washed with warm PBS, and incubated in serum-free medium for 3 h. 2,7dichlorodihydrofluorescein diacetate (DCFH-DA, 25 µM) was then added, and cells were
incubated in the same conditions for another 1 h. Cells were then washed with glucosefree medium without phenol red, followed by treatment at the indicated conditions and
incubated for 2 h. Untreated cells were used as a negative control. Fluorescence emission
scan was measured at 528 nm after excitation at 485 nm. ROS levels were normalized
using a negative control (25 mM glucose without antimycin A).
3.5.11 Determination of thiol concentration
HEK293-GS M4 cells were treated with 0.5 mM azido-Ala and cells were washed
with PBS after 20 h. Cells were induced for glutathionylation for 0.5 h and 2 h as
mentioned in the main text. After induction, cells were harvested and lysed in PBS by 3
times of freeze-thaw cycles. The cell lysates were collected after centrifugation. Proteins
were removed by 3 kDa centrifugal filter device, and the filtrate (FIL) that contains small
molecules (including glutathione) was collected. The total and reduced form of thiol
contents (mostly glutathione) were analyzed by fluorescence assay using bromobimane
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(excitation - 390 nm, emission - 478 nm). Bromobimane assay was performed in 0.1 M
Phosphate buffer, 0.5 mM bromobimane, and 10 µL of protein free lysates (FIL). The
fluorescence signal was measured by using a plate reader. To calculate total GSH levels,
protein free lysates (FIL) were incubated with 1 mM TCEP at 37 oC for 30 minutes before
the bromobimane assay. All the data was duplicated and the background signal was
corrected before the analysis by GraphPad Prism (version 5.01).
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CHAPTER 4 S-GLUTATHIONYLATION OF SERINE/THREONINE PROTEIN
PHOSPHATASE 2Cα (PP2Cα) PROMOTES CANCER CELL MIGRATION UNDER
METABOLIC STRESS
4.1 Introduction
Glutathionylation is implicated in regulation of various signaling pathways that
control cell survival, apoptosis and cancer metastasis (185). Cancer cells are adapted to
an increased uptake of glucose to compensate high energy demand and to maintain
redox homeostasis. While glucose metabolism provides necessary metabolic
intermediates for a sustained energy production in cancer cells, glucose deprivation
induces apoptosis, inflammation, and migration (268-270). For example, glucose
deprivation increases the expression levels of monocarboxylate transporter 1 (MCT1) in
cervical cancer cells and induces migration through mitochondrial ROS production (262).
Protein phosphatases are a class of enzymes that act on phosphoproteins by
removing phosphate group from different amino acid residues thereby regulating
important cellular processes (271-273). Human genome encodes for more than 140
phosphatases that are divided into two major categories, including Ser/Thr protein
phosphatases and protein Tyr phosphatases. Protein Ser/Tre phosphatases consists of
phosphoprotein phosphatases (PPPs) and metal ion-dependent protein phosphatases
(PPM’s) (274). PPM’s are monomeric and structurally distinct from phosphoprotein
phosphatases (PPP’s). PPPs are heteromeric and consist of both catalytic and regulatory
subunits while PPMs are only made of a catalytic subunit (264).
Among different isoforms of PPMs, PP2Cα is the most studied phosphatase and
known to acts as a negative regulator of stress response pathways, such as mitogenactivated protein kinases (MAPK’s) and transforming growth factor-β (TGF-β) signaling
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(264) . PP2Cα is known to directly interact and dephosphorylate several key-signaling
proteins, including p38-MAPK, extra cellular regulated kinase (ERK), c-Jun N-terminal
kinase 1(JNK1) and SMAD2/3 (263,265,275). PP2Cα acts as a tumor suppressor and it
is implicated in cancer migration and invasion through antagonizing a TGF-β- activated
SMAD2/3 signaling in bladder cancer and breast cancer (263,276). Numerous evidences
support that MAPK are also associated in cell migration and invasion (277). p38 and ERK
are known to directly act on several substrate proteins that are involved in migration (278281). Inhibition or overexpression of a dominant negative mutant of MAPK has been
shown to inhibit p38 or ERK-dependent cell migration (278,282).
In addition to its more common roles in apoptosis, inflammation and differentiation,
JNK is an important MAPK family member associated with cell migration. (283-285).
Activation of JNK by EGF, ephrin B1, upstream MEK kinase, constitutively active MKK4
or environmental stress are shown to increase migration in various cell types (286-288).
The importance of active JNK in cell migration has also been documented in several
different studies, by using an inhibitor (SP600125) of JNK, overexpression of a dominant
negative mutant, JNK1AF, and a JNK knockout method (289-291). We found that glucose
metabolism is known to regulate protein glutathionylation, and Ser/Thr protein
phosphatase (PP2Cα) was identified to undergo glutathionylation in response to glucose
deprivation (292). Migration towards nutrients would be important for cancer cells during
a tumor growth. To our knowledge, there is no direct study correlating the expression of
PP2Cα with cancer cell migration. However, there is one proteomic study that measures
expression profiles of PP2Cα among noninvasive and invasive cancer cells, suggesting
a potential positive correlation between cancer cell invasiveness and the expression level
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of PP2Cα availability (293). For instance, invasive MDA-MB-231 cells have a low
expression level of PP2Cα when compared to noninvasive MCF7 and A431 cells (294).
Rapidly proliferating solid tumor cells experience metabolic stress, due to the lack of
oxygen and glucose availability (295). Metabolic stress in primary tumor cells induces
initiation of metastasis, thereby invading other organs, such as lung, brain and bones
(296,297). Although, PP2Cα and MAPK’s are involved in tumor invasion and metastasis,
regulation of PP2Cα function in cancer cell invasion under metabolic stress is not
explored, thus motivated us to study PP2Cα glutathionylation under metabolic stress.
In this study, we found PP2Cα undergoes glutathionylation at C314 in a C-terminal
domain in response to metabolic stress. we further investigated functional role of PP2Cα
glutathionylation under metabolic stress, i.e. limited nutrient availability. The response of
glutathionylation varied depending on cancer cell types and glucose availability. We
further demonstrate that PP2Cα glutathionylation in response to metabolic alterations
enhances cancer cell migration and invasion potentially through activating JNK-MAPK
pathway.
4.2 Results
4.2.1 S-Glutathionylation of serine/threonine protein phosphatase 2Cα (PP2Cα)
PP2Cα is a protein phosphatase which utilizes metal coordinated water molecule
to catalyze the dephosphorylation of several critical proteins including JNK, p38, MAPK,
AMPK, Smad2/3 and NF-Kb (265). Also, a recent study showed that PP2Cα directly
interact with metabotropic glutamate receptor 3 (mGluR3) and dephosphorylates serine
845 (298). mGluR3 is a glutamate receptor which is important for the protection of
neuronal cells against glutamate excitotoxicity (299). Considering the importance of
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PP2Cα in different signaling pathways, we started to further evaluate the consequences
of glutathionylation of PP2Cα.
PP2Cα carries 11 cysteine residues from the available crystal structure (PDB:
4RA2), we predicted Cys204 and Cys314 are potential cysteine for glutathionylation
because of their solvent accessibility and charged lysine residues around Cys314. In
addition, Cys238 was also considered as a potential modification site due to its proximity
to a metal ion in the active site. (Figure 4.1).
We generated all three cysteine-to-serine mutants of PP2Cα and transfected to
HEK293-GS M4 stable cells. After 24 h of transfection, azido-Ala was incubated and cells
were induced for glutathionylation with AMA in glucose-free medium for 2 h. Cells were
then lysed, and lysates were subjected to click reaction with biotin-alkyne. Biotinylated
proteins were captured by streptavidin beads and analyzed in a gel.
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Figure 4.1 – Crystal structure of PP2Cα. Three potential cysteine residues (Cys204, Cys238
and Cys314) out of 11 cysteine residues in PP2Cα are predicted for glutathionylation. Two
manganese atoms (purple) and a phosphate (red) in active site of the crystal structure of PP2Cα
(PDB:4RA2) are shown in space-filling model.

Eluted proteins were probed with anti-HA antibody. As shown in Figure 4.2 A,
PP2Cα WT, Cys204 and Cys238 are significantly glutathionylated. In contrast, PP2Cα
Cys314 mutant showed a reduced signal for glutathionylation (Figure 4.2 A lane 5). Under
similar conditions, there were many proteins, including PTP1B, that are glutathionylated
in addition to PP2Cα (Figure C.4.1).

Figure 4.2 – In cellulo and in vitro glutathionylation studies for identification of modified
cysteine residue in PP2Cα. A) PP2C WT, and cysteine mutants, C204S, C238S and C314S
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transiently transfected to HEK293-GS M4 cells and glutathionylation was induced by treating AMA
in the presence and the absence of glucose. After performing click reaction with biotin alkyne and
subsequent biotin pull-down, eluted proteins were probed with ant-HA antibody to detect
glutathionylation levels of PP2Cα. B) Purified PP2Cα WT and C314S mutant subjected to in vitro
glutathionylation by incubating azido-GSH and diamide. Glutathionylation was detected by in-gel
fluoresce.

S-Glutathionylation of PP2Cα was further confirmed by an in vitro glutathionylation
assay. Briefly, purified PP2Cα WT and C314S mutant (50 μg each) were incubated with
azido-GSH (1 mM). Diamide (50 μM) was then added to induce glutathionylation.
Glutathionylation levels were analyzed by in-gel fluorescence after click reaction with
Cy5-alkyne. In vitro glutathionylation studies showed that PP2Cα WT is strongly
glutathionylated while glutathionylation was significantly decreased with PP2Cα Cys314,
suggesting that Cys314 is the major cysteine for PP2Cα glutathionylation (Figure 4.2 B).
Interestingly, Cys314 has a Lys310 in a close proximity that can enable hydrogen
bonding.
Proximity ligation assay (PLA) has been used to study protein-protein interaction,
localization and posttranslational modifications of individual proteins in fixed cells
(300,301). We sought to couple a clickable-GSH approach with PLA technology to detect
PP2Cα glutathionylation and its localization in cells by fluorescence imaging. Briefly, after
transfection of PP2Cα WT and C314S, cells were treated with 1mM H2O2 for 15 minutes
to induce glutathionylation. Then cells were fixed and permeabilized before the click
reaction with biotin-alkyne. Primary antibodies against PP2Cα and biotin were incubated
for 16 h at 40C followed by incubation of secondary anti-rabbit and anti-mouse that are
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conjugated with PLA probes for 1 h at 37 oC. After ligation and amplification, Images were
captured using confocal microscope.

Figure 4.3 – Schematic representation of visualization of PP2Cα glutathionylation by a
proximity ligation assay.

The PLA signal that represents glutathionylation was significantly detected with
PP2Cα WT versus PP2Cα C314S mutant. Glutathionylated PP2Cα appear to be in the
cytoplasm (Figure 4.4). This method may be useful to study the effect of PP2Cα
glutathionylation on cellular localization and protein-protein interactions.
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Figure 4.4 – Visualization of PP2Cα glutathionylation by proximity ligation assay. WT
PP2Cα and mutant PP2Cα transiently transfected and induced for glutathionylation. Click reaction
was performed to fixed cells followed by PLA and subsequent visualization of PP2Cα
glutathionylation by confocal microscopy.

4.2.2 Functional effects of glutathionylation on PP2Cα
PP2Cα WT and C314S mutant proteins were purified using His-tag purification. It
was found that there are two different sizes of PP2Cα: one matches with a full-length size
(50 kDa) while another one appears to be 10-15 kDa smaller than a full-length mass (~35
kDa). Because His-tag is present at a N-terminus and PP2Cα has a small C-terminal
domain with about 15 kDa, we concluded that a smaller size of purified protein is likely to
be truncated PP2Cα lacking the C-terminal domain. (Figure 4.5 A). First, we evaluated
phosphatase activity of PP2Cα WT and C314S mutant using a simple colorimetric assay.
After incubating PP2Cα WT and mutant enzyme with GSSG, phosphatase substrate
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para-nitrophenyl phosphate (pNPP) was added to the reaction mixture. Phosphatase
activity was quenched by adding NaOH (302). Enzyme activities were determined by
measuring para-nitrophenol absorbance at 405 nm. Our in vitro assay showed that
PP2Cα glutathionylation did not significantly inhibit its phosphatase activity. Although
PP2Cα C314 mutant exhibited a lower catalytic activity compared to PP2Cα WT, it is
unclear yet if this is due to a mutation at C314 Figure 4.5 B). But it should be noted that
pNPP is a nonspecific small molecule substrates for alkaline phosphatases, which may
not represent enzymatic activity on protein substrates that are often mediated by proteinprotein interaction. To examine the functional consequences of glutathionylation in the
context of cellular environment, we tested the phosphorylation levels of AMPK that is a
downstream target of PP2Cα. Under glucose depletion, AMPK is phosphorylated, which
activates downstream signaling pathways as a stress response to metabolic changes.
PP2Cα directly interact and inhibits AMPK activation (Figure 4.5 C) (303). Therefore, we
evaluated phosphorylation level of AMPK in cells expressing PP2Cα WT and C314S in
response to ROS. After transfection of WT and Cys314 mutant, cells were induced for
glutathionylation. Then cell lysates were analyzed for phosphorylation levels of AMPK
using antibodies against p-AMPK and AMPK. Glucose starvation and AMA treatment
significantly induced the phosphorylation of AMPK. However, the level of AMPK
phosphorylation did not change in any of PP2Cα mutants compared to WT (Figure 4.5
D). Because Cys314 is in a C-terminal tail of PP2Cα and C-terminal domain was
suggested to be involved in the substrate specificity and protein-protein interaction (304),
we tested whether glutathionylation can disrupts the interaction with its substrates.
PP2Cα directly interacts and acts on phosphorylated metabotropic glutamate receptor 3
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(mGluR3) (298). Therefore, we carried out co-immunoprecipitation study to investigate
the effect of PP2Cα glutathionylation on mGLUR3 interaction with PP2Cα. After
transfection of HA-tagged PP2Cα WT and Cys314 mutant, cells were induced for
glutathionylation.

Figure 4.5 – Functional effects of PP2Cα glutathionylation. In vitro analysis of PP2Cα
enzymatic activity upon glutathionylation. (A) A gel after purification of His-PP2Cα, which gave a
full-length (FL) and a truncated form (TR) that appear to have excluded about 10 kDa size of the
C-terminus domain. His-tag is on the N-terminus. (B) PP2Cα dephosphorylation assay with pnitrophenyl phosphate (pNPP): PP2Cα (50 ng/uL) and pNPP (20 mM) were incubated with and
without oxidized glutathione (GSSG) (1 mM) for 30 min at 37 oC, and absorbance was measured
at 405 nm.
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Then cells were lysed, and lysates were subjected to immunoprecipitation using
an antibody for mGluR3eluted proteins were analyzed using antibodies against HA-tag
and mGluR3. PP2Cα WT decreased its interaction with mGluR3 under stress condition.
On the other hand, PP2Cα C314 mutant retained the interaction with mGluR3 under the
same stress condition. In agreement with these data, endogenous PP2Cα lost it
interaction with mGluR3 under stress condition (Figure 4.6 lane 1 and 2). These data
showed that PP2Cα glutathionylation disrupts PP2Cα interaction with mGluR3.

Figure 4.6 – Co-immunoprecipitation assay for mGLUR3 and PP2Cα. After transfection of
PP2Cα WT and C314S mutant, HEK293-GS M4 cells were induced for glutathionylation with
AMA and glucose deprivation. After ci-immunoprecipitation, eluted samples were probed with
antibodies against PP2Cα and mGLUR3.

4.2.3 Glutathionylation in response to glucose depletion in different cell lines
PP2Cα is known to have regulatory function in controlling cancer cell migration by
antagonizing a TGF-β-induced SMAD signaling pathway. The correlation between PP2Cα
expression and metastatic properties of several cancer cells are previously reported
(263). PP2Cα expression levels vary by the cell type. For example, invasive breast cancer
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cell line MDA-MB231 contains a lower expression level of PP2Cα when compared to
noninvasive MCF7 and skin cancer cell line A431 (Figure 4.14 B). Therefore, to
understand the significance of PP2Cα glutathionylation in cancer cells, we evaluated
glutathionylation in two different cell lines, MCF7 and MDA-MB-231 cancer cells. Cancer
cells rely on glucose metabolism to provide enough energy and biomass required to
maintain high proliferation rate and to maintain the redox homeostasis (183). Therefore,
we evaluated glutathionylation in response to metabolic changes in MCF7 and MDA-MD231 cells and cardiomyocyte H9c2 cells.

Figure 4.7 - Glutathionylation in different cell lines. Adenovirus transduced to MCF-7, MDAMB-231 and H9c2 cells and incubated with 0.6 mM L-AzAla for 20 h. Then cells were maintained
in different concentrations of glucose containing serum free medium for 5.5 h. Lysates were
subjected to click with Cy-5Alkyne and glutathionylation was analyzed by in-gel fluorescence. A)
H9c2 cells were differentiated using retinoic acid for four days followed by adenovirus
transduction. After inducing glutathionylation detected by in-gel fluorescence. B) Induced MCF7
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cells subjected to click reaction and visualized by in-gel fluorescence. C) Dose dependent
glutathionylation in MDA-MB-231 cells.

Differentiated H9c2 cells, MCF7 and MDA-MB-231 cells were transduced with
adenovirus expressing a GS M4 mutant. After 24 h of virus transduction, cells were
incubated with L-AzAla for another 20 h, followed by treatment of different glucose
concentrations for approximately 5.5 h. Under these conditions, GS M4 stable cells and
differentiated cardiomyocytes H9c2 did not induce protein glutathionylation (Figure 3.4
and 4.7 A). However, Interestingly, there was a low but increase level of glutathionylation
in MCF-7 cell under a low concentration of glucose (3 mM). MDA-MB-231 cells displayed
a significant increment of glutathionylation in response to low glucose (3 mM) (Figure 4.7
B and C). These data indicated that metastatic MDA-MB-231 cells are more sensitive for
inducing glutathionylation in response to glucose availability than non-invasive MCF7.
We also analyzed glutathionylation in both MDA-MB-231 and MCF7 cells with a
deceasing concentration of glucose. We found that glutathionylation was significantly
induced at 3 mM of glucose concentration in MDA-MB-231 cells (Figure 4.8 B). Consistent
with glutathionylation status, ROS levels were higher in MDA-MB-231 cells compared to
MCF7 under glucose depletion (Figure 4.8 A). We confirmed that levels of GS M4 and a
few redox enzymes are similar between MCF7 and MDA-MD-231 cells, suggesting that
glutathionylation signals are likely to represent the different redox states between two cell
lines. (Figure 4.8 C).
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Figure 4.8 – Different redox responses in MCF7 and MDA-MB-231 cells. A) ROS levels were
determined by DCF assay under different glucose concentrations. B) After adenovirus
transduction, cells were induced for glutathionylation under different glucose concentrations for 5
h. Glutathionylation was detected by in-gel fluorescence after performing click. In similar
conditions, C) GS M4 and redox enzyme expression levels were analyzed by Western blotting.
D) PP2Cα glutathionylation levels were determined by biotin pull-down and subsequent elution
and probing with HA antibody.
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Importantly, we confirmed PP2Cα glutathionylation in MDA-MB-231 cells under
glucose depletion (Figure 4.8 C). When cells were incubated with decreasing
concentrations of glucose, PP2Cα glutathionylation was increased in a dose dependent
manner: PP2Cα glutathionylation was significantly increased in response to low glucose
concentrations (3-5 mM) compared to a high concentration of glucose (25 mM) (Figure
4.8 C).
In addition to glucose deprivation, MDA-MB-231 cells displayed higher sensitivity
towards oxygen and glucose deprivation (ODG). After OGD condition, cells were
incubated in normal oxygen atmosphere (21%) for 30 minutes for reoxygenation.
Glutathionylation was analyzed after click reaction with fluorophore-alkyne. Consistently,
glutathionylation was induced in response to GD or OGD within 5 h (Figure C.4.3).
Further, MDA-MB-231 cells slightly induced glutathionylation after 30 minutes of
reoxygenation (Figure C.4.4). Altogether, data show that MDA-MB-231 cells are more
sensitive to metabolic alterations.
4.2.4 Glutamate availability and the metabolic stress in MDA-MB-231 cells
Glucose depletion induces a metabolic stress and an increment of glutathionylation
in the cell. we further evaluated glutathionylation upon addition of different metabolites,
including pyruvate, glutamine and glutamate. MDA-MB-231 cells were incubated in a low
glucose medium, but with addition of pyruvate, glutamine or glutamate for 5.5 h. Then
cells were lysed and analyzed for glutathionylation by in-gel fluorescence. In agreement
with an earlier study, glutathionylation was decreased by the addition of 5 mM pyruvate
(Figure 4.9 A).

136

Figure 4.9 - Rescue of metabolic stress by pyruvate, glutamine and glutamate. A) MDA-MB231 cells were treated with low glucose in the presence of pyruvate, glutamine and glutamate for
indicated time. B) Cells were supplemented with different concentrations of glutamate (0-8 µM)
for 5.5 h. After induction, cells were lysed and subjected to click reaction before analyze by in-gel
fluorescence.

Interestingly, we found that glutathionylation was dramatically suppressed by
glutamate. In contrast, an addition of glutamine did not change the level of
glutathionylation. The gradual decrement of glutathionylation signal was observed upon
addition of increasing concentrations of glutamate (Figure 4.9 B). Glutamine can be
converted to glutamate by glutaminase (GLS). Glutamate can be fluxed to produce
pyruvate and NADPH in cells. (Figure C.4.5). GLS enzyme activity may be inhibited to
prevent glutaminolysis in our condition (305). Overall, supplementation of glutamine did
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not rescue the cells from metabolic stress while glutamate supplementation rescued cells
from metabolic stress (Figure 4.9 A).
4.2.5 PP2Cα glutathionylation in cancer cell migration (wound healing assay)
Next, we investigated the functional importance of PP2Cα glutathionylation in
MDA-MB-231, an invasive breast cancer cell line. Since PP2Cα is implicated in cell
migration through SMAD and MAPK signaling pathways, we speculated that PP2Cα
glutathionylation might be playing an important role in cell migration and invasion. To
probe this hypothesis, we first investigated cell migration of MDA-MD-231 cells after
expressing PP2Cα WT or C314S. Cells were evaluated for a wound-healing assay in high
and low glucose conditions for 36 h. After making a wound across cells using pipet tip
cells were monitored using a light microscope connected to a camera. Non-transfected
MDA-MD-231 cells displayed a higher wound healing capacity in both high glucose (25
mM) and low glucose concentrations (10 mM). Overexpression of PP2Cα WT completely
attenuated the wound healing ability of MDA-MB-231 cells under a high glucose condition.
The same pattern was observed in cells with PP2Cα C314S, indicating an inhibition of
cell migration by PP2Cα (Figure 4.10).
Interestingly, MDA-MD-231 cells with PP2Cα WT restored the wound healing
capacity or increased the migration of cells when incubated in a low glucose condition
(Figure 4.10). On the other hand, migration or wound healing did not increase for MDAMD-231 cells expressing PP2Cα C314 in a low glucose condition (Figure 4.10). These
data suggest that PP2Cα may lead to a loss of its activity in a low glucose condition where
PP2Cα can be glutathionylated (Figure 4.10).
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Figure 4.10 – Wound healing assay with MDA-MB-231 cells. Similar number of PP2C WT and
C314S mutant transfected cells were seeded in a 12-well plate and incubated in 25 mM and 10
mM glucose containing medium for 36 h after creating a wound. After, 36 h, images were captured
in the wounded area and analyzed cell migration by quantifying invaded area. Percent invasion
or migration was represented as a bar graph, (p<0.05).
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Next, we evaluated whether glutathionylation is induced under low glucose
conditions. glutathionylation was readily induced in at low glucose conditions (5-10 mM)
(Figure 4.11 A). We also confirmed PP2Cα is glutathionylated in 10 mM glucose (Figure
4.11 B). Overall, these data support that glutathionylation of PP2Cα leads to a loss of a
negative activity of PP2Cα in cell migration.

Figure 4.11 – Glutathionylation in MDA-MB-231 cells in response to a low glucose
concentration. A) MDA-MB-231 cells were infected with adenovirus and glutathionylation was
induced by incubating 10 mM and 5 mM glucose for 24 h. Glutathionylation levels were analyzed
by performing click reaction with fluorophore alkyne. B) Induced cell lysate subjected to click
reaction with biotin alkyne and subsequent biotin pull-down. Cell lysate and eluted proteins from
biotin pull-down, were analyzed by HA antibody.

In solid tumor, most cancer cells are lacking nutrients and oxygen supplementation
due to the poor vascularization. Glucose and oxygen deprivation are the most common
challenges that solid tumors encounter during later stages of cancer development.
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Therefore, cancer cells adapt to overcome these challenges by growing towards the
vasculature or gaining epithelial-to-mesenchymal transition (EMT) to migrate to other
parts of the body (306). Hence, these data provide evidences on regulatory effects of
PP2Cα glutathionylation in cancer cell invasion under glucose limiting condition.
4.2.6 PP2Cα glutathionylation in response to metabolic stress promotes MDA-MB231 cell invasion: transwell invasion assay
We further evaluated the role of PP2Cα glutathionylation in a transwell invasion
assay. Transwell invasion assay consists of two chamber systems where an upper
chamber holds cells and a lower chamber has the chemoattractant as a stimulant for
invasion (Figure 4.12). Transwell inserts having a basement membrane that allows for
cells to penetrate or invade. A similar number of MDA-MB-231 cells non-transfected or
transfected with PP2Cα WT and C314S) were seeded on a transwell-insert containing 10
mM glucose medium. A Lower chamber was filed with a medium containing 10% FBS.
Cells were then incubated in the incubator for 24 h.

Figure 4.12 – Diagram of transwell set up in a 24-well plate for investigating cancer cell
invasion.

Then invaded cells were fixed and permeabilized before staining with crystal violet.
Images were captured using a camera attached to alight microscope. When cells were
incubated in 25 mM glucose, the number of invaded MDA-MB-231 cells was significantly
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decreased in cells with PP2Cα WT or C314 when compared non-transfected cells,
indicating that PP2Cα WT and C314 showed a negative role in cancer cell invasion under
a high glucose condition (25 mM). In contrast, the number of invaded cells were
significantly increased within 24 h, when cells with PP2Cα WT were incubated in low
glucose (10 mM). However, cells expressing PP2Cα C314 did not show any increased
number of invaded cells. (Figure 4.13).

These data further support that PP2Cα

glutathionylation at C314 enhances cancer cell invasion in response to metabolic stress.
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Figure 4.13 – Transwell invasion assay with MDA-MB-231 cells. Transfected and nontransfected cells were incubated in transwell inserts. Low glucose containing medium was added
to upper chamber and 10% FBS containing medium was added lower chamber. After 24 h,
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invaded cells were fixed and analyzed after crystal violet staining. Migrated cells were quantified
after extracting crystal violet with 33% acetic acid and showed as a bar graph, (p<0.05).

4.2.7 PP2Cα glutathionylation in A431 cells
In order to test the role of endogenous PP2Cα glutathionylation in cancer cell
migration, we carried out a transwell invasion assay in A431 cells. A431 cells have a high
expression level of endogenous PP2Cα compared to other cell lines (294). We confirmed
expression levels of PP2Cα in three different cell lines, including MDA-MB-231, MCF7
and A431. MDA-MB-231 cells displayed lower expression levels of PP2Cα compared to
both MCF7 and A431 cells (Figure 4.14 B). In similar to MDA-MB-231, A431 cells showed
a significantly increased level of glutathionylation in response to low glucose (Figure 4.14
A), indicating susceptibility of A431 cells to metabolic alterations.
A Transwell invasion assay was performed to further investigate about PP2Cα
glutathionylation in A431 cell migration under low glucose supplementation. In a similar
manner to MDA-MB-231 cells, A431 cells gained more invasive properties in a low
glucose condition compared to a high glucose condition. (Figure 4.15 A). Under the same
conditions, global and PP2Cα glutathionylation were induced (Figure 4.15 B and C). Next,
we sought to understand the potential mechanism of PP2Cα glutathionylation in
enhancing cancer cell migration

144

Figure 4.14 – Comparison of glutathionylation among MCF7, MDA-MB-231 and A431 cells.
A) A431 cells induced for glutathionylation by low glucose for 5 h. Cell lysates from MCF7, MDAMB-231 and A431 were subjected to click reaction and analyzed by in-gel fluorescence. B) In
similar experimental conditions, expression levels of GS M4 (flag), PP2Cα and actin were probed
using appropriate antibodies.

145

Figure 4.15 – Effect of PP2Cα glutathionylation on A431 cell migration. A) Transwell invasion
assay for A431 cells was performed under low glucose concentration. After seeding
approximately similar number of cells in transwell insert, invaded cells were stained and captured
using a light microscope. B) Glutathionylation of PP2Cα in A431 cells in response to different
glucose concentrations. After pull down, eluted proteins were probed with anti-PP2Cα antibody.
C) Global glutathionylation levels in A431 cells in response to different glucose concentrations.
After induction, lysates were subjected to click reaction and analyzed by in-gel fluorescence.
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4.2.8 PP2Cα glutathionylation activates c-Jun N-terminal kinase (JNK) in MDAMB-231 cells
PP2Cα acts as a negative regulator of stress responsive pathways and controls
different signaling pathways that are involved in apoptosis and cell migration. Specially,
PP2Cα acts on MAPK pathways by dephosphorylating p38 and JNK. p38 and JNK are
activated in response to cellular stress, such as metabolic stress, and Activation of p38
and JNK is associated with an increased migratory property of cells. Therefore, we
hypothesized that PP2Cα glutathionylation might interfere with dephosphorylation of p38,
JNK, SMAD2 and SMAD3, which may lead to enhance cancer cell migration. To study
the effect of PP2Cα glutathionylation of these proteins, MDA-MB-231 cells were
transfected with PP2Cα WT and C314S. Cells were then induced for glutathionylation
under a low glucose condition (5 mM) for 5 h. Cell lysates were then analyzed by Western
blotting using appropriate antibodies (Figure 4.16). phosphorylation levels of SMAD2 or
SMAD3 were not detectable in a basal level or under a low glucose condition, suggesting
that SMAD2/SMAD3 may not play a crucial role for PP2Cα glutathionylation induced cell
migration (Figure 4.16 C and D). p38 phosphorylation remains unchanged upon
expression of PP2Cα WT or C314 or under both high glucose and low glucose conditions,
suggesting a minimal involvement of PP2Cα in p38 dephosphorylation in MDA-MD-231
cells (Figure 4.16 B).
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Figure 4.16 – Evaluation of phosphorylation levels of several PP2Cα substrates that are
involved in cell migration. After transfection of PP2C WT and C314S, MDA-MB-231 cells were
induced for glutathionylation by incubating low glucose containing medium for 5 h. A) Lysates
were analyzed for phosphorylation levels and total protein levels for A) JNK B) p38 C) SMAD2 D)
SMAD3 using relevant antibodies.

On the other hand, overexpression of PP2Cα WT and C314S mutant strongly
inhibited JNK activation compared to non-transfected cells, indicating that PP2Cα WT
and C314S are involved in dephosphorylating JNK in MDA-B-231 cells. More importantly,
when cells expressing PP2Cα WT showed an increase level of JNK phosphorylation in a
low glucose condition. In contrast, cells with PP2Cα C314S did not increase JNK
phosphorylation under a low glucose condition. These data support that PP2Cα C314
glutathionylation leads to a loss of PP2Cα dephosphorylation activity for JNK under a low
glucose condition. Because an increased JNK phosphorylation is associated with
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enhance migration and invasion of cells, our data support that PP2Cα glutathionylation
promotes cancer cell migration potentially by increasing JNK activation.
4.3 Discussion
PP2Cα is a Ser/Thr protein phosphatase that acts as a negative regulator in
various stress induced cellular pathways (264). Among many substrates, PP2Cα
inactivates SMAD2, SMAD3, p38 and JNK MAPK’s (265,275). Several studies have been
reported to have regulatory function and different expression pattern of PP2Cα in
inflammatory homeostasis and wound healing (307). Previously, we identified PP2Cα as
a potential candidate for S-glutathionylation in response to mitochondrial dysfunction. In
this study, we further determined the role of PP2Cα glutathionylation in in cancer cell
migration.
PP2Cα has 11 cysteine residues and several cysteines are buried inside the
structure, thus not directly accessible for ROS or GSH (308). According to the available
crystal structure of PP2Cα, we predicted three potential cysteine residues for
glutathionylation, including Cys204 and Cys314. Both cysteine residues are solvent
exposed as seen in crystal structure (308). In addition, Cys314 is in close proximity with
a positively charged amino acid Lys310. Therefore, it is possible that Cys314 thiol can be
more nucleophilic or reactive. Because Cys238 is in a close distance to catalytic metal
ion in the active site of PP2Cα, we also considered Cys238 as a potential candidate for
glutathionylation. Our study showed that Cys314 is the major glutathionylated cysteine
residue in response to mitochondrial dysfunction. This modification site is further
confirmed by in vitro glutathionylation assay with purified PP2Cα WT and C314S mutant
proteins.

149
protein phosphatase 2A (PP2A) is a heterotrimeric protein where a B-regulatory
subunit seems to govern the substrate specificity (309). However, PP2Cα does not have
a regulatory subunit, its c-terminal α-helix may be involved in substrate specificity (310).
Also, our data confirmed that Cys314 glutathionylation disrupts interaction with mGLUR3,
indicating PP2Cα glutathionylation potentially regulates its function under cellular stress
conditions. On the other hand, PP2Cα glutathionylation did not impact on AMPK
activation, suggesting that the effect of PP2Cα glutathionylation can depend on individual
substrate proteins.
PP2Cα is known to regulate cancer cell migration through dephosphorylation of
TGF-β induced SMAD signaling (263). Also, other substrates of PP2Cα, such as p38 and
JNK are important players of cancer cell migration (311,312). Moreover, in solid tumor,
cells are rapidly proliferating. Cells that grow away from vasculature may encounter with
oxygen and nutrient deprivation (313). Some cancer cells appear to be more aggressive
and invasive under metabolic stress (314). Therefore, we have investigated the role of
PP2Cα glutathionylation in cancer cell migration under metabolic stress.
First, we evaluated global glutathionylation status in different cell lines, including
two breast cancer cell lines, A431, MCF7 and MDA-MB-231. We used adenovirus
expressing GS M4, which allow to express GS M4 in many cell lines with a high
transfection

efficiency.

Using

adenovirus

transduction,

we

could

evaluate

glutathionylation in differentiated cardiomyocyte, A431, MCF7 and MDA-MB-231 cells.
Glutathionylation studies revealed that MDA-MB 231 and A431 cells are more sensitive
for inducing glutathionylation under metabolic alterations. Also, levels of a few redox
enzymes and GS M4 were not significantly different between MDA-MB-231 and MCF7
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cells, indicating the glutathionylation difference is due to higher metabolic stress in MDAMB-231 cells. We also noticed that MDA-MB-231 cells are associated with a higher ROS
level, and a higher sensitivity to low glucose condition when compared to MCF7 cells.

Figure 4.17 – Cell migration induces by PP2Cα glutathionylation under metabolic stress.

Further, glutamate supplementation could rescue MDA-MB-231 cells from
metabolic stress resulting from a low glucose condition. But, glutamine addition did not
recover cells from metabolic stress. It may be explained by the fact that the enzymatic
activity of GLS depends on the availability of phosphate, acetyl-CoA and succinyl-CoA,
and metabolic state of the cells (315,316). Also, in many cancer cells, sirtuin 5 is
overexpressed and involved in desuccinylating GLS to inhibits its catalytic activity
(315,316). Therefore, glutamate availability rather than glutamine may be important for
maintaining redox homeostasis under low glucose.
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Next, we evaluated the functional roles of PP2Cα glutathionylation in cell migration
using MDA-MB-231 cells. Wound healing experiments and transwell invasion assay
revealed that overexpression of PP2Cα WT or C314 significantly inhibited cell migration
under a high glucose concentration. Interestingly, cells expressing PP2Cα WT could
recover its wound healing capacity under a low glucose condition. On the other hand,
cells with PP2Cα C314S could not recover wound healing ability. We also found that
PP2Cα is glutathionylated at C314 position in response to low glucose, indicating PP2Cα
glutathionylation promotes cancer cell migration under metabolic stress. When tumor is
growing away from vasculature, cells are always encounter glucose-oxygen deprivation.
There are number of studies suggesting that cancer cells are more invasive under
metabolic stress. In agreement with other studies, our data collectively provide evidences
that cancer cells are gaining more invasive properties through PP2Cα glutathionylation.
We also found that PP2Cα C314 glutathionylation inhibits its dephosphorylating activity
toward JNK, suggesting that PP2Cα glutathionylation increases cancer cell migration
potentially via activating JNK and subsequent activation of downstream signaling
associated with cell migration.
4.4 Experimental procedure
4.4.1 Cloning and mutagenesis
Human PP2Cα cDNA clone was purchased from OriGene and the gene was
subcloned into pcDNA3.1/hygro (+) mammalian vector using BamHI and XhoI restriction
sites. PCR reaction was performed using a forward primer (5'-GGT GGT GGA TCC GCC
ACC ATG GGA GCA TTT TTA GAC AAG C-3') containing Kozak sequence and BamHI
restriction site and a reverse primer containing HA tag and XhoI restriction site (5'-GGT
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GGT CTC GAG CTA AGC GTA ATC TGG AAC ATC GTA TGG GTA CCA CAT ATC ATC
TGT TGA TGT AGA G-3'). Both PCR product and the empty pcDNA3.1 vector were
double digested with above two restriction enzymes and ligated using T4 DNA ligase. All
the mutants were generated using pcDNA3.1-PP2Cα clone as the template.
QuickChange mutagenesis was performed using following mutagenic primers. PP2Cα
mutant C204S (forward: 5’-GCC CTT GGG GAT TTT GAT TAC AAA AGT GTC CAT
GGA AAA GGT CC-3’ and reverse: 5’-GGA CCT TTT CCA TGG ACA CTT TTG TAA
TCA AAA TCC CCA AGG GC-3’), C238S (forward: 5’-CAG TTC ATT ATC CTT GCA AGT
GAT GGT ATC TGG GAT GTT ATG G-3’ and reverse: 5- CCA TAA CAT CCC AGA TAC
CAT CAC TTG CAA GGA TAA TGA ACT G-3’) and C314S (forward: 5’-GGA CAA GTA
CCT GGA AAG CAG AGT AGA AGA AAT CAT AAA GAA GC 3’ and reverse: 5’-GCT
TCT TTA TGA TTT CTT CTA CTC TGC TTT CCA GGT ACT TGT CC-3’). pcDNA3.1PP2Cα and empty pET28a vectors were double digested using BamHI and XhoI. The
digested PP2Cα and pET28a were gel purified and ligation was performed using T4 DNA
ligase at 22 oC for 1h. To generate adenovirus containing GS M4 gene, flag-GS M4 was
subcloned into Dual-CCM+ shuttle vector.

All plasmids were confirmed by DNA

sequencing of entire open reading frames.
4.4.2 Purification of PP2Cα
pET28a-PP2Cα was transformed in to BL21(DE3) cells and single colony was
incubated overnight in LB containing 50 µg/mL kanamycin. Overnight culture (5 mL) was
diluted into 1 L of LB and grown at 37 oC until OD600 reaches 0.4. Protein overexpression
was induced for 4 h at 37 oC with 0.5 mM IPTG. Cells were harvested, lysed and purified
as described in section 3.3.
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4.4.3 Enzyme assay of PP2Cα
PP2Cα enzyme (WT and C314S) activities were calculated by end point assay
using para-nitrophenyl phosphate (pNPP) as the substrate. Proteins were incubated with
or without 0.5 mM GSSG in 20 mM Tris, pH 7.4 for 15 minutes at 37 oC. Phosphatase
assay was performed in the colorimetric assay buffer containing 20 mM Tris, pH 7.4, 5
mM MgCl2, 1 mM ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid
(EGTA) and 0.1 mg/mL BSA. Different amounts of each protein were mixed with 20 mM
pNPP in 100 µL final volume and incubated for 30 minutes at 37 oC before quenching the
reaction with 50 µL of 5 N NaOH. Enzyme activities (µmoles/min/µg) were calculated
using absorbance measured at 405 nm. Data analyzed by GraphPad Prism (version 5.01)
software.
4.4.4 Mammalian cell culture and transfection
General cell culture and transfection methods were discussed in section 2.5.10
and section 2.5.13.
4.4.5 Adenovirus transduction
Adenovirus production was performed by Vector BioLabs. Briefly, flag-GS M4 was
cloned into dual-CCM+ shuttle vector and then transferred expression cassette to an
adenovirus vector (pAd Vector). Then low-titer viral particles were produced by
transfecting linearized adenoviral DNA to HEK293 cells over couple of weeks. Next, virus
was amplified by growing in a 300 mL culture and then virus was concentrated to 2 mL in
viral storage buffer. Concentration of viral particles was determined by performing a
plaque formation assay. To find out the multiplicity of infection (MOI) of Ad-CMV-GS M4,
different volumes from virus stock (corresponding to MOI- 10, 50 and 100) were infected
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to MDA-MB-231 cells. After cells were reached to 85-90% confluency in 100 mm cell
culture dish, growth medium was replaced with 5 mL of 2% FBS containing DMEM
(without penstrep) and transferred back to the incubator. Viral particles were diluted in
500 μL of 2% FBS containing DMEM medium in the presence of 1 mg/mL Polybrene in a
sterile eppendorf tube. Virus and polycationic transfecting agent (Polybrene) complex was
incubated for 20 minute at room temperature before adding to the cells. After 5-8 h of
virus infection, virus containing medium was replaced with complete growth medium and
incubated for 24 h or 48 h. During the use of virus in cell culture, extreme safety
precautions must be followed. Cell culture dishes, pipette tips, and all other material
should be touched with 10% regular bleach for at least 30 minutes. Cell culture medium
containing virus should not aspirate into regular aspirator setup, instead, all contaminated
medium and other liquids should be disposed in to bleach and final concentration of
bleach should be 10%. Avoiding generation of splashes while transferring medium and
cross contamination with other sterile cell culture medium or other equipment should be
considered. Virus containing liquids on metal surfaces should disinfect with spore-Klenz
for at least 30 minutes. Switching gloves is a must before leaving the cell culture room
and appropriate waste disposal to a trash bin labeled with biohazard sticker for virus.
Regular autoclaving of virus disposals must be maintained at least once a week.
4.4.6 Cell lysis
General mammalian cell lysis was described in section 2.5.14.
4.4.7 Click reaction and biotin pull-down
Click reaction and biotin pull-down experiments were described in section 2.5.18
and section 2.5.23.
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4.4.8 Proximity ligation assay
HEK293-GS M4 stable cells were transfected with PP2C WT and C314S mutant
using PEI-max as the transfecting agent. After 24 h of transfection, 0.6 mM of L-AzAla
was incubated for another 20 h and induced for glutathionylation using 1 mM H 2O2 for 15
minutes. After induction, cells were washed several times with cold PBS, and fixed for 15
minutes using ice cold methanol at -20 0C. After fixation, cells were then permeabilized
with 1X PBST (pH-7.4, 10 mM Na2HPO4, 1.8 mM KH2PO4, 150 mM NaCl, 0.1% TrionX100) for 10 minutes at room temperature. Cells were washed three more times with PBS
and subjected to click reaction with biotin-alkyne. Briefly, click reaction mixture was
prepared by using the same protocol described in section 2.5.18. In this procedure, TBTA
was replaced with THPTA (Tris(3-hydroxypropyltriazolylmethyl)amine) because of water
solubility. Individual cover slips were incubated with 100 μL of click reaction mixture at 37
0Chumidified

incubator. Cover slips were then washed at least three times with 10-minute

incubation at room temperature. Then, cells were incubated in the blocking buffer (pH7.4, 10 mM Na2HPO4, 1.8 mM KH2PO4, 150 mM NaCl, 0.3% Trion-X100, 5% BSA) for 1
h at room temperature. Primary antibodies against PP2Cα (mouse anti-HA, 1:100 dilution)
was prepared in the blocking buffer and incubated with cells for 16 h (overnight) at 4 oC.
Cells were washed three times with PBS and primary antibodies against biotin (rabbit
anti-biotin, 1:100 dilution) was incubated for 1 h at room temperature followed by three
washings with PBS. PLA probes were diluted in 1:5 ratio with blocking buffer (for 40 μL
of final antibody solution, 8 μL from each minus and plus PLA probes were mixed with 24
μL of blocking buffer) and incubated with individual slides for 1 h in a humidified incubator
at 37 oC. After incubation of PLA probes, cover slips were washed two times with Duolink
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wash buffer A for 10 minutes. Ligation mixture was prepared by diluting ligation buffer in
1:5 ratio with distilled water and 1 μL of ligase (1:40) was added just before the incubation.
Ligation step was carried out at 37 0C in a humidified incubator for 30 minutes.
Amplification-polymerase reaction mixture was prepared by diluting amplification stock
1:5 in distilled water and 0.5 μL of polymerase enzyme (1:80) was mixed at the time of
incubation. After 30 minutes of ligation, cells were washed tice with 1X Duolink wash
buffer A or 5 minutes. Soon after washings, cells were incubated with amplificationpolymerase reaction mixture for 100 minutes at 37 0C. After amplification, cells were
washed twice with 1X Duolink wash buffer B for 15 minutes and anti-mouse secondary
antibody conjugated to Alexa-488 was incubated for 1 h at room temperature to detect
total PP2Cα levels. After three times washings with 1X Duolink wash buffer B, cells were
washed once with 0.01X wash buffer B and mounted on microscope slides with a
mounting solution containing DAPI. Fluorescence images were captured using Leica
DMi8 inverted confocal microscope and images were processed by LAS AF analysis
software. Microscope filters were set for nucleus staining with a DAPI channel (λex 350nm,
λem 470nm), for proximity ligation signal with Texas Red channel (λex 594 nm, λem 624 nm)
and for total PP2Cα with Alexa-488 (λex 490 nm, λem 525 nm).
4.4.9 Co-immunoprecipitation
After transfection of PP2Cα WT and C314S mutant, cells were induced for
glutathionylation with 2 μg/mL AMA treatment in the absence of glucose for 2 h. Coimmunoprecipitation was performed after lysing cells using the protocol described in
section 4.4.7. HEK293-GS M4 cells were transfected with PP2Cα WT and C314S mutant
and incubated for glucose starvation with antimycin A. Cells were then lysed using a lysis
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buffer PBST (pH-7.4, 50 mM Tris-HCl, 150 mM NaCl, 0.1% Tween) without NEM. Lysates
(1 mg/0.5 mL) were incubated with mouse mGluR3 primary antibody (3 µg) at 4°C for 1
h, mixed with pre-washed protein G agarose beads (30 µL), and incubated overnight at
4°C. Beads were then washed three times with PBST (pH-7.4, 50 mM Tris-HCl, 150 mM
NaCl, 0.1% Tween) for 10 min each time. Beads were eluted with a SDS-loading buffer
in the presence of β-mercaptoethanol. Eluted proteins were separated by SDS-PAGE,
transferred to PVDF membrane, and incubated with primary mouse mGluR3 or rabbit
PP2Cα antibodies in a TBST buffer (Tris HCl 50 mM, NaCl 150 mM, 0.1% Tween 20, 3%
BSA) overnight at 4°C. HRP-conjugated light chain specific secondary mouse and rabbit
antibodies were incubated for 1 h at room temperature. After washing 3 times with a TBST
buffer, immunoprecipitated proteins were visualized by chemiluminescence.
4.4.10 SDS-PAGE and Western blotting
SDS-PAGE and Western blotting were conducted using the protocol described in
section 2.5.15 and 2.5.17.
4.4.11 DCF assay for ROS detection
HEK293 cells (10,000 cells per well) were seeded and incubated at 37 oC, 5% CO2
for 24 h for attachment on 96-well black plates with transparent flat bottom. Cells were
then washed with warm PBS, and incubated in serum-free medium for 3 h. 2,7dichlorodihydrofluorescein diacetate (DCFH-DA, 25 µM) was then added, and cells were
incubated in the same conditions for another 1 h. Cells were then washed with glucosefree medium without phenol red, followed by treatment at the indicated conditions and
incubated for 2 h. Untreated cells acted as a negative control. Fluorescence emission
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scan was measured at 528 nm after excitation at 485 nm. ROS levels were normalized
using a negative control (25 mM glucose without antimycin A).
4.4.12 Wound healing assay
MDA-MB-231 cells were transfected with PP2Cα WT and C314S using
lipofectamine 3000 (ThermoFisher, catalog number L3000015) transfecting agent
according to the manufacturer’s instructions. After 24 h of transfection, approximately
similar number of non-transfected and transfected cells (1X107) were seeded on a 12well plate and incubated for another 24 h. Next, an even wound was created using a
sterile 10 L pipette tip across the well and washed with warm PBS twice to remove any
floating cells. This time point was considered as the 0 h and cells were incubated in 25
mM and 10 mM glucose containing medium for 36 h. Images of wounded area were
captured at 0 h and after 36 h using a camera attached to a microscope. Images were
analyzed by ImageJ software using MRI Wound Healing Tool. Briefly, an image can be
opened by clicking on file and then hitting on open button. Once image is uploaded to the
program, right click on ‘’m’’ button and set the method to find edges, variance filter radius
to 10, threshold to 50, radius open to 4 and adjust min.size according to the picture quality
or use default setting. Before analyzing the images, option black background was
selected by following process>binary>options. Then, images analyzed by clicking on
‘’m’’. The area of the open wound will be calculated and give as number with arbitrary
units. By subtracting the area of the wound at 36 h from the area of the wound at 0 h,
percent migration was calculated and data from three independent trial were showed as
a bar graph using GraphPad Prism software.
4.4.13 Transwell invasion assay

159
On the first day, MDA-MB-231 cells were transfected with PP2Cα WT and C314S
using Lipofectamine 3000 according to the manufacturer’s protocol and incubated for 24
h. On the same day, 0.5X Basement Membrane Extract (BME) was prepared by diluting
5X BME stock solution in 1X Travigen Inc coating buffer. Briefly, 100 μL of 10X coating
buffer was diluted in 900 μL of sterile water. Then 900 μL of 1X coating buffer was mixed
with 100 μL of 5X BME to make working 0.5X BME solution. Six Corning transwell
permeable inserts were placed on six well of 24-well plate separately. Then 100 μL of
0.5X BME solution was added to each transwell insert and incubated overnight. Following
day, transfected cells were trypsinized and similar number of non-transfected and
transfected cells (~3X105 cells) were seeded on all six transwell inserts. Trypsinized cells
were mixed with glucose free medium and approximately 100 μL from each cell
suspension was added to appropriate transwell inserts followed by another 100 μL from
50 mM and 20 mM glucose containing, but FBS free medium to get final 25 mM and 10
mM glucose concentrations respectively. Lower chamber was filled with 10% FBS
containing medium without glucose. Whole setup was incubated in mammalian cell
culture incubator for 24 h. After 24 h, cell culture medium was removed from both lower
and upper chambers and washed three times with PBS. Non-invasive cells were removed
using a cotton swab and bottom side of the membrane of transwell inserts were fixed with
4% formaldehyde for 10 minutes at room temperature followed by permeabilization with
PBST (pH-7.4, 50 mM Tris-HCl, 150 mM NaCl, 0.1% Triton-X100) for another 10 minutes.
Inserts were washed once with PBS and stained with 0.2% (W/V) crystal violet solution
for 20 minutes at room temperature. Inserts were then extensively washed with PBS to
remove all excess dye. Imagers were captured using a camera attached to a microscope.
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After taking pictures, stained dye was extracted with 300 µL of 33% acetic acid and
absorbance was measured at 560 nm using a plate reader. Similar invasion assay was
performed to A431 cells without transfection of PP2Cα.
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APPENDIX A - CHAPTER 2 SUPPORTING FIGURES

Figure A.2.1 – SDS-PAGE analysis of the purity of GS WT and GS mutants. A) Purified
proteins were diluted to 1 μg/mL working concentrations and boiled with SDS loading dye in the
presence of reducing agents. Protein samples were separated from SDS-PAGE and stained with
Coomassie blue and captured. B) After overexpression lysis, GS M4 was purified by Ni-NTA
beads. A portion of 5 μL from lysate, flow through (FT), washings (W1, W2) and elution (E1, E2,
etc) was loaded to SDS-PAGE and analyzed by Coomassie staining. C) To measure the
concentrations of purified GS mutants, protein band intensities were compared to BSA standards.
According to gel comparison and Bradford assay, purified GS M4 concentration was ~ 8 mg/mL.
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Figure A.2.2 – Kinetic analysis of GS WT and GS M4 mutant. Different concentrations of each
substrate were analyzed by measuring the absorbance at 340 nm. To calculate initial rates for
each concentration, initial absorbance data was plotted against time and slope was calculated.
Then Michaelis-Menten constants were calculated by plotting initial rates against different
substrate concentrations.
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Figure A.2.3 – LC-MS analysis of in vitro GS enzyme assay reaction mixture. A) Ion
extraction for FL-IA modified endogenous GSH and mass spectra showing m+1 for FL-IA modified
GSH. B) Ion extraction for different GSH derivatives and m+1 for GSH, azido-GSH and Met-GSH.
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Figure A.2.4 – LC-MS analysis of L-AzAla dose dependent azido-GSH biosynthesis. After
transient transfection of GS M4, HEK293 cells were incubated with increasing concentrations of
L-AzAla for 20 h. Protein free lysates were analyzed by LC-MS and masses corresponding to
different glutathione derivatives were extracted and overlaid.
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Figure A.2.5 – Glutathionylated proteome visualized by rhodamine-alkyne or biotin alkyne.
Different concentrations or 1 mM of L-AzAla incubated with HEK293 stable cells with or without
overexpression of GS M4, for 20 h. Cells were then induced for glutathionylation with or without
H2O2. After induction, cell lysates were subjected to click reaction either with biotin-alkyne or
rhodamine-alkyne. Glutathionylation was analyzed by in-gel fluorescence or by Western blotting.
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Figure A.2.6 – Analysis of glutathionylation in different cell lines using azido-GSH. GS M4
transfected using PEI-max. After 24 h, 1 mM L-AzAla was incubated for 20 h and glutathionylation
was induced with H2O2 for 15 minutes. Glutathionylation levels analyzed in different cells by
analyzing in-gel fluorescence after performing click reaction with fluorophore-alkyne.
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APPENDIX B – CHAPTER 3 SUPPORTING FIGURES

Figure B.3.1 – Glutathionylation in response to 13 h glucose deprivation. L-AzAla incubated
with HEK293-GS M4 cells and induced for glutathionylation by incubating glucose free medium
for 13 h. Lysates were analyzed for glutathionylation after performing the click reaction with biotinalkyne.
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Figure B.3.2 – Glutathionylation in response to CoCl2 induced hypoxia and glucose
deprivation. L-AzAla incubated with HEK293-GS M4 for 20 h. Cells were washed with PBS and
treated with different concentrations of CoCl2 with or without glucose for 6 h. After cell lysis, cell
lysates were subjected to click reaction with Cy5-alkyne and analyzed by in-gel fluorescence.
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Figure B.3.3 – Analysis of glutathionylation in response to oxygen-glucose deprivation and
reoxygenation (OGD/R). HEK293-GS M4 cells were induced for glutathionylation by incubating
glucose free medium under high (21%) and low (1%) oxygen concentrations for 13 h. After
hypoxic condition, cells were incubated under high oxygen (21%) environment for 15 minutes and
60 minutes or immediately lysed. After lysis, cell lysates were subjected to click reaction and
analyzed for in-gel fluorescence.
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Table B.3.1 - A list of glutathionylated proteins identified in mass analysis that have a
high spectral count and a high enrichment in the positive over negative sample.
aNeg
bLoc

and Pos = spectral count of the negative and positive samples, respectively.
= Localization (C: cytosol, N: nucleus, EC: extracellular, L: lysosome, M:

mitochondrion)
cFunction

= molecular function determined by DAVID GO analysis

dProcess

= biological processes determined by DAVID GO analysis

eG
fS

= glutathionylation proteomic result by exogenous H2O2

= sulfenylation proteomic result by exogenous H2O2

Neg

Pos

Loc

a

a

b

Functionc

Gene

Protein

ACE

Angiotensin-converting
enzyme

0.0

79.8

EC

Peptidase

TBA1A

Tubulin alpha-1A chain

0.0

59.5

C

GTPase

CTPS1

CTP synthase 1

0.0

43.5

C

ligase

0.0

35.0

C

ATP
binding

0.0

30.5

C

Ligase

RRM1
GMPS
PPP2R
1A
NPEPP
S
DHX15

GSPT1

Ribonucleosidediphosphate reductase
large subunit
GMP synthase
Serine/threonine-protein
phosphatase 2A 65 kDa
regulatory subunit A
alpha isoform
Puromycin-sensitive
aminopeptidase
Putative pre-mRNAsplicing factor ATPdependent RNA helicase
Eukaryotic peptide chain
release factor GTPbinding subunit ERF3A

Processd

Ge

Sf

+

-

+

-

-

+

-

+

-

+

Apoptosis

-

-

Cell
proliferatio
n
Cell
division
B cell
proliferatio
n
Cell
proliferatio
n
Metabolic

0.0

29.0

C

Phosphat
ase
regulatory

0.0

28.8

C, N

Peptidase

Stress
response

-

-

0.0

28.3

N

Helicase

mRNA
processing

+

-

0.0

24.8

C

GTPase

Cell cycle

-

+

171

PARP1
NAA15

Poly [ADP-ribose]
polymerase 1
N-alphaacetyltransferase 15,
NatA auxiliary subunit

0.0

23.5

N

Glycosyltr
ansferase

DNA repair

+

-

0.0

23.0

C

Acetyltran
sferase

Angiogene
sis

+

+

0.0

20.0

C

Ligase

Protein
biosynthesi
s

-

+

Proteolysis

-

+

proteolysis

-

-

-

-

-

-

VARS

Valine-tRNA synthetase

CAND1

Cullin-associated
NEDD8-dissociated
protein 1

0.0

19.5

C, N

CSTB

Cystatin-B

0.0

19.0

C, N

0.0

18.0

C, N

Peptidase

DNA repair

0.0

18.0

C,N

Endonucl
ease

Tubulin alpha-3C/D chain

0.0

18.0

C

GTPase

Tripeptidyl-peptidase 2
Histone-binding protein
RBBP7
Heat shock 70 kDa
protein 4L
Microtubule-associated
protein 4
Heat shock protein 105
kDa

0.0

17.5

C, N

0.0

16.8

N

0.0

16.8

C, N

0.0

16.3

C

0.0

15.8

C

TIP41-like protein

0.0

14.8

C

Peptidase
RNA
binding
Chaperon
e
Microtubul
e binding
ATP
binding
PP2A
inhibitor

rRNA
processing
Protein
folding
Proteolysis
DNA
replication
Stress
response
Cell
division
Stress
response

0.0

14.8

C, N

0.0

14.5

0.0

USP7
DIS3
TUBA3
D
TPP2
RBBP7
HSPA4
L
MAP4
HSPH1
TIPRL
HUWE1
PPP2R
2A
MCMB
P

Ubiquitin carboxylterminal hydrolase 7
Exosome complex
exonuclease RRP44

E3 ubiquitin-protein
ligase
Serine/threonine-protein
phosphatase 2A 55 kDa
regulatory subunit B
alpha isoform
Mini-chromosome
maintenance complexbinding protein

Ubiquitin
conjugatio
n
Peptidase
inhibitor

+

+

+

-

-

+

+

+

-

+

Cell cycle

+

-

Ligase

DNA repair

-

+

C

Phosphat
ase

Cell cycle

-

+

14.3

N

Chromatin
binding

Cell cycle

+

-

+

+

-

-

UBA6

Ubiquitin-like modifieractivating enzyme 6

0.0

14.3

C

ATP
binding

USP5

Ubiquitin carboxylterminal hydrolase 5

0.0

14.3

L

Hydrolase

Protein
ubiquitinati
on
Protein
catabolism
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SNRNP
200
GSTM3
DNM1L
KHSRP

AIMP2
PABPC
4
NCAPD
2
MARS

U5 small nuclear
ribonucleoprotein 200
kDa helicase
Glutathione Stransferase Mu 3
Dynamin-1-like protein
Far upstream elementbinding protein 2
Aminoacyl tRNA
synthase complexinteracting multifunctional
protein 2
Polyadenylate-binding
protein 4
Condensin complex
subunit 1
Methionine--tRNA ligase,
cytoplasmic

0.0

14.3

N

0.0

14.0

C

0.0

14.0

C

0.0

14.0

N

0.0

14.0

C, N

0.0

14.0

C

0.0

14.0

N

0.0

13.8

C

UNC45
A

Protein unc-45 homolog
A

0.0

13.8

C

STIP1

Stress-inducedphosphoprotein 1

0.0

13.5

C, N

CORO1
C

Coronin-1C

0.0

12.8

C

0.0

12.5

N

0.0

12.5

C

0.0

12.0

C, N

0.0

12.0

MSH6
IARS
PABPC
1
EIF4G1

SPAG9

KHDRB
S1

PSMD2
ABCE1

DNA mismatch repair
protein Msh6
Isoleucine--tRNA ligase,
cytoplasmic
Polyadenylate-binding
protein 1
Eukaryotic translation
initiation factor 4 gamma
1
C-Jun-amino-terminal
kinase-interacting protein
4
KH domain-containing,
RNA-binding, signal
transduction-associated
protein 1
26S proteasome nonATPase regulatory
subunit 2
ATP-binding cassette
sub-family E member 1

Helicase

mRNA
processing

Glutathion
e binding
Hydrolase
DNA
binding

Detoxificati
on
Apoptosis
mRNA
processing

Developm
ent-al
protein
mRNA
binding
Chromatin
binding
tRNA
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APPENDIX C – CHAPTER 4 SUPPORTING FIGURES

Figure C.4.1 – Glutathionylation in response to mitochondrial dysfunction in PP2Cα
transfected HEK293-GS M4 cells. PP2C transfected to HEK293-GS M4 using PEI-max and
after 24 h, L-AzAla was incubated with Cells. After 20 h, cells were washed with PBS and
incubated with 2 μg/mL AMA with or without glucose. Lysates were subjected to click reaction
with biotin-alkyne and incubated with streptavidin agarose beads. After incubation bound protein
were eluted and probed with strep-HRP, anti-HA and anti-PTP1B.
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Figure C.4.2 – Cellular GSH levels in MCF7 and MDA-MB-231 cells. MDA-MB-231 and MCF7
cells were infected with adenovirus for the overexpression of GS M4. After 24 h, L-AzAla
incubated with cells for 20 h. Cells were induced for glutathionylation by incubating different
concentrations of glucose for 5 h. Cells were trypsinized and collected by centrifugation. Cells
were lysed using several freeze-thaw cycles and protein free lysates were subjected to the
bromobimane assay.

Figure C.4.3 – Glutathionylation in response to oxygen-glucose deprivation (OGD) and
reoxygenation (OGD/R) in MDA-MB-231 cells. MDA-MB-231 cells were infected with
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adenovirus having GS M4 gene. After 24 h, L-AzAla was incubated for another 20 h and induced
for glutathionylation in low glucose medium under normal oxygen (21%) or low oxygen
concentration (1%) for 5.5 h. After 5.5 h, cells were immediately lysed or incubated in normal
oxygen environment for 30 minutes. Cell lysates were subjected to click reaction with Cy5-alkyne
and analyzed for in-gel fluorescence.

Figure C.4.4 – Glutamine metabolism and redox homeostasis. Glutaminase (GLS) catalyzes
glutamate synthesis using glutamine as the substrate. Glutamate enters TCA cycle and takes part
in NADPH and pyruvate production. Glutamate also a precursor for GSH biosynthesis.
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ABSTRACT
DEVELOPMENT OF CHEMICAL TOOLS TO INVESTIGATE
PROTEIN S-GLUTATHIONYLATION IN RESPONSE TO METABOLIC ALTERATION
by
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Degree: Doctor of Philosophy
Oxidative stress is a common characteristic of age-related diseases such
as vascular diseases, diabetes and cancer. Many diseases are known to be regulated by
glutathionylation. Glutathionylation is referred to as the formation of disulfide bond
between a protein cysteine and a glutathione. To understand the molecular mechanisms
behind the disease initiation and progression, identification of such glutathionylated
proteins is important. Even though existing methods have been widely used, several
limitations of these methods hinder the identification of such proteins in disease
conditions. Therefore, we developed a versatile chemical method that generates clickable
glutathione inside the cells. In this method, we generated a mutant form of glutathione
synthetase (GS M4) to metabolically synthesize clickable glutathione for studying and
identifying proteins in disease conditions. Using clickable glutathione approach, we
uncovered a regulatory role of glucose metabolism in glutathionylation. Also, we have
identified over 1400 of glutathionylated proteins in response to mitochondrial dysfunction
and glucose deprivation, a common characteristic found in metabolic disorders.
Moreover, we have identified several new glutathionylated proteins including ser/thr

236
protein phosphatase 2Cα (PP2Cα). Further, we uncovered a new role for PP2Cα
glutathionylation that promotes cancer cell migration through the activation of JNK in
response to metabolic alterations.
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